Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3027273	vb-ahco3	mmol/l (mmol/l)	10086	37206	0.00%
3027273	vb-shco3	mmol/l (mmol/l)	6903	21019	0.00%
3027273	vp-shco3	mmol/l (mmol/l)	1311	7251	0.00%
3027273	vb-ahco3	— (—)	1115	1860	100.00%	Distribution not available
3027273	vb-ahco3vt	— (—)	302	409	100.00%	Distribution not available
3027273	vb-hco3	mmol/l (mmol/l)	283	1151	0.00%
3027273	vb-he-tase,vb-hco3	mmol/l (mmol/l)	240	330	0.00%
3027273	vb-ahco3vt	mmol/l (mmol/l)	236	353	0.00%
3027273	vb-shco3	— (—)	137	187	100.00%	Distribution not available
3027273	vb-hco3	— (—)	120	144	100.00%	Distribution not available
3027273	vb-hco3	mmo/l (mmol/l)	48	55	0.00%
3027273	vb-vekaas5,chco3	mmol/l (mmol/l)	44	75	0.00%
3027273	vp-hco3st	mmol/l____ (mmol/l)	41	102	0.00%
3027273	vp-shco3	— (—)	38	47	100.00%	Distribution not available
3027273	vbhco3pika	mmol/l (mmol/l)	24	26	0.00%
3027273	vp-hco3st	mmol/l (mmol/l)	15	21	0.00%
3027273	vb-ahco3	mmol/L (mmol/l)	14	19	0.00%
3027273	vp-hco3st	— (—)	5	7	100.00%	Distribution not available	Distribution not available
3027273	vb-ahco3	MMOL/L (mmol/l)	5	5	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Nausea and vomiting

1463

4889

3.12

321.70

5.9

3.2

24.99

25.25

mmol/l

1.84

1411

4730

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3920

12631

2.02

318.01

5.5

2.9

24.98

25.30

mmol/l

6.56

3811

12187

Extracorporeal dialysis

587

1087

6.80

317.54

19.8

3.1

23.62

25.23

mmol/l

20.97

573

1044

Bacterial pneumoniae

2049

7318

2.60

314.70

5.5

2.9

25.79

25.05

mmol/l

13.48

1965

7100

Kidney transplant status

486

751

8.11

313.89

17.8

3.1

23.23

25.17

mmol/l

23.83

474

721

Transplanted organ and tissue status

697

1504

5.34

310.19

14.3

2.9

23.76

25.30

mmol/l

22.88

676

1451

Insulin, fast-acting or short human

2267

7462

3.30

307.65

6.2

3.3

24.96

25.17

mmol/l

1.69

2197

7214

Insulin, intermediate and long-acting

3540

11420

3.25

307.65

5.2

3.2

24.89

25.29

mmol/l

7.46

3441

11035

Disorders of lipoprotein metabolism and other lipidaemias

3607

9991

2.28

307.65

4.2

2.9

25.12

25.35

mmol/l

3.28

3490

9681

Pain in throat and chest

3444

9017

2.34

307.65

3.9

3.1

25.35

25.12

mmol/l

3.38

3323

8694

Influenza and pneumonia

4883

12509

2.51

307.65

4.9

2.9

25.38

25.14

mmol/l

4.17

4713

12102

STROKE

2334

5572

2.96

307.65

4.1

2.6

25.29

25.51

mmol/l

2.32

2261

5394

Angina pectoris

2814

7610

2.60

307.65

4.4

3.0

25.39

25.34

mmol/l

0.28

2724

7383

Persons encountering health services for specific procedures and health care

4979

11908

2.58

307.65

5.3

2.7

25.15

25.25

mmol/l

0.98

4814

11490

Bacterial infection, other or unspecified, including avohilmo

3765

9635

3.47

307.65

6.2

2.8

24.97

25.36

mmol/l

8.28

3641

9338

Renal failure

3801

9410

3.86

307.65

7.8

2.7

23.90

25.54

mmol/l

109.84

3686

9115

Type 2 diabetes, strict (exclude DM1)

4037

9918

2.46

307.65

3.7

3.0

25.12

25.47

mmol/l

7.10

3931

9548

Dyspnoea

4351

13874

2.37

307.65

4.5

3.2

25.45

25.17

mmol/l

5.36

4225

13412

All pneumoniae

4776

12873

2.52

307.65

4.9

3.0

25.41

25.14

mmol/l

4.99

4610

12450

Implicit bacterial Sepsis, including avohilmo

3040

8304

3.32

307.65

6.4

2.8

24.96

25.30

mmol/l

4.38

2915

8075

Type 2 diabetes

4475

10051

2.70

307.65

4.3

3.0

25.07

25.45

mmol/l

9.09

4357

9676

Care involving use of rehabilitation procedures

3508

10846

3.10

307.65

4.7

2.7

25.42

25.26

mmol/l

1.79

3392

10470

Fever of other and unknown origin

2998

8577

3.21

307.65

5.2

2.9

25.12

25.17

mmol/l

0.27

2914

8271

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4422

14030

2.21

307.65

5.5

3.0

24.80

25.38

mmol/l

20.56

4279

13565

All chronic kidney diseases

3897

8643

3.96

307.65

7.6

2.5

24.19

25.58

mmol/l

88.61

3794

8371

Diabetes mellitus

4701

10377

2.74

307.65

4.3

3.0

25.06

25.43

mmol/l

8.70

4566

9989

Acute tubulo-interstitial nephritis

3080

10221

2.68

307.65

5.1

2.5

24.92

25.59

mmol/l

19.06

2978

9894

Other septicaemia

2583

7457

3.58

307.65

6.5

2.8

24.67

25.30

mmol/l

12.78

2479

7226

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4693

13021

2.51

307.65

5.0

3.0

25.42

25.15

mmol/l

5.07

4538

12590

Codes for special purposes

3832

10454

4.01

307.65

4.5

3.4

25.48

25.12

mmol/l

8.28

3747

10104

4144

9798

2.58

307.65

5.0

2.8

25.44

25.11

mmol/l

6.23

4008

9475

Nephropathy related operations

1042

2250

5.53

307.65

15.9

2.9

23.61

25.26

mmol/l

38.41

1011

2173

Other bacterial diseases, including avohilmo

5196

11873

2.88

307.65

5.2

2.7

25.05

25.36

mmol/l

7.10

5025

11473

Type 2 diabetes, definitions combined, including avohilmo

3977

9675

2.47

307.65

3.7

3.0

25.14

25.46

mmol/l

6.19

3874

9311

Any reimbursement code in KELA

1660

2627

3.26

307.65

4.1

1.9

25.12

25.43

mmol/l

2.60

1598

2520

Heart failure,strict

3134

7297

3.25

307.65

5.5

2.6

25.35

25.20

mmol/l

1.17

3032

7085

Renal tubulo-interstitial diseases

5200

12122

3.37

307.65

6.2

2.5

24.49

25.58

mmol/l

71.88

5040

11720

Other septicaemia, including avohilmo

2625

7577

3.56

307.65

6.4

2.8

24.67

25.31

mmol/l

13.22

2519

7344

Asthma, unspecified (mode), excluding more controls

2066

5749

2.67

307.65

4.2

2.6

25.74

25.16

mmol/l

9.73

1987

5564

Chronic kidney disease

2655

7093

4.09

307.65

9.3

2.7

23.82

25.49

mmol/l

90.13

2579

6877

Other heart diseases

1936

2968

4.47

307.65

5.4

2.3

25.29

25.43

mmol/l

0.83

1861

2856

Cardiac arrhythmias

2179

4131

3.53

307.65

4.2

2.7

25.37

25.46

mmol/l

0.49

2099

3974

Hard cardiovascular diseases

3542

9068

2.41

307.65

4.6

3.1

25.26

25.36

mmol/l

0.87

3436

8768

Cardiovascular diseases (excluding rheumatic etc)

2076

3586

3.43

307.65

4.7

2.3

25.12

25.31

mmol/l

1.45

1988

3446

Other bacterial diseases

5284

12088

3.08

307.65

5.3

2.7

25.04

25.37

mmol/l

7.64

5110

11685

Speech therapy

1912

5145

4.20

307.65

4.7

3.5

25.54

25.19

mmol/l

4.04

1885

4973

Ischemic heart diseases

3492

9633

2.25

307.65

4.7

3.1

25.22

25.35

mmol/l

1.27

3378

9327

Hypertensive diseases (excluding secondary)

2011

2902

4.23

307.65

5.1

2.2

25.05

25.48

mmol/l

4.81

1934

2795

Presence of cardiac and vascular implants and grafts

2449

7650

2.51

307.65

4.6

3.0

25.12

25.22

mmol/l

0.70

2382

7409

Cerebrovascular diseases (FINNGEN)

1273

2126

4.44

307.65

4.5

2.2

25.27

25.59

mmol/l

2.32

1232

2052

Bacterial infection, other or unspecified

3482

9248

3.45

307.65

6.4

2.8

25.00

25.34

mmol/l

5.95

3366

8972

Type 1 diabetes, wide definition, subgroup 1

1150

2792

4.48

307.65

6.4

3.2

24.89

25.31

mmol/l

3.04

1107

2678

Implicit Sepsis

4193

11229

2.93

307.65

5.5

2.8

25.02

25.36

mmol/l

6.02

4039

10901

Implicit Sepsis, including avohilmo

4266

11655

2.76

307.65

5.4

2.7

25.02

25.36

mmol/l

6.40

4106

11315

Care involving dialysis

748

1230

7.51

307.65

18.4

2.7

23.50

25.02

mmol/l

22.91

731

1180

Hyperlipidaemia, other/unspecified

2105

7325

2.76

307.65

4.4

2.9

25.23

25.31

mmol/l

0.44

2076

7118

Atrial fibrillation and flutter

1405

2000

4.84

307.65

4.6

2.1

25.40

25.64

mmol/l

1.48

1352

1934

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

4172

11527

2.55

307.65

5.1

2.8

25.02

25.36

mmol/l

6.25

4001

11203

Abnormalities of breathing

3752

9111

2.44

307.65

4.5

3.1

25.36

25.11

mmol/l

3.73

3641

8785

Anaemias

976

693

9.63

307.65

7.4

2.3

24.75

25.38

mmol/l

4.07

937

659

Explicit Sepsis

2886

8367

3.42

307.65

6.3

2.7

24.74

25.29

mmol/l

11.27

2770

8124

Implicit bacterial Sepsis

2851

7850

3.41

307.65

6.5

2.8

24.97

25.31

mmol/l

3.88

2737

7631

Hypertensive diseases

3102

6427

2.84

307.65

4.8

2.6

25.10

25.43

mmol/l

5.09

2986

6209

Condition for Implicit Sepsis (Organ dysfunction codes)

4207

11586

2.64

307.65

5.3

2.7

24.98

25.38

mmol/l

8.10

4041

11258

Bacterial Sepsis

3161

8454

3.37

307.65

6.4

2.7

24.99

25.31

mmol/l

4.00

3033

8219

Erysipelas, including avohilmo

3291

10733

2.37

307.65

4.7

2.7

25.25

25.39

mmol/l

1.22

3194

10382

Type 2 diabetes, wide definition

4449

9169

3.27

307.65

4.5

3.0

25.05

25.49

mmol/l

10.91

4328

8839

Covid-19 confirmed case

1979

7868

2.68

307.65

5.5

3.4

25.34

25.09

mmol/l

2.40

1910

7603

Percutaneous Coronary Intervention

3541

9454

2.38

307.65

4.8

3.1

25.20

25.36

mmol/l

1.76

3430

9157

Type 1 diabetes, wide definition

1164

3070

4.10

307.65

6.5

3.2

24.89

25.31

mmol/l

3.16

1121

2948

Major coronary heart disease event

3691

10124

2.28

307.65

4.7

3.1

25.22

25.36

mmol/l

1.52

3578

9799

Atrial fibrillation and flutter with reimbursement

1250

1597

5.32

307.65

4.0

2.1

25.38

25.58

mmol/l

1.02

1208

1546

Erysipelas

2673

9873

2.45

307.65

4.8

2.7

25.29

25.35

mmol/l

0.35

2594

9567

Type 2 diabetes, definitions combined

4021

9855

2.47

307.65

3.7

3.0

25.13

25.47

mmol/l

6.77

3915

9489

General symptoms and signs

4390

9495

2.40

307.65

4.4

2.9

25.25

25.19

mmol/l

0.49

4255

9144

Heart failure, strict

3430

9228

2.78

307.65

5.4

3.1

25.36

25.14

mmol/l

2.38

3317

8955

Emergency coronary revascularization (for ACS)

3923

10766

2.30

307.65

4.6

3.2

25.18

25.35

mmol/l

1.96

3797

10429

Metabolic disorders

4526

10724

2.65

307.65

5.0

2.9

25.09

25.33

mmol/l

3.82

4378

10376

Hypertension, essential

3107

6319

2.90

307.65

4.3

2.5

25.16

25.44

mmol/l

3.77

2997

6105

Hypertensive heart and/or renal disease

1560

3113

3.99

307.65

5.8

2.6

25.07

25.31

mmol/l

1.43

1532

3036

Septicaemia

2830

8024

3.51

307.65

6.3

2.8

24.74

25.30

mmol/l

11.13

2719

7773

Hypertension

3099

6425

2.83

307.65

4.8

2.6

25.09

25.43

mmol/l

5.12

2983

6207

Infections, IBD-co-morbidities

791

943

6.35

307.65

7.3

2.6

24.69

25.29

mmol/l

3.40

762

907

Cardiovascular diseases

1786

3095

3.16

307.65

4.7

2.3

25.11

25.24

mmol/l

0.80

1711

2969

All-cause Heart Failure

3380

9117

2.77

307.65

5.4

3.1

25.38

25.14

mmol/l

2.64

3269

8849

Insulin, combination of fast acting with intermediate-acting or long-acting

3831

12135

3.09

307.65

5.3

3.2

24.87

25.29

mmol/l

9.19

3720

11726

Acute renal failure

1686

4802

3.97

307.65

7.4

2.7

23.73

25.47

mmol/l

46.86

1626

4647

Pneumonias (Asthma/COPD co-morbidities)

4756

12873

2.52

307.65

4.9

2.9

25.42

25.15

mmol/l

4.93

4595

12443

Heart failure and antihypertensive medication

1459

1735

6.02

307.65

6.4

2.5

25.39

25.62

mmol/l

1.05

1414

1689

Endocrine, nutritional and metabolic diseases

2765

5301

2.72

307.65

4.3

2.5

25.06

25.43

mmol/l

5.25

2663

5098

Other (not insulin) diabetes medications

4316

10834

2.44

307.65

3.8

3.1

25.07

25.43

mmol/l

7.70

4197

10447

Non-invasive ventilation

1347

1853

6.82

307.65

5.0

2.5

26.01

25.53

mmol/l

3.09

1202

1797

Heart failure and coronary heart disease

2571

6380

3.06

307.65

5.7

3.1

25.25

25.24

mmol/l

0.06

2485

6186

Pneumonia, organism unspecified

4286

12145

2.53

307.65

5.0

2.9

25.41

25.15

mmol/l

4.43

4152

11758

Implicit viral Sepsis

1432

4034

3.94

307.65

6.6

2.7

25.14

25.26

mmol/l

0.51

1370

3917

Other medical care

2372

8296

2.53

307.65

4.4

2.7

25.19

25.24

mmol/l

0.28

2292

8024

Insulin, fast-acting

2260

6865

3.60

307.65

6.2

3.2

24.96

25.21

mmol/l

2.40

2190

6635

Covid-19 suspected case

2080

3015

8.25

307.65

4.0

3.4

25.63

25.10

mmol/l

8.80

2060

2898

Explicit Sepsis, including avohilmo

2929

8480

3.40

307.65

6.2

2.7

24.74

25.29

mmol/l

11.52

2811

8235

Diabetes, varying definitions

4661

10411

2.71

307.65

4.3

3.1

25.07

25.43

mmol/l

8.26

4528

10021

Viral Sepsis

1435

4038

3.95

307.65

6.6

2.7

25.13

25.25

mmol/l

0.54

1373

3920

Insulin medication

3819

9399

3.66

307.65

5.3

3.2

24.87

25.39

mmol/l

12.96

3708

9061

Implicit viral Sepsis, including avohilmo

1761

6123

3.10

307.65

6.1

2.7

25.09

25.30

mmol/l

1.34

1687

5946

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3289

8988

3.10

307.65

4.3

3.3

24.86

25.41

mmol/l

13.40

3204

8683

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

4707

10002

2.94

307.65

4.4

3.1

25.00

25.46

mmol/l

12.68

4572

9632

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

4144

9798

2.58

307.65

5.0

2.8

25.44

25.11

mmol/l

6.23

4008

9475

Diabetes medication

4851

11309

2.62

307.65

4.3

3.1

25.05

25.40

mmol/l

8.08

4705

10903

Biguanides

4264

11472

2.34

307.65

3.7

3.3

25.09

25.39

mmol/l

5.77

4152

11059

Dialysis, with operation codes

1063

2163

5.84

307.65

15.9

2.6

23.54

25.55

mmol/l

56.38

1033

2089

Type 1 diabetes

1364

3595

4.10

307.65

6.7

3.2

24.75

25.31

mmol/l

5.66

1318

3454

Diseases of arteries, arterioles and capillaries (FINNGEN)

1062

1627

4.81

307.65

6.5

2.2

24.85

25.59

mmol/l

7.20

1029

1572

Malaise and fatigue

2733

7540

3.02

307.65

4.9

2.9

25.33

25.17

mmol/l

1.56

2667

7283

Other heart diseases, wide

3611

9370

2.42

307.65

4.7

2.9

25.24

25.26

mmol/l

0.08

3491

9058

All kidney diseases

5278

12117

3.09

307.65

5.9

2.4

24.64

25.58

mmol/l

57.35

5115

11700

Hypertensive Heart Disease

1381

2950

3.86

307.65

5.3

2.6

25.27

25.31

mmol/l

0.14

1360

2878

Bleeding

3772

13061

2.11

307.65

4.9

3.2

25.04

25.32

mmol/l

4.68

3665

12635

Other disorders of fluid, electrolyte and acid-base balance

2203

5943

3.86

307.65

6.4

2.9

25.05

25.32

mmol/l

2.22

2131

5767

Coronary revascularization (ANGIO or CABG)

3512

9457

2.36

307.65

4.8

3.1

25.20

25.36

mmol/l

1.77

3400

9160

Heart failure, not strict

4321

9408

3.33

307.65

5.8

2.6

25.10

25.29

mmol/l

2.24

4181

9127

Diabetes, insulin treatment (Kela reimbursement)

5053

11562

2.74

307.65

4.4

3.1

24.99

25.43

mmol/l

12.65

4909

11146

Provisional assignment of new diseases of uncertain etiology

3828

10446

4.01

307.65

4.5

3.4

25.48

25.12

mmol/l

8.10

3743

10097

Hypo-osmolality and hyponatraemia

1143

3492

3.58

306.83

5.4

2.9

25.03

25.29

mmol/l

1.45

1109

3394

Certain infectious and parasitic diseases

3535

8623

2.11

304.59

4.5

2.5

25.11

25.37

mmol/l

4.16

3432

8322

Glomerular diseases

1141

3545

3.57

303.33

11.6

3.2

24.03

25.25

mmol/l

25.39

1114

3413

Antihypertensive medication - note that there are other indications

1776

3316

2.88

297.26

4.9

2.4

24.93

25.44

mmol/l

6.93

1703

3193

Ischaemic heart disease, wide definition

3256

9842

2.12

293.54

4.5

3.1

25.27

25.37

mmol/l

0.92

3150

9551

Any death

2937

9867

2.19

291.49

5.3

3.0

25.10

25.35

mmol/l

2.61

2851

9573

Bacterial pneumonia, not elsewhere classified

1934

7000

2.56

288.90

5.5

2.9

25.82

25.05

mmol/l

13.58

1851

6791

Asthma, excluding more controls

2630

5994

2.32

285.68

3.8

2.6

25.56

25.15

mmol/l

6.77

2538

5794

Headache

2450

8542

2.29

285.14

3.8

2.9

25.27

25.23

mmol/l

0.27

2369

8223

Other CVD (FINNGEN)

602

858

5.86

280.91

5.1

2.2

25.13

25.40

mmol/l

0.93

582

832

Paroxysmal tachycardia

840

1766

4.16

279.73

4.1

2.2

25.16

25.44

mmol/l

1.29

815

1706

Complications of surgical and medical care, not elsewhere classified

4085

14793

1.90

279.34

4.9

3.2

25.06

25.29

mmol/l

3.63

3966

14292

Obesity due to excess calories

1989

8528

2.44

277.80

4.5

3.4

25.40

25.18

mmol/l

1.96

1944

8235

Syncope and collapse

2009

7104

2.47

277.68

4.1

2.9

25.35

25.15

mmol/l

1.75

1945

6866

Major coronary heart disease event excluding revascularizations

2666

8232

2.24

277.56

4.6

3.0

25.09

25.33

mmol/l

2.60

2595

7982

Asthma, unspecified (mode)

2148

6688

2.40

274.10

4.2

2.8

25.72

25.08

mmol/l

12.48

2068

6478

Asthma (only as main-diagnosis), excluding more controls

2447

5994

2.33

272.93

3.8

2.6

25.52

25.15

mmol/l

5.61

2367

5794

L04AD Calcineurin inhibitors

695

1653

4.76

272.84

13.4

3.3

23.81

25.33

mmol/l

23.18

674

1595

Other nutritional deficiencies

2684

11868

2.14

272.02

4.3

3.4

25.43

25.22

mmol/l

2.36

2609

11458

Valvular heart disease excluding rheumatic fever

2029

6137

2.47

271.15

4.6

2.9

25.14

25.24

mmol/l

0.66

1966

5961

Intestinal infectious diseases

3846

15488

1.90

270.41

5.3

3.2

24.99

25.29

mmol/l

5.89

3724

14965

Non-rheumatic valve diseases

2017

6097

2.47

269.43

4.6

2.9

25.14

25.26

mmol/l

0.75

1954

5923

Hypothyroidism (congenital or acquired)

672

704

5.52

267.87

4.2

2.1

25.01

25.44

mmol/l

2.12

642

668

Aplastic and other anaemias

2402

10322

2.25

267.66

6.2

3.2

24.54

25.30

mmol/l

18.82

2330

10005

Dialysis

393

577

8.73

267.31

18.7

2.8

23.54

25.41

mmol/l

17.80

383

557

Non-ischemic cardiomyopathy

1548

4703

2.78

263.99

4.7

2.8

25.57

25.16

mmol/l

3.19

1500

4567

Glomerular disorders in diseases classified elsewhere

801

2175

4.18

263.45

12.0

3.1

23.88

25.24

mmol/l

20.89

781

2097

Obesity

2518

11440

2.15

258.90

4.2

3.4

25.45

25.22

mmol/l

2.57

2453

11042

Obesity and other hyperalimentation

2528

11487

2.15

258.75

4.2

3.4

25.46

25.21

mmol/l

2.67

2463

11087

Symptoms and signs involving the circulatory and respiratory systems

3523

9131

1.98

257.74

4.1

3.1

25.23

25.11

mmol/l

1.21

3411

8804

Intracranial trauma

2157

6419

2.34

257.43

3.8

3.3

25.28

25.12

mmol/l

1.22

2100

6198

Substance abuse, excluding more controls

2338

9127

2.22

255.86

4.0

3.4

25.06

25.12

mmol/l

0.29

2260

8824

Sub-endpoint used in defining T1D endpoints

1454

5521

2.75

255.56

6.6

3.4

24.81

25.15

mmol/l

2.63

1404

5326

Hypothyroidism and >3 levothyroxin purchases

652

701

5.38

253.77

3.8

2.1

25.02

25.45

mmol/l

2.10

625

665

Hypothyroidism, levothyroxine purchases

652

701

5.38

253.77

3.8

2.1

25.02

25.45

mmol/l

2.10

625

665

Diarrhoea and gastroenteritis of presumed infectious origin

2917

13368

2.01

250.07

5.3

3.1

24.94

25.28

mmol/l

5.97

2825

12908

Symptoms and signs involving the digestive system and abdomen

3777

10148

1.91

249.40

4.2

3.2

25.15

25.24

mmol/l

0.79

3642

9805

Asthma

2789

6953

2.13

247.36

3.8

2.8

25.56

25.07

mmol/l

9.77

2691

6727

Medical observation and evaluation for suspected diseases and conditions

2554

6112

2.20

245.19

4.6

2.9

25.15

25.24

mmol/l

0.59

2490

5881

Abdominal and pelvic pain

3750

10145

1.91

244.12

4.1

3.2

25.20

25.24

mmol/l

0.26

3626

9802

Secondary hypertension

423

699

6.58

243.65

12.6

2.2

24.25

25.19

mmol/l

5.22

411

678

Oral corticosteroids

4136

13704

1.82

240.70

4.1

3.2

25.31

25.21

mmol/l

0.88

3993

13253

Heart failure and bmi 25plus

1765

4936

2.54

240.10

5.2

2.8

25.50

25.11

mmol/l

3.35

1708

4782

Oxycodone

2018

7847

2.32

239.89

4.9

3.2

25.38

25.26

mmol/l

0.79

1943

7641

COPD/asthma/ILD related infections

3635

9798

1.91

237.17

4.4

2.8

25.34

25.11

mmol/l

3.31

3523

9475

COPD/asthma related infections

3635

9798

1.91

237.17

4.4

2.8

25.34

25.11

mmol/l

3.31

3523

9475

First line medication for Crohn's disease

4143

12582

1.82

236.64

5.1

2.9

25.12

25.25

mmol/l

1.58

4010

12159

Bacterial pneumonia (organism specified)

2175

9320

2.22

236.24

5.5

3.3

25.73

25.06

mmol/l

12.37

2088

9041

Pure hypercholesterolaemia

2957

9659

2.01

235.11

4.1

2.9

25.16

25.36

mmol/l

2.17

2827

9365

Asthma (only as main-diagnosis)

2577

6953

2.13

234.62

3.8

2.8

25.54

25.07

mmol/l

8.68

2494

6727

Other anaemias

2205

9910

2.19

232.98

5.7

3.2

24.55

25.30

mmol/l

16.78

2139

9598

Diseases of oesophagus, stomach and duodenum

4081

13717

1.80

232.06

4.3

3.3

25.17

25.28

mmol/l

1.10

3966

13241

All influenza

1276

4853

2.79

231.82

5.4

3.0

25.43

25.01

mmol/l

3.52

1217

4701

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1228

2688

2.97

230.11

4.7

2.1

25.16

25.49

mmol/l

2.23

1185

2586

ILD medications: prednisolone, methylprednisolone, prednisone

4139

13128

1.80

230.08

5.2

2.9

25.12

25.26

mmol/l

1.54

3996

12684

Symptoms and signs involving cognition, perception, emotional state and behaviour

3763

14134

1.83

229.59

4.0

3.4

25.22

25.23

mmol/l

0.03

3642

13663

Other and unspecified anaemias

2184

9869

2.19

229.41

5.7

3.2

24.55

25.30

mmol/l

16.93

2118

9557

General examination and investigation of persons without complaint and reported diagnosis

2466

6088

2.17

229.00

4.5

2.9

25.19

25.24

mmol/l

0.29

2398

5857

Complications of medical and surgical care

3050

14778

1.92

226.36

5.0

3.3

25.20

25.26

mmol/l

0.42

2958

14300

Other neurological diseases

3133

13131

1.92

225.47

4.0

3.5

25.18

25.26

mmol/l

0.61

3037

12725

Other arrhythmias

2266

8147

2.14

222.91

3.7

2.9

25.34

25.27

mmol/l

0.42

2190

7884

Hypothyroidism, drug reimbursement

408

429

6.93

221.06

3.6

2.0

25.48

25.47

mmol/l

0.01

387

409

Fitting and adjustment of other devices

1742

6805

2.37

220.83

4.0

2.7

25.33

25.19

mmol/l

1.00

1719

6576

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1295

5086

2.68

219.81

3.7

3.3

25.21

25.46

mmol/l

1.72

1268

4905

Glucagon-like peptide-1 (GLP-1) analogues

1295

5086

2.68

219.81

3.7

3.3

25.21

25.46

mmol/l

1.72

1268

4905

Coronary atherosclerosis

2581

8205

2.06

218.10

4.6

3.0

25.13

25.35

mmol/l

2.40

2494

7965

Unstable angina pectoris

1764

6180

2.37

216.40

4.5

3.0

25.26

25.23

mmol/l

0.11

1711

5992

Complications of procedures, not elsewhere classified

3235

14416

1.86

216.40

4.7

3.2

25.05

25.30

mmol/l

3.36

3141

13937

Asthma (mode)

2666

7048

2.04

213.54

3.6

2.8

25.51

25.07

mmol/l

7.95

2570

6819

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1053

1665

3.26

213.16

3.7

2.3

25.24

25.20

mmol/l

0.12

1010

1595

Concussion

1822

6376

2.29

212.24

3.8

3.4

25.27

25.12

mmol/l

0.90

1771

6158

Depression medications

664

739

4.64

211.45

3.7

2.0

25.16

25.54

mmol/l

1.74

641

701

Parasetamol

2432

5969

2.11

211.36

3.9

3.0

25.04

25.24

mmol/l

1.88

2336

5765

Abnormalities of heart beat

1495

6173

2.45

210.64

4.1

3.0

25.34

25.11

mmol/l

1.69

1455

5967

Inflammatory bowel disease treatment related agents

4258

13938

1.73

210.20

4.4

3.3

25.26

25.20

mmol/l

0.53

4112

13474

Asthma, hospital admission 2, infections

2476

12524

2.00

209.50

4.4

3.5

25.70

25.13

mmol/l

11.96

2389

12125

Asthma-related infections

2476

12524

2.00

209.50

4.4

3.5

25.70

25.13

mmol/l

11.96

2389

12125

Dizziness and giddiness

3028

12895

1.88

208.17

4.0

3.4

25.28

25.23

mmol/l

0.32

2948

12485

ILD medications

4179

13270

1.74

206.05

5.2

3.0

25.11

25.25

mmol/l

1.63

4043

12823

Poisoning by medicine

921

3148

3.10

204.11

3.8

3.5

25.29

25.25

mmol/l

0.10

883

3026

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

994

3497

2.93

201.87

3.6

3.1

25.24

25.22

mmol/l

0.03

949

3383

Poisoning by drugs, medicaments and biological substances

989

3540

2.95

201.23

3.7

3.5

25.29

25.24

mmol/l

0.13

948

3410

Pain, not elsewhere classified

1141

4399

2.72

200.18

4.9

2.9

25.39

25.12

mmol/l

1.79

1099

4235

Autoimmune diseases excluding thyroid diseases

3905

12388

1.75

197.54

4.9

3.2

25.06

25.26

mmol/l

2.45

3789

11961

Other diseases of intestines

3763

12165

1.76

197.10

4.2

3.3

25.15

25.24

mmol/l

0.82

3642

11735

Myocardial infarction

2060

7003

2.15

197.01

4.7

3.0

24.95

25.29

mmol/l

3.83

1998

6796

Mental and behavioural disorders due to psychoactive substance use

2405

11533

1.98

196.01

4.0

3.6

25.06

25.18

mmol/l

0.77

2326

11142

Combinations of oral blood glucose lowering drugs

1294

5386

2.55

195.47

3.5

3.4

24.79

25.31

mmol/l

6.63

1274

5201

Disorders of gallbladder, biliary tract and pancreas

3782

13870

1.74

193.19

4.3

3.3

25.11

25.29

mmol/l

2.08

3663

13419

Diseases of arteries, arterioles and capillaries

2914

11826

1.87

193.09

5.4

3.2

24.81

25.34

mmol/l

11.79

2812

11486

Substance abuse

2338

11368

1.98

191.29

4.0

3.6

25.06

25.18

mmol/l

0.71

2260

10979

Autoimmune diseases excluding thyroid diseases, strict definition

3764

12014

1.74

188.83

4.9

3.1

25.03

25.24

mmol/l

2.63

3653

11608

Cerebrovascular diseases

3095

12141

1.83

188.18

4.1

3.4

25.25

25.27

mmol/l

0.15

3006

11764

GASTRO-related operations

2595

6772

1.97

186.56

4.2

2.6

25.09

25.39

mmol/l

3.70

2501

6529

Any gastric operation

2595

6772

1.97

186.56

4.2

2.6

25.09

25.39

mmol/l

3.70

2501

6529

Hypokalaemia

687

2109

3.56

185.25

6.1

2.9

26.27

25.32

mmol/l

6.10

659

2041

Convulsions, not elsewhere classified

963

3504

2.85

184.38

4.6

3.0

25.19

24.97

mmol/l

1.15

925

3385

Diseases of the digestive system

2092

10705

2.02

182.46

5.1

3.5

24.78

25.23

mmol/l

6.56

2027

10364

Other functional intestinal disorders

1944

8809

2.08

182.30

4.5

3.3

25.35

25.25

mmol/l

0.55

1873

8526

Unspecified kidney failure

686

2141

3.57

181.75

9.0

2.7

23.90

25.51

mmol/l

20.23

668

2062

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2792

13662

1.84

180.41

4.4

3.4

25.36

25.23

mmol/l

1.01

2715

13228

Asthma-related pneumonia

1724

8308

2.17

180.37

4.9

3.5

25.85

25.11

mmol/l

12.61

1664

8052

Asthma-related pneumonia or sepsis

1726

8324

2.17

180.18

4.9

3.5

25.86

25.11

mmol/l

12.67

1666

8067

Asthma, hospital admissions 3, pneumonia

1726

8324

2.17

180.18

4.9

3.5

25.86

25.11

mmol/l

12.67

1666

8067

Oedema, not elsewhere classified

1362

5841

2.38

179.54

4.7

2.8

25.62

25.17

mmol/l

4.98

1320

5648

Diabetic maculopathy, excluding more controls

579

1629

3.89

178.41

7.0

3.0

24.58

25.31

mmol/l

4.24

556

1562

Caries of dentine

1133

4469

2.59

176.21

6.5

3.2

24.98

25.24

mmol/l

1.55

1092

4345

Other special examinations and investigations of persons without complaint or reported diagnosis

2348

6115

2.00

175.77

4.2

2.9

25.15

25.24

mmol/l

0.55

2263

5884

Diverticular disease of intestine

2872

10019

1.84

175.44

4.1

3.2

25.14

25.31

mmol/l

1.81

2799

9701

Nutritional anaemias

2191

11104

1.95

172.79

5.0

3.4

24.82

25.27

mmol/l

6.77

2112

10759

Personality disorders, excluding more controls

869

3130

2.88

172.58

3.5

3.1

25.37

25.25

mmol/l

0.41

846

3022

GI-bleeding

1601

7727

2.18

169.26

5.1

3.4

24.76

25.19

mmol/l

4.58

1552

7484

Dental caries

1225

4977

2.45

168.99

6.5

3.2

24.99

25.24

mmol/l

1.54

1183

4836

Iron deficiency anaemia

1917

9676

2.03

167.77

5.1

3.3

24.83

25.28

mmol/l

5.96

1845

9377

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

679

2183

3.30

167.54

3.9

3.3

25.18

25.28

mmol/l

0.30

649

2103

Mental and behavioural disorders due to alcohol

2047

10239

1.97

166.73

4.0

3.6

24.96

25.16

mmol/l

1.59

1980

9889

2298

11149

1.90

166.55

4.1

3.6

24.88

25.20

mmol/l

3.69

2223

10770

2379

11374

1.88

165.22

4.0

3.6

24.90

25.20

mmol/l

3.44

2301

10985

Stroke, including SAH

2643

10687

1.84

164.30

4.2

3.4

25.26

mmol/l

0.02

2567

10363

Other diseases of the digestive system

1582

7690

2.17

164.16

5.1

3.4

24.75

25.20

mmol/l

4.79

1533

7448

Myocardial infarction, strict

1881

6718

2.06

163.47

4.6

3.0

24.97

25.28

mmol/l

2.98

1819

6523

Hyperkalaemia

441

1107

4.58

162.66

10.0

3.1

23.58

25.17

mmol/l

12.45

428

1076

Diabetic nephropathy, excluding more controls

937

2948

2.85

162.00

9.8

3.0

24.16

25.22

mmol/l

14.67

910

2876

Viral pneumonia

672

2202

3.29

161.97

6.6

2.8

25.38

25.05

mmol/l

1.33

638

2119

Symptoms and signs involving the urinary system

3017

13392

1.75

161.53

4.8

3.3

25.17

25.28

mmol/l

0.98

2908

12978

Insulin, fast-acting (human)

632

2002

3.37

160.27

8.0

3.0

25.06

25.25

mmol/l

0.63

610

1924

Volume depletion

595

1834

3.57

160.06

6.3

2.9

24.56

25.20

mmol/l

2.91

565

1775

COPD (mode)

1347

4740

2.32

159.71

4.8

2.8

26.13

24.95

mmol/l

19.35

1300

4620

Nerve, nerve root and plexus disorders

3920

14690

1.64

159.35

4.0

3.4

25.34

25.21

mmol/l

1.33

3764

14235

Alcohol use disorder, Swedish definition

2176

10752

1.90

158.05

4.1

3.6

24.91

25.19

mmol/l

2.80

2103

10390

4062

12873

1.63

157.43

4.3

3.2

25.36

25.15

mmol/l

3.38

3931

12449

Other pulmonary diagnosis

2549

7022

1.86

155.47

4.0

2.8

25.42

25.07

mmol/l

4.81

2462

6794

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1796

9199

2.01

155.02

4.1

3.6

24.98

25.16

mmol/l

1.18

1735

8886

Unspecified mental disorder

1475

7112

2.15

154.06

3.6

3.5

25.65

25.16

mmol/l

5.42

1428

6875

Neurological diseases, wide definition

784

1270

3.18

153.37

3.8

2.6

25.15

25.20

mmol/l

0.12

758

1218

Any mental disorder

3793

11747

1.65

153.16

4.0

3.4

25.31

25.22

mmol/l

0.85

3667

11375

Intestinal infectious diseases, including avohilmo, including avohilmo

4154

14721

1.60

152.89

4.8

3.2

25.07

25.30

mmol/l

3.72

4011

14243

Schizophrenia or delusion, excluding more controls

1088

4588

2.43

152.67

3.4

3.3

25.75

25.19

mmol/l

4.79

1043

4445

Polyarthropathies

2544

9228

1.82

151.93

5.0

3.4

24.98

25.22

mmol/l

2.56

2463

8935

Low back pain

2814

11075

1.76

151.69

3.7

3.5

25.46

25.15

mmol/l

4.80

2713

10727

Alcohol use disorder, ICD-based

1673

8536

2.04

150.29

4.1

3.6

25.02

25.17

mmol/l

0.84

1619

8242

Stroke, excluding SAH

2511

10336

1.81

150.15

4.2

3.5

25.28

25.23

mmol/l

0.26

2441

10019

Excluding asthma or asthma-COPD overlap

2525

7022

1.84

149.44

4.0

2.8

25.40

25.07

mmol/l

4.38

2437

6794

Paralytic ileus and intestinal obstruction

1215

5544

2.30

147.62

4.6

3.2

25.20

25.23

mmol/l

0.08

1164

5367

Injuries to the head

3979

15040

1.60

147.59

3.8

3.5

25.22

mmol/l

0.04

3865

14523

ILD medications: immunosuppressive drugs

2285

11662

1.82

146.48

6.5

2.9

24.87

25.29

mmol/l

7.42

2212

11273

Bronchitis

3918

14960

1.60

146.24

4.5

3.2

25.41

25.19

mmol/l

3.48

3789

14459

Alcohol abuse, main dg, excluding more controls

662

2278

3.09

145.56

3.8

3.5

24.99

25.10

mmol/l

0.29

640

2206

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4005

13551

1.60

145.55

4.9

3.1

25.32

25.21

mmol/l

1.10

3886

13090

Myocardial infarction, without ST-elevation

1923

9364

1.94

144.93

5.0

3.4

24.89

25.19

mmol/l

3.03

1859

9094

1702

8761

1.99

144.51

4.4

3.5

25.69

25.13

mmol/l

9.41

1641

8482

Obesity related asthma

1391

6742

2.15

144.26

4.2

3.5

25.73

25.17

mmol/l

7.17

1348

6533

Pain in limb

2990

11386

1.71

144.02

4.4

3.3

25.40

25.14

mmol/l

3.75

2906

10998

Lower back pain or/and sciatica

3861

15308

1.60

144.01

3.6

3.5

25.41

25.20

mmol/l

3.18

3733

14802

COPD differential diagnosis

2510

7050

1.82

143.92

3.9

2.8

25.40

25.07

mmol/l

4.50

2422

6821

Other retinal disorders

2671

11958

1.75

143.27

5.2

3.3

24.97

25.31

mmol/l

4.95

2576

11608

Other dialysis

264

487

6.73

143.21

18.9

3.5

23.70

24.96

mmol/l

5.91

258

469

Chronic lower respiratory diseases

4191

14248

1.58

143.06

3.9

3.4

25.53

25.10

mmol/l

11.71

4040

13774

ILD differential diagnosis

2503

7048

1.82

142.31

3.9

2.8

25.40

25.07

mmol/l

4.53

2415

6819

Disorders of thyroid, IBD co-morbidities

518

983

3.73

142.22

3.3

2.4

25.43

25.26

mmol/l

0.46

502

946

Asthma (diagnoses ohter than nonallergic)

3184

15898

1.65

142.15

4.0

3.5

25.65

25.14

mmol/l

12.90

3070

15378

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

421

712

4.39

141.28

4.7

2.6

25.64

25.21

mmol/l

1.18

395

689

L04AA Selective immunosuppressants

920

3802

2.55

140.78

10.1

3.2

24.26

25.34

mmol/l

17.51

893

3673

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

957

4054

2.53

140.28

3.8

3.3

25.04

25.30

mmol/l

1.36

935

3923

Used for control exclusion in common control thyroid runs

3639

11488

1.63

139.95

4.5

3.1

25.02

25.24

mmol/l

3.20

3514

11101

Other soft tissue disorders, not elsewhere classified

3302

11562

1.66

139.91

4.4

3.4

25.39

25.13

mmol/l

3.84

3205

11163

Other disorders of urethra and urinary system

2597

10581

1.75

139.00

4.7

3.2

25.18

25.20

mmol/l

0.11

2518

10230

Pacemaker

1763

8750

1.96

138.30

4.2

3.5

25.19

25.16

mmol/l

0.14

1702

8492

Infections of the skin and subcutaneous tissue

2183

12209

1.81

138.10

5.4

3.4

25.10

25.19

mmol/l

0.60

2120

11798

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

994

4276

2.41

137.57

3.6

3.4

25.24

25.19

mmol/l

0.15

949

4124

Liquid cancers, including Hilmo

1589

7213

2.03

136.77

4.0

3.5

25.00

25.33

mmol/l

3.26

1551

6981

Certain infectious and parasitic diseases, including avohilmo

2361

6614

1.83

136.56

3.9

2.5

25.13

25.38

mmol/l

2.61

2275

6395

Examination and observation for other reasons

1994

6025

1.91

136.38

4.0

2.9

24.95

25.25

mmol/l

3.47

1940

5796

Peripheral artery disease

2007

8768

1.88

136.33

6.2

3.2

24.62

25.29

mmol/l

12.15

1945

8512

Transient ischemic attack

2203

9975

1.82

135.93

4.1

3.4

25.22

25.25

mmol/l

0.13

2137

9667

Dorsalgia

3430

11330

1.64

135.87

3.5

25.30

25.14

mmol/l

1.78

3310

10968

Other disorders of skin and subcutaneous tissue

2792

14334

1.69

134.65

5.3

3.3

25.13

25.27

mmol/l

1.27

2707

13882

Haemorrhage from respiratory passages

1403

6147

2.10

134.06

4.7

3.0

25.11

25.06

mmol/l

0.19

1359

5951

Statin medication

2040

6225

1.89

134.03

4.2

3.0

25.10

25.47

mmol/l

4.51

1971

5999

Tramadol

2755

9871

1.72

133.90

4.4

3.1

25.12

25.30

mmol/l

1.79

2650

9567

Episodal and paroxysmal disorders

3690

11894

1.60

133.56

3.8

3.4

25.27

25.16

mmol/l

1.05

3577

11484

Suicide or other Intentional self-harm

901

3779

2.49

132.64

3.8

3.4

25.32

25.22

mmol/l

0.33

861

3646

Autoimmune diseases

3815

12435

1.59

132.10

4.6

3.2

25.05

25.26

mmol/l

3.06

3692

12007

Hydronephrosis

582

1977

3.18

132.10

6.1

2.6

24.16

25.60

mmol/l

16.04

568

1907

Conduction disorders

1198

4470

2.24

131.96

4.1

2.9

24.96

25.17

mmol/l

1.23

1151

4336

Sulfonylureas

1474

5909

2.07

131.89

4.7

3.3

24.78

25.32

mmol/l

5.93

1442

5705

Status post-ami

1203

4274

2.25

130.49

4.3

3.0

24.93

25.20

mmol/l

1.84

1166

4158

Kela-code for severe mental illness

1312

6462

2.10

129.73

3.6

25.63

25.16

mmol/l

4.41

1267

6243

Constipation

3283

14066

1.62

129.66

4.1

3.5

25.39

25.18

mmol/l

2.90

3163

13626

Substance use, excluding alcohol

759

2979

2.67

128.98

4.2

3.4

25.49

25.29

mmol/l

0.71

731

2865

Misadventures to patients during surgical and medical care

704

2680

2.82

128.95

5.5

3.1

25.35

25.23

mmol/l

0.38

686

2591

Cholelithiasis, broad definition with cholecystitis

3128

13052

1.63

127.62

3.9

3.3

25.20

25.28

mmol/l

0.52

3036

12635

Early onset COPD, excluding more controls

811

3305

2.57

127.25

4.8

2.8

26.38

24.96

mmol/l

16.81

787

3214

Problems related to lifestyle

487

1522

3.43

126.61

4.3

2.9

25.31

25.18

mmol/l

0.27

469

1467

Other and unspecified iron deficiency

1470

7613

2.01

126.18

5.0

3.3

24.80

25.25

mmol/l

4.85

1416

7359

Disorders of choroid and retina

3091

13613

1.63

126.00

4.9

3.3

24.96

25.32

mmol/l

6.60

2987

13188

Obesity, other/unspecified

1163

5541

2.17

125.43

4.0

3.4

25.40

25.23

mmol/l

0.90

1136

5354

Neurological diseases

2672

7973

1.71

125.29

3.7

3.4

25.22

25.10

mmol/l

0.97

2580

7712

AV-block

857

3050

2.54

125.07

4.3

2.8

24.76

25.08

mmol/l

1.69

818

2966

Other acute lower respiratory infections

2099

11555

1.78

124.89

5.1

3.4

25.55

25.13

mmol/l

6.32

2031

11173

Continuous positive airway pressure

549

1514

3.14

121.97

5.3

2.7

25.51

25.42

mmol/l

0.25

539

1474

Mood disorders, excluding more controls

3086

11389

1.62

121.41

4.0

3.4

25.37

25.24

mmol/l

1.18

2961

11026

Ischaemic Stroke, excluding all haemorrhages

2311

10094

1.74

120.59

4.2

3.5

25.27

25.22

mmol/l

0.25

2247

9783

Atherosclerosis, excluding cerebral and coronary sclerosis

1880

8316

1.85

120.36

6.0

3.2

24.60

25.27

mmol/l

11.52

1821

8077

Persons encountering health services in other circumstances, wide

4004

13666

1.53

119.84

4.7

3.1

25.27

25.21

mmol/l

0.45

3868

13202

Disorders of mineral metabolism

439

1341

3.57

119.42

8.6

2.9

25.49

25.43

mmol/l

0.10

424

1296

Pain (limb, back, neck, head abdominally)

2414

7089

1.74

119.22

3.9

3.3

25.22

25.11

mmol/l

0.73

2328

6837

Asthma/COPD (KELA code 203)

3303

14232

1.58

119.16

3.9

3.4

25.64

25.10

mmol/l

14.53

3201

13758

Other bacterial intestinal infections

846

3640

2.46

118.94

7.1

3.1

24.88

25.21

mmol/l

1.67

818

3517

Intracranial injury

2224

12319

1.73

118.91

3.8

3.6

25.31

25.18

mmol/l

0.97

2160

11913

Other or unspecified ileus, impaction or obstruction

890

3915

2.40

118.78

4.6

3.3

25.30

25.21

mmol/l

0.26

856

3794

Gastrointestinal diseases

1689

4465

1.93

116.67

3.9

2.6

25.22

25.24

mmol/l

0.08

1624

4281

Disorders of calcium metabolism

368

1023

3.99

116.36

8.4

2.8

25.53

25.45

mmol/l

0.13

357

984

Fall on same level

3794

13386

1.54

115.99

4.2

3.3

25.31

25.15

mmol/l

1.89

3685

12913

Cholelithiasis

2966

12854

1.61

115.32

3.8

3.3

25.21

25.28

mmol/l

0.51

2881

12443

Implicit fungal Sepsis, including avohilmo

398

1173

3.74

115.09

7.0

2.7

25.15

25.37

mmol/l

0.51

383

1131

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2257

13355

1.70

115.03

5.1

3.3

25.09

25.26

mmol/l

1.36

2184

12937

Gout

1338

5934

2.03

114.08

5.9

3.4

24.59

25.16

mmol/l

6.46

1301

5759

Epilepsy

1203

6003

2.07

113.94

4.2

3.6

25.31

25.09

mmol/l

1.39

1158

5807

Intestinal stricture

1351

7067

2.00

113.80

4.6

3.5

25.09

25.18

mmol/l

0.37

1297

6840

Gastroduodenal ulcer

1192

5973

2.08

112.73

4.8

3.3

24.66

25.11

mmol/l

3.79

1169

5778

Glomerulonephritis

503

1730

3.16

112.30

11.5

3.4

24.17

25.23

mmol/l

9.45

495

1667

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

3486

14788

1.54

111.16

4.7

3.2

25.02

25.29

mmol/l

4.72

3358

14309

Sciatica+with lumbago

1852

9421

1.79

111.06

3.3

3.5

25.32

25.19

mmol/l

0.87

1803

9126

Fungal Sepsis

284

682

4.77

111.03

8.0

2.6

25.19

25.27

mmol/l

0.10

272

659

Persons encountering health services for examination and investigation

2116

6115

1.77

110.91

3.7

2.9

25.16

25.24

mmol/l

0.45

2043

5884

Other antidepressants

3550

11948

1.54

109.75

3.9

3.5

25.23

25.17

mmol/l

0.46

3432

11562

Diabetic retinopathy, excluding more controls

1281

3594

2.11

109.36

6.3

3.0

24.70

25.26

mmol/l

5.64

1238

3495

Personality disorders

869

3899

2.31

109.02

3.5

25.37

25.21

mmol/l

0.64

846

3752

Alcohol dependence

1079

5295

2.13

108.70

4.3

3.7

25.08

25.15

mmol/l

0.22

1051

5113

Disorders of adult personality and behaviour

904

4127

2.27

108.62

3.5

25.39

25.19

mmol/l

0.91

875

3976

Disorders of lens

2384

8999

1.68

108.47

5.2

3.3

24.95

25.37

mmol/l

6.81

2310

8729

Type 1 diabetes, strict (exclude DM2)

341

929

3.87

108.35

3.8

3.7

24.92

25.23

mmol/l

0.75

326

888

Opioids

3129

10389

1.58

108.17

4.1

3.1

25.10

25.27

mmol/l

1.72

3004

10059

Codeine

2978

10262

1.60

107.86

3.9

3.1

25.16

25.28

mmol/l

0.99

2849

9937

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

754

3239

2.48

107.15

3.7

3.4

25.24

25.21

mmol/l

0.09

744

3132

Genitourinary diseases

1843

5166

1.83

107.05

5.1

2.3

24.93

25.43

mmol/l

6.79

1771

5000

COPD

1863

8800

1.78

106.77

4.8

3.4

26.02

25.01

mmol/l

21.29

1807

8543

Type 1 diabetes, definitions combined

341

939

3.83

106.63

3.8

3.6

24.92

25.23

mmol/l

0.75

326

899

Other reaction to severe stress, and adjustment disorders

1101

5446

2.08

106.62

4.5

3.2

25.36

25.28

mmol/l

0.31

1062

5247

Osteopathies and chondropathies

2095

11537

1.70

106.43

4.9

3.4

25.27

25.31

mmol/l

0.20

2023

11179

Schizophrenia or delusion

1088

5386

2.09

106.15

3.4

3.6

25.75

25.20

mmol/l

4.75

1043

5205

Hernia of abdominal wall, postoperative

756

3218

2.44

106.14

5.7

2.6

24.86

25.35

mmol/l

3.21

737

3118

Asthma, hospital admissions , main diagnosis only

2809

15779

1.58

105.47

3.9

3.5

25.56

25.17

mmol/l

7.44

2721

15250

Schizophrenia, schizotypal and delusional disorders

1093

5434

2.08

105.39

3.4

3.6

25.74

25.20

mmol/l

4.59

1048

5251

Alcohol abuse, main dg

662

2693

2.60

105.21

3.8

24.99

25.17

mmol/l

0.59

640

2596

Other infectious diseases, including avohilmo

492

1735

3.09

105.19

6.4

3.4

25.09

25.15

mmol/l

0.16

485

1670

Unknown and unspecified causes of morbidity

333

920

3.91

105.17

5.1

2.8

24.69

25.00

mmol/l

0.88

325

889

Disorders of other endocrine glands

1606

8922

1.82

104.53

6.2

3.4

25.12

25.26

mmol/l

0.80

1542

8640

Viral and other specified intestinal infections

731

3022

2.45

104.32

7.0

3.1

24.93

25.15

mmol/l

0.90

704

2898

Abnormal findings on diagnostic imaging of lung

1956

11066

1.73

104.07

4.4

3.5

25.41

25.19

mmol/l

1.87

1908

10732

Specific personality disorders

758

3276

2.40

103.98

3.6

3.5

25.45

25.20

mmol/l

1.04

733

3150

Psychiatric diseases

3228

10556

1.56

103.83

4.0

3.4

25.21

25.24

mmol/l

0.23

3119

10222

Dermatitis

2273

13792

1.65

103.62

4.2

3.4

25.15

25.27

mmol/l

0.85

2218

13335

Vocal cord dysfunction

372

951

3.57

103.35

3.9

2.2

25.86

25.70

mmol/l

0.37

362

917

Retention of urine

1514

6775

1.88

102.96

4.6

3.4

25.03

25.11

mmol/l

0.37

1453

6573

Unspecified acute lower respiratory infection

694

2924

2.51

102.30

5.8

3.4

25.73

25.17

mmol/l

3.26

673

2816

Acute alcohol intoxication, ICD10

816

3682

2.32

102.11

3.9

3.8

24.94

25.14

mmol/l

0.75

789

3554

Acute peritonitis

379

1176

3.59

101.71

12.3

3.3

23.96

25.13

mmol/l

6.97

371

1134

Implicit fungal Sepsis

259

621

4.77

101.49

8.1

2.6

25.17

25.27

mmol/l

0.13

248

598

Autoimmune diseases related-to ILD

2895

15830

1.56

101.45

4.2

3.4

25.24

mmol/l

0.00

2812

15307

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1204

6289

1.99

101.15

4.5

3.5

25.37

25.16

mmol/l

1.26

1162

6088

Anxiety disorders, excluding more controls

2559

10314

1.61

100.51

4.2

3.3

25.45

25.28

mmol/l

1.71

2485

9982

Benign neoplasm of colon, rectum, anus and anal canal

2464

13243

1.62

99.85

4.4

3.4

25.10

25.30

mmol/l

2.07

2409

12834

Bacterial intestinal infections, IBD co-morbidities

836

3855

2.29

99.77

7.1

3.3

24.86

25.22

mmol/l

1.98

809

3732

Unspecified haematuria

1745

8273

1.78

99.55

5.3

3.4

24.99

25.14

mmol/l

1.06

1686

8032

Disorders resulting from impaired renal tubular function

257

627

4.78

99.14

16.0

3.2

23.50

25.01

mmol/l

8.67

248

608

Factors influencing health status and contact with health services

943

2130

2.28

98.89

3.8

2.3

25.13

25.12

mmol/l

0.02

906

2042

Pulmonary heart disease, diseases of pulmonary circulation

1358

7446

1.90

98.74

4.6

3.5

25.52

25.15

mmol/l

3.15

1304

7212

Other bacterial intestinal infections, including avohilmo

954

4639

2.15

98.49

6.6

3.1

24.92

25.22

mmol/l

1.76

922

4486

Other chronic obstructive pulmonary disease

1781

8585

1.76

97.74

4.8

3.4

26.09

25.00

mmol/l

23.14

1725

8337

Acute alcohol intoxication

1010

5032

2.09

97.48

3.8

3.7

25.04

25.12

mmol/l

0.25

981

4858

Presence of other functional implants

2197

9277

1.66

97.03

4.9

3.0

25.18

25.32

mmol/l

1.04

2143

8985

Other diseases of pleura

1890

9882

1.72

96.79

5.3

3.4

26.13

25.02

mmol/l

26.19

1809

9581

Venous thromboembolism

2082

12409

1.66

96.29

4.7

3.4

25.34

25.23

mmol/l

0.71

2013

12033

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

321

925

3.76

95.50

4.1

3.4

25.18

25.20

mmol/l

0.04

310

888

Explicit bacterial Sepsis, including avohilmo

504

1886

2.85

95.34

6.0

2.8

25.04

25.21

mmol/l

0.47

484

1819

Calcific aortic valvular stenosis

1408

7600

1.87

95.29

4.7

3.4

25.00

25.14

mmol/l

0.75

1372

7368

Calcific aortic valvular stenosis, operated

1408

7600

1.87

95.29

4.7

3.4

25.00

25.14

mmol/l

0.75

1372

7368

Explicit bacterial Sepsis

496

1842

2.87

95.25

5.9

2.8

25.05

25.20

mmol/l

0.41

476

1776

Other dorsopathies, not elsewhere classified

3267

11340

1.52

95.02

3.6

3.5

25.27

25.14

mmol/l

1.32

3145

10978

Streptococcal septicaemia, including avohilmo

448

1582

3.05

95.01

6.0

2.8

25.13

25.17

mmol/l

0.07

432

1524

Spondylopathies

2723

10419

1.58

94.90

3.4

3.5

25.35

25.17

mmol/l

1.75

2635

10096

Streptococcal septicaemia

440

1540

3.08

94.87

5.8

2.9

25.14

25.17

mmol/l

0.05

424

1482

Operations 2 for CAVS

1405

7590

1.86

94.81

4.7

3.4

25.00

25.14

mmol/l

0.76

1369

7358

Calcific aortic valvular stenosis, diagnosis (helper)

1405

7590

1.86

94.81

4.7

3.4

25.00

25.14

mmol/l

0.76

1369

7358

Gout, FINNGEN

1338

7363

1.89

94.53

5.9

3.4

24.59

25.09

mmol/l

5.28

1301

7147

Dysphagia

974

4847

2.09

94.21

4.3

3.1

25.73

25.24

mmol/l

3.99

939

4692

Asthma, including avohilmo

3960

15206

1.46

94.09

3.8

3.5

25.51

25.14

mmol/l

8.75

3821

14707

Viral hepatitis, IBD co-morbidity

183

342

5.66

93.89

4.4

2.3

25.00

25.21

mmol/l

0.32

174

330

Calcific aortic valvular stenosis, including rheumatic fever

1406

7612

1.86

93.81

4.7

3.4

25.00

25.14

mmol/l

0.79

1370

7380

DVT of lower extremities and pulmonary embolism

1683

9944

1.74

92.62

4.6

3.4

25.38

25.20

mmol/l

1.24

1626

9645

Conductive and sensorineural hearing loss

2867

12596

1.54

92.60

3.5

3.6

25.26

25.27

mmol/l

0.06

2773

12208

Benzodiazepine use

3401

15723

1.48

92.40

3.8

3.5

25.35

25.22

mmol/l

1.31

3296

15201

Enterocolitis due to Clostridium difficile

560

2262

2.66

91.48

8.2

3.1

24.93

25.13

mmol/l

0.56

540

2185

Other and unspecified dermatitis

1868

11406

1.68

91.33

4.1

3.4

25.13

25.28

mmol/l

1.15

1824

11022

Cholecystectomy

2482

13681

1.57

91.31

3.8

3.5

25.25

25.26

mmol/l

0.04

2409

13252

Hypertensive Renal Disease

226

528

4.80

90.98

8.4

2.7

23.77

25.24

mmol/l

6.30

220

518

Sensorineural hearing loss

2775

12212

1.55

90.87

3.6

25.26

25.27

mmol/l

0.02

2689

11845

Anaemia in chronic diseases classified elsewhere

198

425

5.62

90.37

15.8

3.1

23.70

25.48

mmol/l

9.19

190

407

Thiazolidinediones

525

2072

2.72

89.90

4.6

3.4

24.92

25.29

mmol/l

1.57

517

1999

Diseases of the respiratory system

1956

5867

1.70

89.59

3.7

2.8

25.36

25.04

mmol/l

3.39

1887

5674

Benign neoplasm: Colon

2118

12577

1.63

89.28

4.5

3.5

25.05

25.30

mmol/l

2.66

2068

12197

Type 1 diabetes, strict definition, subgroup 1

242

603

4.22

87.24

3.3

4.0

24.72

25.21

mmol/l

1.06

230

578

Other disorders of kidney and ureter

613

2638

2.48

86.98

10.4

3.4

24.41

25.19

mmol/l

6.05

592

2548

Enlarged lymph nodes

559

2293

2.54

86.57

3.8

2.9

25.26

25.06

mmol/l

0.72

544

2216

Falls/tendency to fall

3354

11487

1.48

86.48

4.1

3.3

25.28

25.14

mmol/l

1.37

3260

11071

Viral and other specified intestinal infections, including avohilmo

885

4199

2.09

86.30

6.4

3.0

24.97

25.18

mmol/l

1.04

852

4031

Abnormal findings on examination of blood, without diagnosis

1849

10324

1.67

86.12

4.8

3.6

25.10

25.13

mmol/l

0.13

1782

10015

Cough

1312

6868

1.83

86.09

4.7

3.1

25.18

25.13

mmol/l

0.20

1275

6636

Pulmonary embolism

1220

6754

1.88

86.05

4.6

3.5

25.42

25.15

mmol/l

1.83

1173

6545

Cardiac arrest

267

596

4.05

85.93

6.2

2.3

25.24

25.28

mmol/l

0.07

245

584

Symptoms and signs concerning food and fluid intake

448

1663

2.85

85.39

4.6

3.0

24.97

24.98

mmol/l

0.02

426

1603

Pulmonary heart disease

1220

6780

1.87

84.98

4.6

3.5

25.42

25.16

mmol/l

1.67

1173

6570

Emotionally unstable personality disorder

388

1344

3.02

83.81

3.6

3.4

25.22

25.24

mmol/l

0.03

377

1286

Other diseases of urinary system

3239

12495

1.48

83.61

4.4

3.4

25.16

25.19

mmol/l

0.19

3127

12081

Other blood glucose lowering drugs, excl. Insulins

655

2947

2.34

83.11

4.3

3.3

25.17

25.29

mmol/l

0.33

638

2845

Other chronic obstructive pulmonary disease, including avohilmo

2088

10946

1.61

83.09

4.5

3.5

25.97

25.07

mmol/l

19.51

2025

10627

COPD related to multimorbidity

1648

8418

1.71

82.93

5.0

3.5

26.08

24.99

mmol/l

21.18

1595

8170

Type 1 diabetes, strict definition

250

665

3.95

82.23

3.4

3.9

24.71

25.23

mmol/l

1.22

238

637

Chronic ulcer of skin, not elsewhere classified

385

1363

3.10

82.17

7.8

3.2

24.67

25.18

mmol/l

1.85

378

1315

Senile cataract

2156

8342

1.61

81.79

4.9

3.3

24.97

25.37

mmol/l

5.42

2088

8110

Mycoses

1044

5589

1.94

81.62

4.9

3.5

25.27

25.17

mmol/l

0.41

1008

5406

Cutaneous abscess, furuncle and carbuncle

928

4775

2.01

81.47

6.1

3.4

24.98

25.18

mmol/l

1.01

898

4613

Non-allergic asthma (mode), excluding more controls

624

2731

2.34

81.31

3.7

2.5

25.53

25.00

mmol/l

3.36

606

2644

Other intervertebral disc disorders

2698

10751

1.52

81.05

3.2

3.5

25.25

25.17

mmol/l

0.52

2575

10416

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

189

425

4.92

79.49

8.9

3.1

25.24

25.35

mmol/l

0.14

184

412

Other disorders of glucose regulation and pancreatic internal secretion

400

1466

2.93

79.23

6.5

3.4

24.99

25.26

mmol/l

0.72

380

1407

Diseases of liver

1275

7332

1.80

78.66

4.6

3.5

24.70

25.24

mmol/l

5.75

1230

7097

Acute upper respiratory infections of multiple and unspecified sites

2474

12028

1.53

78.10

4.5

3.3

25.30

25.21

mmol/l

0.71

2392

11605

Depression

2994

13815

1.47

78.08

4.0

3.4

25.34

25.26

mmol/l

0.62

2882

13369

Diabetic nephropathy

944

4968

2.02

77.86

9.7

3.5

24.15

25.04

mmol/l

11.34

915

4844

Disorder of lipoprotein metabolism, unspecified

574

2519

2.41

77.48

4.9

2.9

25.13

25.15

mmol/l

0.06

567

2448

Other CVD

948

5044

1.97

76.60

4.9

3.4

25.14

mmol/l

0.00

914

4887

Codeine or tramadol medication

3654

14157

1.42

76.52

3.8

3.4

25.12

25.26

mmol/l

1.50

3507

13720

Cervicobrachial syndrome

770

3793

2.10

76.48

3.5

3.4

25.38

25.17

mmol/l

1.04

749

3685

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2019

13081

1.58

76.18

5.0

3.4

25.08

25.28

mmol/l

1.62

1951

12676

Mood disorders

3265

14697

1.44

75.93

3.9

3.4

25.34

25.27

mmol/l

0.53

3133

14231

Elevated blood glucose level

396

1478

2.88

75.81

6.2

3.4

25.06

25.22

mmol/l

0.34

376

1419

Functional dyspepsia

941

4987

1.95

75.67

4.1

3.2

25.54

25.30

mmol/l

1.50

910

4814

Sequelae of external causes of morbidity and mortality

999

5414

1.92

75.47

4.7

3.5

25.17

25.20

mmol/l

0.10

967

5243

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

269

802

3.57

75.45

3.7

3.6

25.31

25.09

mmol/l

0.37

253

776

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

398

1497

2.84

74.79

5.5

3.0

25.56

25.32

mmol/l

0.58

384

1441

Mood [affective] disorders

3249

14681

1.44

74.72

3.9

3.4

25.34

25.26

mmol/l

0.59

3118

14214

Cardiomyopathy

652

3048

2.23

74.66

4.8

2.9

24.99

25.09

mmol/l

0.27

627

2962

Hypoglycaemia, other or unspecified

333

1145

3.15

74.40

7.1

3.5

25.00

25.24

mmol/l

0.54

318

1099

Type of accident

1060

5872

1.86

74.19

4.4

3.5

25.45

25.14

mmol/l

2.18

1027

5685

COPD, early/later onset

1792

9535

1.62

74.05

4.8

3.5

26.09

25.02

mmol/l

22.43

1736

9247

Organic, including symptomatic, mental disorders

2050

9374

1.58

73.62

3.7

3.6

25.27

25.19

mmol/l

0.49

1988

9101

Acute bronchitis

1497

8954

1.68

73.60

5.0

3.4

25.53

25.12

mmol/l

4.43

1443

8658

Other cataract

1575

7155

1.68

73.44

5.0

3.3

24.99

25.36

mmol/l

3.96

1517

6951

Ulcer of lower limb, not elsewhere classified

689

3340

2.18

72.94

7.8

3.3

24.74

25.18

mmol/l

2.15

671

3236

Diseases of peritoneum

461

1889

2.61

72.92

10.8

3.2

24.21

25.26

mmol/l

7.30

450

1818

Other headache syndromes

1261

7337

1.75

72.79

3.5

3.3

25.35

25.22

mmol/l

0.70

1216

7093

Focal epilepsy

811

4157

2.03

72.43

3.9

3.7

25.26

25.15

mmol/l

0.39

784

4013

Schizophrenia

560

2496

2.34

72.14

3.6

25.90

25.22

mmol/l

3.62

538

2408

Iron deficiency anaemia secondary to blood loss (chronic)

705

3455

2.14

72.05

5.8

3.2

24.81

25.17

mmol/l

1.61

682

3354

Ascites

357

1297

2.96

72.04

6.9

2.9

24.34

25.23

mmol/l

3.93

345

1253

COPD, hospital admissions

1767

9473

1.62

71.88

4.8

3.5

26.11

25.02

mmol/l

22.89

1711

9185

Finngen Rheumatological endpoints

2938

11594

1.46

71.42

3.9

3.3

25.16

25.22

mmol/l

0.42

2830

11200

Peripheral arterial reconstruction

809

4196

2.03

70.97

6.6

3.5

24.29

25.12

mmol/l

7.92

779

4067

Anxiety (asthma-related co-morbidities)

1660

7863

1.63

70.92

4.2

3.4

25.39

25.28

mmol/l

0.68

1614

7590

Non-selective monoamine reuptake inhibitors

1312

7488

1.73

70.89

4.1

3.3

25.60

25.24

mmol/l

2.99

1279

7261

Later onset COPD, excluding more controls

876

3490

2.00

70.76

4.9

2.8

25.86

24.86

mmol/l

10.11

849

3403

Additional codes for the location of defect, injury or illness

293

966

3.31

70.74

3.9

3.1

25.23

25.26

mmol/l

0.06

285

925

Vascular disorders of the intestines

373

1406

2.88

70.51

5.3

3.2

24.38

25.13

mmol/l

2.53

358

1367

Viral infections characterized by skin and mucous membrane lesions

1445

8834

1.68

70.35

5.1

3.5

25.18

25.20

mmol/l

0.09

1405

8541

Schizoaffective disorder

295

974

3.22

70.16

3.3

25.64

25.25

mmol/l

0.90

285

937

Unspecified dementia

611

2556

2.27

70.16

3.9

3.5

25.20

24.97

mmol/l

0.70

598

2476

Hypotension

842

4441

1.99

70.10

5.0

3.4

25.05

25.14

mmol/l

0.33

815

4305

Unspecified misadventure during surgical and medical care

306

1045

3.22

69.82

5.5

3.2

25.59

25.23

mmol/l

0.96

296

1004

Gastric ulcer

761

3882

2.05

69.39

5.0

3.3

24.94

25.13

mmol/l

0.70

747

3754

Neurotic, stress-related and somatoform disorders

2669

12735

1.46

68.68

4.2

3.4

25.46

25.27

mmol/l

2.03

2593

12282

ILD medications: azathioprine

511

2238

2.38

68.56

8.1

2.9

24.72

25.31

mmol/l

3.13

493

2155

Other disorders of ear

3017

13803

1.43

68.38

3.5

3.6

25.23

25.26

mmol/l

0.17

2915

13357

Other and unspecified drugs and medicaments

380

1464

2.78

68.31

5.6

3.2

25.58

25.36

mmol/l

0.50

367

1412

Other postsurgical states

302

1033

3.15

68.03

3.7

2.9

24.89

25.29

mmol/l

1.15

297

990

Osteoporosis

1072

5631

1.81

67.13

4.4

3.2

25.52

25.34

mmol/l

0.89

1030

5465

Amputation

505

2248

2.40

66.51

8.9

3.3

24.04

25.14

mmol/l

8.03

490

2169

Other gastritis (incl. Duodenitis)

852

4577

1.93

66.22

4.5

3.3

24.91

25.16

mmol/l

1.17

834

4421

Adjustment and management of implanted device

741

3812

2.03

65.91

5.2

2.7

25.30

25.10

mmol/l

0.89

723

3677

Anxiety disorders

2688

12888

1.45

65.90

4.2

3.4

25.45

25.27

mmol/l

1.97

2610

12430

Acute sinusitis

1551

8883

1.62

65.45

4.2

3.3

25.38

25.22

mmol/l

1.06

1508

8563

Peripheral artery operations in Hilmo

588

2796

2.22

65.28

7.9

3.2

24.20

25.20

mmol/l

8.10

576

2704

Undefined dementia

620

2764

2.19

65.24

3.9

3.4

25.20

25.06

mmol/l

0.40

607

2677

Other infectious diseases

371

1449

2.76

65.22

7.2

3.3

24.97

25.16

mmol/l

0.48

365

1398

Non-allergic asthma (mode)

624

2986

2.14

65.17

3.7

2.7

25.53

24.92

mmol/l

4.22

606

2892

Soft tissue disorders

3186

11673

1.42

64.83

4.0

3.4

25.23

25.13

mmol/l

0.86

3080

11269

COPD, hospital admission 2, with asthma infections

1312

6875

1.70

64.56

5.2

3.4

26.27

24.97

mmol/l

23.71

1269

6669

Cardiomyopathies, Primary/intrinsic

474

2072

2.41

64.39

4.8

2.9

24.65

25.10

mmol/l

1.79

452

2015

Tobacco use

252

802

3.41

64.38

4.5

3.5

25.64

25.09

mmol/l

1.37

245

773

Diseases of the skin and subcutaneous tissue

3095

11061

1.42

64.33

4.5

3.1

25.11

25.23

mmol/l

1.07

3009

10642

Urinary track infection

1490

4541

1.67

64.24

3.8

2.8

25.29

25.50

mmol/l

1.42

1447

4385

Azathioprine

511

2302

2.31

64.16

8.1

3.2

24.72

25.25

mmol/l

2.63

493

2218

Other/unspecified dorsalgia

1241

7386

1.70

63.86

3.8

3.5

25.58

25.17

mmol/l

3.98

1201

7163

External causes of morbidity and mortality

1908

6190

1.57

63.84

3.8

3.1

25.15

25.21

mmol/l

0.29

1840

5974

Coronary artery bypass grafting

1003

4197

1.84

63.21

4.3

3.0

24.84

25.18

mmol/l

2.18

961

4076

Cytomegaloviral disease

148

333

5.10

63.07

11.1

3.3

24.08

25.23

mmol/l

2.80

138

322

Cytomegaloviral disease, including avohilmo

149

337

5.07

63.06

11.0

3.3

24.09

25.22

mmol/l

2.75

139

326

Cardiomyopathy (excluding other)

488

2184

2.35

62.71

4.8

2.9

24.64

25.10

mmol/l

1.89

466

2123

Dorsopathies

3135

11386

1.41

62.70

3.7

3.5

25.32

25.14

mmol/l

2.07

3020

11021

All influenza (not pneumonia)

511

2324

2.29

62.64

5.2

2.8

25.41

25.12

mmol/l

0.93

488

2239

Gastro-oesophageal reflux disease

2185

12627

1.48

61.88

4.2

3.3

25.17

25.31

mmol/l

1.11

2110

12203

Early onset COPD

811

4386

1.92

61.87

4.8

3.5

26.38

25.01

mmol/l

16.10

787

4245

Cytomegalovirus infection, IBD co-morbidity

148

339

5.04

61.84

11.1

3.4

24.08

25.25

mmol/l

2.93

138

329

Disorders of parathyroid gland

824

4432

1.91

61.63

7.2

3.2

25.08

25.29

mmol/l

0.92

793

4299

Hypocalcemia

156

374

4.83

61.63

11.0

3.3

25.83

25.12

mmol/l

0.89

150

362

Gout, idiopatic and unspecified

1063

6250

1.77

61.51

6.0

3.5

24.67

25.14

mmol/l

3.85

1035

6059

Caries of enamel

1475

15004

0.63

61.39

3.6

3.5

25.20

25.27

mmol/l

0.36

1429

14493

Open wound of head

1913

12058

1.52

61.32

3.8

3.6

25.11

25.19

mmol/l

0.46

1858

11660

Benign neoplasms

3052

11938

1.41

61.23

4.2

3.4

25.11

25.19

mmol/l

0.69

2962

11499

Focal epilepsy, mode (most common among epilepsy diagnosis)

707

3666

2.01

61.22

3.8

3.7

25.30

25.20

mmol/l

0.34

685

3540

ILD, hospital admission 2, with pulmonary infections

432

1861

2.46

61.09

5.0

2.8

25.66

24.97

mmol/l

3.07

407

1797

Carpal tunnel syndrome

1962

11445

1.51

61.08

3.8

3.3

25.42

25.29

mmol/l

0.93

1897

11113

Noninfective enteritis and colitis

1495

9532

1.60

60.89

4.9

3.5

24.93

25.22

mmol/l

2.40

1447

9217

Bipolar affective disorders

538

2520

2.20

60.88

3.1

3.3

25.15

25.19

mmol/l

0.09

518

2435

Sleep apnoea

2997

13628

1.41

60.74

4.0

3.4

25.54

25.22

mmol/l

5.46

2909

13167

Focal epilepsy, strict definition

738

3895

1.97

60.60

3.8

3.7

25.31

25.17

mmol/l

0.51

714

3761

Superficial injury of head

890

4972

1.85

60.48

4.0

3.5

25.35

25.15

mmol/l

1.01

861

4798

Valvular operations

542

2578

2.20

59.73

4.6

2.9

24.94

25.07

mmol/l

0.34

525

2510

Other symptoms and signs involving cognitive functions and awareness

1694

9874

1.56

59.66

3.9

3.4

25.27

25.22

mmol/l

0.26

1632

9572

Chronic pancreatitis

507

2357

2.27

59.63

5.4

3.5

24.69

25.21

mmol/l

2.27

487

2272

Other diseases of the respiratory system

847

4723

1.87

58.78

5.6

3.5

27.30

24.94

mmol/l

38.64

798

4577

Other respiratory disorders and diseases

847

4723

1.87

58.78

5.6

3.5

27.30

24.94

mmol/l

38.64

798

4577

Malignant neoplasm, wide definition

2634

10854

1.43

58.59

3.9

3.4

25.19

25.34

mmol/l

1.32

2557

10474

Neoplasms

2125

7557

1.49

57.88

4.0

3.3

25.13

25.21

mmol/l

0.48

2045

7265

Other and unspecified nonorganic psychotic disorders

557

2697

2.13

57.87

3.3

3.6

25.70

25.20

mmol/l

1.98

531

2594

Sequelae of cerebrovascular disease

1427

7777

1.61

57.71

4.3

3.5

25.27

25.17

mmol/l

0.52

1384

7536

Other/unspecified cytomegaloviral diseases

129

280

5.36

57.67

12.0

3.6

24.02

24.99

mmol/l

1.95

123

270

Malignant neoplasm, including Hilmo

2620

10834

1.43

57.35

4.0

3.4

25.18

25.34

mmol/l

1.49

2542

10454

Candidiasis

511

2414

2.21

57.23

5.5

3.2

25.31

25.28

mmol/l

0.06

494

2333

Exclusions for E4_PCOS_BROAD

588

2924

2.09

57.11

5.2

3.7

25.18

25.29

mmol/l

0.32

563

2816

Hyperparathyroidism

734

3911

1.93

56.80

7.5

3.2

24.98

25.28

mmol/l

1.46

705

3804

Malignant neoplasm of digestive organs, including Hilmo

1581

7570

1.57

56.71

3.6

3.4

24.80

25.34

mmol/l

6.65

1528

7332

Cellulitis

793

4372

1.88

56.65

6.0

3.5

24.97

25.15

mmol/l

0.68

767

4227

All anxiety disorders

1683

8610

1.54

56.55

4.2

3.4

25.37

25.21

mmol/l

1.13

1637

8299

COPD, hospital admissions 3, with asthma pneumonia sepsis

1124

5836

1.71

56.46

5.5

3.4

26.31

24.90

mmol/l

23.02

1087

5660

Allergic asthma (mode), excluding more controls

564

2694

2.09

56.17

3.0

2.6

25.43

25.06

mmol/l

2.01

543

2596

Acute upper respiratory infections

3321

14763

1.36

55.98

4.1

3.4

25.31

25.21

mmol/l

0.96

3213

14275

Other metabolic disorders

406

1761

2.39

55.66

4.3

2.7

26.02

25.44

mmol/l

2.70

391

1697

Other skin changes

782

4327

1.88

55.60

5.1

3.4

24.98

25.17

mmol/l

0.85

757

4186

Intestinal adhesions without obstruction

378

1605

2.50

55.34

4.5

3.2

25.05

25.21

mmol/l

0.31

363

1553

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

599

3055

2.06

55.01

5.4

3.7

24.28

25.15

mmol/l

5.89

576

2951

Impacted teeth

487

1936

2.21

54.78

4.4

3.6

25.22

24.95

mmol/l

1.15

473

1855

Undetermined asthma, excluding more controls

414

1823

2.35

54.62

5.1

2.5

25.88

24.98

mmol/l

4.50

396

1762

Use of hypnotics and sedatives

3332

14176

1.36

54.45

4.2

3.4

25.28

25.22

mmol/l

0.46

3221

13707

Nonorganic sleeping disorders, excluding more controls

571

2857

2.05

54.11

4.0

3.2

25.07

25.14

mmol/l

0.19

549

2765

Gout, strict definition

794

4470

1.86

53.83

6.1

3.6

24.63

25.11

mmol/l

2.94

770

4325

Spinal stenosis

1790

8916

1.51

53.71

3.5

25.29

25.16

mmol/l

0.81

1737

8667

ILD, hospital admissions 3, with pneumonia sepsis

384

1666

2.45

53.67

5.3

2.8

25.71

24.98

mmol/l

3.00

360

1603

Malignant neoplasm

2557

10719

1.42

53.58

3.9

3.4

25.15

25.34

mmol/l

2.04

2488

10342

Shoulder lesions

2451

10453

1.43

53.43

3.7

3.3

25.27

25.19

mmol/l

0.59

2363

10103

Hernia

2940

14375

1.38

53.26

4.1

3.4

25.19

25.29

mmol/l

0.83

2847

13891

Injuries to the thorax

1639

10999

1.52

53.20

4.1

3.5

25.39

25.18

mmol/l

1.81

1595

10651

Pain in thoracic spine

512

2487

2.13

53.07

3.4

3.3

25.36

25.11

mmol/l

1.03

494

2409

Acidosis

135

325

4.76

52.92

7.3

2.5

22.82

25.35

mmol/l

6.06

130

314

Noninfectious colitis NAS

505

2453

2.15

52.68

5.5

3.3

24.81

25.27

mmol/l

2.29

491

2367

Abnormal findings on diagnostic imaging of other body structures

537

2670

2.10

52.68

5.0

3.4

25.35

25.23

mmol/l

0.31

523

2582

Post-traumatic stress disorder

227

758

3.10

52.36

5.2

3.1

25.19

24.97

mmol/l

0.44

217

727

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

920

5255

1.76

52.28

3.6

3.4

25.17

25.28

mmol/l

0.41

895

5082

Failure and rejection of transplanted organs and tissues

187

6.29

52.09

13.5

3.4

23.22

25.33

mmol/l

5.93

181

Postprocedural endocrine and metabolic disorders, not elsewhere classified

376

1627

2.40

51.89

4.1

2.7

26.14

25.46

mmol/l

3.52

361

1569

Other external causes of accidental injury

2393

8484

1.43

51.71

3.8

3.3

25.23

25.17

mmol/l

0.38

2306

8191

Malignant neoplasm

2543

10716

1.41

51.69

3.9

3.4

25.15

25.34

mmol/l

2.08

2474

10339

Other complications of surgical and medical care, not elsewhere classified

368

1590

2.43

51.45

5.1

2.9

25.41

25.39

mmol/l

0.04

351

1534

Traumatic subdural haemorrhage

559

2649

2.06

51.44

4.1

3.5

25.21

24.92

mmol/l

1.19

542

2569

Leisure time condition

651

3481

1.94

51.43

4.2

3.4

25.50

25.17

mmol/l

1.61

631

3361

Hernia of abdominal wall

1554

10400

1.53

51.41

4.8

3.4

25.16

25.19

mmol/l

0.12

1515

10060

Somatoform disorder

505

2470

2.11

51.34

4.2

3.2

25.63

25.26

mmol/l

1.79

488

2387

Symptoms and signs involving the skin and subcutaneous tissue

2276

15425

1.41

50.77

4.4

3.5

25.19

25.25

mmol/l

0.39

2208

14922

Other viral diseases

836

4804

1.78

50.77

6.6

3.6

25.10

25.16

mmol/l

0.18

798

4626

Injuries to the hip and thigh

1755

10779

1.49

50.74

4.1

3.5

25.37

25.18

mmol/l

1.46

1707

10440

Liquid cancers

1081

6325

1.66

50.63

4.2

3.4

24.91

25.32

mmol/l

3.42

1050

6117

Fentanyl

468

2247

2.18

50.46

4.8

3.3

25.42

25.15

mmol/l

0.86

454

2186

Other anxiety disorders

1203

6443

1.61

50.45

4.1

3.4

25.20

25.22

mmol/l

0.07

1167

6211

Familial hypercholesterolemia

578

3001

2.01

50.21

4.4

3.0

24.89

25.19

mmol/l

1.17

557

2915

Other disorders of skin and subcutaneous tissue, not elsewhere classified

560

2877

2.03

50.19

6.6

3.3

24.89

25.22

mmol/l

1.35

546

2784

Toxic effects of substances chiefly nonmedicinal as to source

403

1829

2.30

50.04

3.6

3.5

25.31

25.25

mmol/l

0.12

395

1760

Respiratory insufficiency

346

1474

2.47

49.78

5.8

2.8

28.83

24.71

mmol/l

34.71

325

1423

Ventral hernia

869

5114

1.75

49.75

4.5

3.4

25.25

25.20

mmol/l

0.15

847

4950

Accidents

2378

8484

1.42

49.62

3.8

3.3

25.23

25.17

mmol/l

0.37

2294

8191

Amputation of toe

352

1530

2.47

49.46

9.4

3.3

24.00

25.15

mmol/l

6.05

343

1477

Certain disorders involving the immune mechanism

640

3448

1.92

49.42

5.9

3.5

24.79

25.27

mmol/l

3.09

614

3327

Cirrhosis of liver, NAS

273

1056

2.81

49.41

6.1

3.2

24.14

25.27

mmol/l

4.10

263

1017

Viral pneumonia (unknown virus, not influenza)

279

1085

2.73

49.23

7.8

3.4

25.20

mmol/l

0.00

272

1039

Sleep apnoea, including avohilmo

3057

13821

1.35

49.10

3.8

3.5

25.50

25.22

mmol/l

4.58

2950

13366

Extreme obesity with alveolar hypoventilation

198

645

3.35

49.04

4.9

3.1

28.51

25.30

mmol/l

12.93

186

623

Sequelae with surgical and medical care as external cause

753

4282

1.82

48.88

4.8

3.5

25.19

25.20

mmol/l

0.01

728

4142

Spondylosis

1776

9570

1.48

48.43

3.3

3.5

25.56

25.21

mmol/l

4.20

1720

9285

Symptoms and signs involving the nervous and musculoskeletal systems

1886

13238

1.45

48.39

3.7

3.6

25.50

25.19

mmol/l

3.69

1820

12832

Malignant neoplasm of digestive organs

1430

7236

1.55

48.14

3.6

3.4

24.69

25.33

mmol/l

8.26

1382

7008

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

326

1381

2.51

48.13

5.9

3.1

25.04

25.36

mmol/l

0.91

321

1327

Cystitis

2559

11099

1.39

48.12

4.2

3.3

25.18

25.19

mmol/l

0.05

2464

10727

Other noninfective gastroenteritis and colitis

824

4812

1.76

48.12

5.7

3.5

24.92

25.18

mmol/l

1.25

798

4651

Panic disorder

387

1748

2.28

47.99

4.1

3.1

25.33

25.24

mmol/l

0.19

377

1670

Solid cancers, including Hilmo

2527

10718

1.39

47.89

3.9

3.4

25.20

25.35

mmol/l

1.31

2453

10341

Allergic asthma (mode)

564

2861

1.96

47.49

3.0

2.8

25.43

25.03

mmol/l

2.33

543

2760

Depression or dysthymia

2005

7651

1.45

47.49

3.9

3.5

25.34

25.23

mmol/l

0.65

1935

7419

Amiodarone users

445

2170

2.18

46.85

4.4

3.6

25.17

25.09

mmol/l

0.21

432

2093

Candidiasis, including avohilmo

926

5624

1.69

46.64

4.6

3.4

25.29

25.23

mmol/l

0.24

897

5431

Other ulcerative colitis

226

811

2.96

46.60

5.8

3.5

24.95

25.29

mmol/l

0.66

218

777

Nonischemic cardiomyopathy

377

1717

2.30

46.55

4.4

3.0

25.04

25.26

mmol/l

0.50

362

1662

COPD, hospital admissions 1, only main diagnosis

1300

7338

1.56

46.40

5.3

3.4

26.24

24.99

mmol/l

22.68

1262

7117

Undetermined asthma

414

1953

2.19

46.22

5.1

2.7

25.88

24.92

mmol/l

5.01

396

1889

Other symptoms and signs involving the nervous and musculoskeletal systems

1311

8659

1.54

46.03

3.6

25.62

25.18

mmol/l

4.69

1265

8381

Decubitus ulcer and pressure area

318

1366

2.50

45.92

7.5

3.2

25.18

25.17

mmol/l

0.02

307

1317

Systemic connective tissue disorders

1165

7515

1.59

45.86

4.2

3.4

25.34

25.28

mmol/l

0.28

1121

7280

Fibrosis and cirrhosis of liver

335

1469

2.43

45.84

6.1

3.2

24.35

25.30

mmol/l

3.76

320

1415

Gout, unspecified

836

4995

1.74

45.76

6.1

3.4

24.63

25.14

mmol/l

3.62

814

4831

Congenital malformations of the urinary system

234

865

2.89

45.75

11.1

3.5

23.56

25.18

mmol/l

11.26

226

828

Delirium, not induced by alcohol and other psychoactive substances

554

2927

1.98

45.71

5.0

3.5

25.16

25.07

mmol/l

0.25

534

2835

Acute pancreatitis

694

3928

1.83

45.66

5.0

3.4

24.74

25.17

mmol/l

2.38

670

3797

Other and unspecified effects of external causes

785

4588

1.75

45.58

4.3

3.5

25.08

25.18

mmol/l

0.34

758

4425

Other disorders of adrenal gland

200

682

3.16

45.54

7.6

3.6

25.63

25.18

mmol/l

0.84

195

657

Adrenocortical insufficiency

175

555

3.44

45.32

8.1

3.5

25.66

25.19

mmol/l

0.81

170

535

Diagnoses used for exclusion with ILD

915

5604

1.68

45.03

4.6

3.5

25.46

25.09

mmol/l

2.71

873

5427

Unspecified fall

1706

11693

1.46

45.02

4.5

3.6

25.21

25.22

mmol/l

0.04

1647

11330

Diabetic retinopathy

1625

6934

1.51

45.01

6.0

3.7

24.76

25.10

mmol/l

3.13

1569

6756

Other and unspecified local infections of skin and subcutaneous tissue

371

1704

2.28

44.97

6.4

3.4

25.20

25.19

mmol/l

0.03

363

1642

Any event in cancer register

2646

11444

1.37

44.96

3.9

3.4

25.17

25.31

mmol/l

1.29

2573

11043

Myocarditis

144

400

3.78

44.90

4.7

2.3

25.32

25.38

mmol/l

0.07

137

388

Vitreous haemorrhage

414

1995

2.19

44.64

8.7

3.4

24.48

25.25

mmol/l

4.31

399

1928

Pneumonitis due to solids and liquids

386

1817

2.25

44.43

5.1

3.5

25.66

24.98

mmol/l

3.33

368

1751

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

517

2603

1.99

44.32

7.4

3.7

24.56

25.23

mmol/l

4.42

502

2503

Type1 diabetes, definitions combined, early onset

187

618

3.15

43.87

4.4

4.6

24.81

24.96

mmol/l

0.22

179

591

Other viral diseases, including avohilmo

1013

6315

1.62

43.72

5.9

3.5

25.10

25.17

mmol/l

0.25

965

6088

Congenital malformations of the urinary system, including avohilmo

243

937

2.76

43.71

10.8

3.5

23.61

25.18

mmol/l

11.06

235

897

Mental and behavioural disorders due to sedatives or hypnotics

241

926

2.74

43.41

4.0

3.5

25.35

25.24

mmol/l

0.15

232

893

Other degenerative diseases of the nervous system

909

4027

1.68

43.40

3.4

3.2

25.42

25.09

mmol/l

2.05

878

3912

Solid cancers

2449

10572

1.38

43.33

3.9

3.4

25.19

25.35

mmol/l

1.45

2383

10205

Other diseases of pancreas

341

1541

2.34

43.31

5.6

3.3

24.86

25.26

mmol/l

1.29

335

1489

Infective dermatitis

421

2062

2.13

43.20

4.2

3.4

25.17

25.27

mmol/l

0.22

409

1981

Other obstructive and reflux uropathy

172

554

3.32

42.98

8.6

2.5

23.91

25.56

mmol/l

6.80

167

531

Other viral diseases, not elsewhere classified

563

3034

1.90

42.76

6.2

3.5

25.44

25.16

mmol/l

1.15

539

2918

Osteomyelitis

284

1197

2.53

42.58

9.3

3.3

24.69

25.12

mmol/l

1.17

276

1155

Duodenal ulcer

455

2310

2.06

42.46

4.5

3.4

24.18

25.11

mmol/l

5.38

442

2223

Diabetic neuropathy

608

3405

1.90

42.43

7.0

4.1

24.89

25.00

mmol/l

0.31

589

3316

Disorders of the thyroid gland

2887

14216

1.33

42.35

3.6

3.5

25.23

25.19

mmol/l

0.22

2788

13770

Other local infections of skin and subcutaneous tissue

383

1828

2.19

42.10

6.4

3.4

25.17

25.21

mmol/l

0.08

375

1760

Injuries to the abdomen, lower back, lumbar spine and pelvis

1378

9234

1.50

42.06

4.2

3.5

25.45

25.18

mmol/l

2.02

1334

8938

Lumbar disc prolapse

1898

10044

1.42

42.04

3.3

3.5

25.25

25.21

mmol/l

0.23

1810

9731

Mental and behavioural disorders due to opioids

140

402

3.71

41.91

4.0

3.5

25.36

25.11

mmol/l

0.36

130

387

Injury, poisoning and certain other consequences of external causes

1479

4993

1.50

41.48

3.5

3.2

25.09

25.26

mmol/l

0.98

1424

4808

Other diseases of anus and rectum

1012

6446

1.60

41.36

3.8

3.2

25.19

25.25

mmol/l

0.19

989

6240

Special screening examination for other diseases and disorders

379

1805

2.17

41.33

6.8

2.9

24.43

25.15

mmol/l

3.33

364

1739

Other symptoms and signs involving the digestive system and abdomen

501

2637

1.95

41.32

4.8

2.9

25.21

25.32

mmol/l

0.30

482

2556

Zoster [herpes zoster]

680

3944

1.78

41.26

4.5

3.3

25.35

25.18

mmol/l

0.67

665

3817

Coxarthrosis [arthrosis of hip](FG)

1842

9032

1.43

41.24

3.5

3.3

25.36

25.26

mmol/l

0.61

1793

8760

Polyneuropathies and other disorders of the peripheral nervous system

809

4921

1.70

41.19

5.7

3.5

25.49

25.10

mmol/l

2.34

786

4761

Diseases of the ear and mastoid process

3359

13010

1.31

41.13

3.7

3.5

25.19

25.23

mmol/l

0.25

3257

12558

Other specified and unspecified personality disorders

274

1147

2.49

41.00

3.3

25.32

25.24

mmol/l

0.13

266

1103

Periapical abscess

1388

9526

1.48

40.38

4.3

3.5

25.17

25.27

mmol/l

0.47

1342

9203

Selective serotonin reuptake inhibitors

3017

11995

1.32

40.32

3.7

3.5

25.38

25.17

mmol/l

2.56

2915

11609

Diseases of the eye and adnexa

2140

7772

1.39

40.32

4.2

3.1

25.06

25.26

mmol/l

1.81

2055

7503

Viral pneumonia (known virus, not influenza)

155

493

3.48

40.30

8.0

3.5

25.44

25.03

mmol/l

0.56

147

477

Abnormal findings on examination of urine, without diagnosis

201

737

2.95

40.28

6.2

3.5

24.31

25.14

mmol/l

2.56

194

709

Other and unspecified polyneuropathies, also in other diseases

720

4281

1.74

40.08

5.8

3.5

25.39

25.11

mmol/l

1.31

699

4139

Injuries to the shoulder and upper arm

2710

15922

1.33

40.06

3.9

3.5

25.25

mmol/l

0.02

2624

15398

Cholangitis (primary sclerosing, PSC)

266

1120

2.52

39.89

5.5

3.2

24.42

25.19

mmol/l

2.96

257

1078

Diabetic retinopathy, strict definition

800

4351

1.71

39.87

8.1

3.7

24.62

25.07

mmol/l

2.68

766

4242

Other and unspecified myopathies

375

1828

2.16

39.41

4.4

3.4

24.98

25.21

mmol/l

0.57

366

1768

Recurrent or chronic depression

1023

4526

1.59

39.39

3.7

3.4

25.35

25.36

mmol/l

0.06

995

4380

Speech and linguistic disorders, excluding more controls

219

780

2.72

39.39

4.7

4.1

24.77

25.03

mmol/l

0.61

214

742

Endocarditis

161

528

3.29

39.32

8.9

2.8

24.57

24.94

mmol/l

0.63

155

507

Irritable bowel syndrome

763

4608

1.69

39.24

3.9

3.1

25.38

25.29

mmol/l

0.36

751

4445

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1009

6531

1.58

39.07

3.8

3.5

25.51

25.28

mmol/l

1.34

960

6325

Hypercalcemia

215

832

2.81

39.03

6.8

3.1

25.42

25.34

mmol/l

0.11

210

800

Hypothyroidism, strict autoimmune

2101

10111

1.38

38.95

3.6

3.1

25.20

25.23

mmol/l

0.14

2026

9794

Phobic anxiety disorders

319

1447

2.26

38.94

4.6

3.3

25.66

25.21

mmol/l

1.47

308

1387

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

533

2833

1.88

38.91

7.3

3.7

24.59

25.21

mmol/l

4.12

517

2724

Status epilepticus

171

586

3.15

38.77

6.1

3.3

24.97

25.13

mmol/l

0.26

164

563

Migraine

1197

6204

1.52

38.50

3.2

3.4

25.19

25.23

mmol/l

0.17

1158

5979

Primary_lymphoid and hematopoietic malignant neoplasms

869

5471

1.64

38.45

4.3

3.6

24.94

25.14

mmol/l

0.97

848

5301

Maltreatment syndromes

166

561

3.11

37.96

3.7

3.3

24.96

25.18

mmol/l

0.33

158

540

Cholecystitis

527

2911

1.88

37.86

4.7

3.3

25.11

25.13

mmol/l

0.05

513

2810

Diseases of the myoneural junction and muscle

468

2495

1.96

37.80

4.2

3.5

25.13

25.24

mmol/l

0.28

455

2408

Transport accidents

1330

7585

1.48

37.73

3.5

3.2

25.23

25.16

mmol/l

0.30

1286

7320

Acute gastritis

292

1312

2.34

37.58

4.8

3.0

25.13

25.25

mmol/l

0.26

281

1259

Dermatitis and eczema

3415

15924

1.28

37.29

4.0

3.5

25.20

25.24

mmol/l

0.28

3324

15370

Congenital malformations, deformations and chromosomal abnormalities

1544

10366

1.43

37.25

5.1

3.4

25.14

25.21

mmol/l

0.34

1494

10010

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

368

1816

2.12

37.22

6.0

3.3

25.16

25.26

mmol/l

0.19

358

1749

Mental and behavioural disorders due to tobacco

309

1425

2.27

37.18

4.5

3.5

25.80

25.22

mmol/l

1.77

303

1378

Diseases of the musculoskeletal system and connective tissue

1443

4961

1.48

37.07

3.7

3.3

25.24

25.08

mmol/l

0.83

1385

4789

Smoking dependency

309

1427

2.27

37.05

4.5

3.5

25.80

25.20

mmol/l

1.83

303

1378

Other respiratory diseases principally affecting the interstitium

694

4179

1.72

36.92

5.2

3.5

25.52

25.09

mmol/l

2.15

661

4045

Disorders of skin appendages

1370

9491

1.46

36.68

4.7

3.4

25.14

25.20

mmol/l

0.29

1339

9160

Cerebral cysts

211

830

2.68

36.40

4.7

3.5

23.79

25.21

mmol/l

5.58

204

795

Fracture of rib(s), sternum and thoracic spine

1085

7262

1.53

36.25

4.2

3.6

25.47

25.12

mmol/l

2.74

1056

7034

Other pleural conditions

427

2254

1.99

35.77

6.2

3.3

25.41

24.90

mmol/l

2.04

409

2170

Alzheimer’s disease (Atypical or mixed), excluding more controls

404

1537

2.05

35.49

3.1

3.2

25.51

24.85

mmol/l

3.39

387

1495

Other diseases of pericardium

180

665

2.88

35.35

5.1

2.9

25.07

25.02

mmol/l

0.06

173

644

Acute pancreatitis (for exclusion)

694

4228

1.69

35.09

5.0

3.5

24.74

25.19

mmol/l

2.53

670

4085

Any dementia, excluding more controls

1358

6502

1.47

34.83

3.5

3.4

25.33

25.11

mmol/l

1.52

1314

6318

Rotator cuff syndrome

1948

9920

1.37

34.80

3.7

3.3

25.27

25.21

mmol/l

0.32

1883

9599

Visual disturbances

1501

10745

1.42

34.75

4.6

3.5

25.24

25.26

mmol/l

0.09

1447

10413

Other viral diseases, not elsewhere classified, including avohilmo

719

4387

1.66

34.67

5.5

3.5

25.35

25.16

mmol/l

0.85

686

4233

Other systemic involvement of connective tissue (FG)

818

5096

1.61

34.57

3.6

3.2

25.51

25.24

mmol/l

1.40

786

4943

Use of disulfiram, acamprosate or naltrexone

291

1350

2.25

34.47

3.9

3.6

25.29

25.27

mmol/l

0.03

280

1300

Embedded and impacted teeth

588

2754

1.76

34.40

4.3

3.7

25.15

25.07

mmol/l

0.25

570

2634

COPD-related respiratory insufficiency

469

2588

1.89

34.15

6.5

3.4

27.57

24.93

mmol/l

23.55

445

2499

Hypothyroidism, other/unspecified

2597

13183

1.31

33.86

3.6

3.5

25.28

25.20

mmol/l

0.61

2496

12782

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2942

14583

1.29

33.79

4.3

3.4

25.20

25.25

mmol/l

0.32

2855

14102

Coxarthrosis

1679

7860

1.40

33.62

3.5

3.3

25.32

25.24

mmol/l

0.45

1635

7635

Visual disturbances and blindness

1631

11903

1.39

33.38

4.7

3.5

25.19

25.26

mmol/l

0.37

1574

11532

Allergic contact dermatitis

379

1957

1.99

33.28

3.7

3.1

25.70

25.39

mmol/l

1.20

370

1884

Vascular syndromes of brain in cerebrovascular disorders

218

917

2.57

33.28

3.5

3.4

25.59

25.16

mmol/l

1.01

208

884

Other problems related to primary support group, including family circumstances

286

1294

2.21

33.08

7.0

3.4

25.04

25.18

mmol/l

0.32

280

1238

Myalgia

669

4093

1.67

32.86

3.7

3.2

25.59

25.17

mmol/l

2.60

651

3966

Vascular diseases of the intestine

191

763

2.70

32.46

5.2

3.0

23.80

25.16

mmol/l

3.62

182

736

Lung diseases due to external agents

535

3112

1.78

32.40

4.8

3.5

25.70

25.07

mmol/l

3.97

513

3003

Familial hypercholesterolemia, with ischemic heart disease

362

1871

2.03

32.35

4.5

3.0

24.70

25.26

mmol/l

2.02

348

1813

Hypothyreosis and Thyroxine purchase for inclusion criteria

2687

13731

1.29

32.35

3.6

3.5

25.32

25.21

mmol/l

0.97

2583

13315

Assault

354

1815

2.00

31.68

4.5

3.7

24.93

25.19

mmol/l

0.64

341

1751

Event of undetermined intent

220

941

2.45

31.68

4.4

3.5

25.00

25.22

mmol/l

0.34

215

904

Other diseases of biliary tract

336

1707

2.06

31.46

5.1

3.3

24.45

25.26

mmol/l

3.62

329

1655

Other arthritis (FG)

919

6116

1.53

31.38

4.4

3.3

25.31

25.19

mmol/l

0.43

889

5929

Migraine without aura

414

2235

1.88

31.38

3.1

3.4

24.97

25.18

mmol/l

0.67

396

2151

Fracture of femur

1032

6334

1.50

31.33

4.2

3.5

25.35

25.16

mmol/l

0.89

1006

6135

Benign neoplasm: Colon, unspecified

883

5858

1.55

31.05

5.1

3.5

25.02

25.14

mmol/l

0.51

859

5674

Aneurysms, operations, SAH

542

3198

1.75

31.02

4.0

3.4

25.27

25.19

mmol/l

0.21

528

3084

Gonarthrosis [arthrosis of knee](FG)

2286

10085

1.32

30.89

3.3

25.30

25.27

mmol/l

0.14

2209

9762

Pleural effusion

584

3528

1.71

30.79

5.2

3.4

25.52

24.96

mmol/l

2.97

567

3407

Mental retardation, excluding more controls

128

405

3.22

30.78

6.1

4.6

25.55

24.99

mmol/l

1.00

123

389

Inflammatory bowel disease

877

5812

1.54

30.53

4.4

3.6

24.97

25.22

mmol/l

1.29

847

5618

Idiopathic gout

389

2104

1.94

30.43

6.0

3.4

24.70

25.10

mmol/l

1.20

382

2035

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

638

3884

1.65

30.31

5.4

3.3

25.24

25.18

mmol/l

0.15

612

3733

Dementia, including avohilmo

1681

8490

1.38

30.26

3.3

3.6

25.21

25.15

mmol/l

0.31

1638

8244

Parkinson's disease, excluding more controls

459

2384

1.83

30.22

3.6

3.2

25.55

24.94

mmol/l

3.41

437

2322

Tubulo-interstitial nephritis, not specified as acute or chronic

241

1095

2.30

30.15

5.7

2.6

24.78

25.63

mmol/l

3.09

230

1055

Migraine with aura

542

3209

1.72

29.96

3.1

3.2

25.30

25.19

mmol/l

0.33

523

3096

Cervicalgia

629

3888

1.66

29.85

3.7

3.4

25.51

25.13

mmol/l

2.36

600

3767

Intentional self-harm by sharp object

261

3.84

29.74

3.6

3.3

24.41

24.78

mmol/l

0.43

246

Other diseases of liver

555

3330

1.71

29.73

4.0

3.3

24.79

25.30

mmol/l

2.66

541

3216

L04AX Other immunosuppressants

1571

11615

1.37

29.63

4.8

3.5

25.20

25.27

mmol/l

0.36

1517

11229

Somnolence, stupor and coma

177

714

2.63

29.26

6.3

3.3

25.78

25.12

mmol/l

1.27

166

687

Second line medication for Crohn's disease

1605

11922

1.36

29.25

4.7

3.5

25.18

25.27

mmol/l

0.46

1551

11528

Nontraumatic intracranial haemmorrhage

714

4580

1.60

29.24

4.1

3.5

25.32

25.13

mmol/l

0.85

692

4439

Blood alcohol or alcohol intoxication level

102

304

3.63

29.21

5.3

3.2

24.44

24.94

mmol/l

0.62

289

Cardiodefibrillation

1248

8926

1.43

29.08

4.4

3.6

25.38

25.13

mmol/l

1.90

1213

8658

Hypopituitarism

237

1087

2.27

28.94

4.9

4.0

24.96

25.15

mmol/l

0.39

224

1047

Sleep disorders (combined)

3278

13799

1.25

28.90

3.7

3.5

25.33

25.20

mmol/l

1.36

3172

13337

Benign neoplasm: Skin of other and unspecified parts of face

378

2055

1.91

28.85

4.3

3.4

25.30

25.23

mmol/l

0.16

369

1979

Nonorganic sleeping disorders

571

3473

1.68

28.80

4.0

3.5

25.07

25.21

mmol/l

0.44

549

3345

Other and unspecified injuries of head

273

1329

2.15

28.72

4.0

3.4

25.41

25.21

mmol/l

0.41

268

1280

Other symptoms and signs involving the circulatory and respiratory systems

206

893

2.40

28.67

4.9

2.6

25.63

25.10

mmol/l

1.30

193

852

Thyroiditis, ILD-related definition

324

1672

2.00

28.64

3.8

3.2

25.41

25.31

mmol/l

0.21

314

1608

Diabetic maculopathy

571

3338

1.69

27.80

6.8

3.7

24.58

25.05

mmol/l

2.14

548

3259

Alcohol-induced chronic pancreatitis

234

1090

2.26

27.79

5.7

3.8

24.94

25.25

mmol/l

0.56

224

1054

Psoriatic and enteropathic arthropathies

353

1898

1.92

27.64

4.5

3.4

25.53

25.26

mmol/l

0.80

345

1838

Special screening examination for infectious and parasitic diseases

2030

0.32

27.63

3.2

2.7

25.56

25.30

mmol/l

0.42

1943

Dermatophytosis

465

2730

1.76

27.25

4.2

3.5

25.21

25.16

mmol/l

0.13

452

2636

Any dementia

1476

7541

1.38

27.17

3.5

3.6

25.33

25.13

mmol/l

1.38

1429

7321

Arthrosis

2106

8907

1.31

26.89

3.5

3.3

25.30

25.25

mmol/l

0.23

2029

8629

Other condition

443

2574

1.77

26.80

4.6

3.4

25.40

25.25

mmol/l

0.37

429

2471

Hepatic failure, not elsewhere classified

162

656

2.65

26.80

5.8

3.0

24.00

25.17

mmol/l

3.59

149

629

Acute and transient psychotic disorders

324

1711

1.95

26.79

3.5

3.4

25.79

25.26

mmol/l

1.52

309

1650

Viral warts

295

1511

2.02

26.76

6.9

3.4

24.87

25.26

mmol/l

1.21

286

1455

Ulcer of oesophagus

266

1323

2.11

26.64

4.7

3.3

25.18

25.08

mmol/l

0.20

261

1276

Corns and callosities

243

1171

2.18

26.40

6.0

3.2

25.00

25.30

mmol/l

0.59

232

1131

Parkinson's disease, strict definition, excluding more controls

425

2281

1.79

26.38

3.7

3.2

25.61

24.94

mmol/l

4.00

404

2219

Secondary uncertain malignant neoplasm

483

2893

1.72

26.35

3.9

3.3

25.09

25.20

mmol/l

0.26

476

2791

Haemorrhage, not elsewhere classified

158

636

2.64

26.29

4.9

2.8

24.98

24.94

mmol/l

0.04

152

613

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

912

5414

1.48

26.28

3.4

3.0

25.29

25.45

mmol/l

0.70

879

5230

Paralytic ileus

162

663

2.61

26.13

6.0

3.0

25.22

25.21

mmol/l

0.01

154

642

Papulosquamous disorders

1153

8298

1.41

26.09

3.9

3.5

25.28

25.25

mmol/l

0.10

1133

8034

Postprocedural disorders of nervous system

185

797

2.40

26.09

3.5

3.2

24.91

25.21

mmol/l

0.57

180

763

Other viral hepatitis, including avohilmo

190

830

2.38

26.05

4.4

3.7

24.82

25.21

mmol/l

0.81

180

803

Arthropathies

2487

9923

1.28

26.03

3.9

3.4

25.19

mmol/l

0.00

2373

9597

Vitamin deficiency, wide

178

760

2.47

25.97

4.3

3.3

24.71

25.18

mmol/l

0.97

170

729

Vitamin deficiency

178

760

2.47

25.97

4.3

3.3

24.71

25.18

mmol/l

0.97

170

729

Other viral hepatitis

181

779

2.42

25.70

4.5

3.6

24.92

25.26

mmol/l

0.63

172

754

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1644

11370

1.33

25.58

4.8

3.4

25.17

25.23

mmol/l

0.29

1588

10968

Polycystic ovarian syndrome, consortium definition

1689

7310

1.34

25.54

3.4

3.1

25.73

25.37

mmol/l

4.18

1637

7066

Agranulocytosis

357

1981

1.87

25.48

5.2

3.4

25.26

25.33

mmol/l

0.12

343

1910

Arthropod-borne viral fevers and viral haemorrhagic fevers

314

1678

1.95

25.34

3.7

3.5

24.55

25.31

mmol/l

3.76

300

1614

Purpura and other haemorrhagic conditions

437

2573

1.75

25.33

5.5

3.6

24.71

25.21

mmol/l

2.45

425

2481

Urolithiasis

1032

7337

1.43

25.25

4.1

3.7

24.95

25.11

mmol/l

0.78

1004

7100

Disorders of vitreous body and globe

1585

11373

1.34

25.23

4.9

3.4

25.24

25.30

mmol/l

0.30

1541

11031

severe traumatic brain injury, does not include concussion

791

5360

1.51

25.17

4.0

3.6

25.25

25.05

mmol/l

0.91

768

5182

Benign neoplasm of other and unspecified endocrine glands

417

2429

1.77

25.16

4.9

3.4

25.28

25.29

mmol/l

0.01

400

2350

Dementia

1555

8014

1.35

25.00

3.3

3.6

25.26

25.15

mmol/l

0.60

1515

7784

Malignant neoplasm of bladder, including Hilmo

468

2787

1.72

24.94

4.7

3.4

24.50

25.09

mmol/l

2.86

456

2681

Examination and encounter for administrative purposes

276

1419

2.02

24.93

3.3

3.0

24.74

25.08

mmol/l

1.08

262

1364

Oesophagitis

204

940

2.28

24.93

5.5

3.1

25.23

25.29

mmol/l

0.08

197

900

Total colectomy

153

623

2.60

24.85

6.5

3.3

24.48

25.30

mmol/l

1.76

148

602

Total colectomy operation

153

623

2.60

24.85

6.5

3.3

24.48

25.30

mmol/l

1.76

148

602

Abnormal findings on diagnostic imaging of central nervous system

167

707

2.48

24.77

4.4

3.1

25.13

25.24

mmol/l

0.15

159

675

Amputation of foot

134

518

2.83

24.71

9.2

3.3

23.80

25.15

mmol/l

2.95

129

496

Disorders of eyelid, lacrimal system and orbit

2589

15268

1.25

24.60

3.8

3.5

25.31

25.23

mmol/l

0.54

2510

14769

Benign neoplasm of other and ill-defined parts of digestive system

572

3635

1.62

24.55

4.0

3.4

25.23

mmol/l

0.01

556

3509

840

5401

1.49

24.45

3.9

3.3

25.18

25.22

mmol/l

0.13

819

5248

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

719

10181

0.67

24.43

3.2

3.4

25.34

25.32

mmol/l

0.06

700

9830

Viral haemorrhagic fevers, not elsewhere classified/unspecified

260

1321

2.05

24.42

3.7

3.4

24.44

25.30

mmol/l

3.92

253

1270

Disorders of vitreous body

1536

11096

1.34

24.36

4.8

3.4

25.27

25.31

mmol/l

0.15

1494

10759

Dilated cardiomyopathy

420

2482

1.76

24.29

4.6

3.7

24.70

25.13

mmol/l

1.51

402

2396

Exclusions for E4_PCOS_CONSORTIUM

1789

8576

1.31

24.23

3.7

3.4

25.34

mmol/l

0.03

1726

8290

Cardiac murmurs and other cardiac sounds

244

1197

2.07

24.03

5.8

3.1

24.94

25.05

mmol/l

0.21

224

1146

Left ventricular outflow tract obstruction (LVOTO), broad definition

304

1635

1.92

23.97

6.7

3.9

25.06

25.25

mmol/l

0.44

299

1577

Degeneration of macula and posterior pole

1641

9697

1.33

23.95

4.1

3.4

25.08

25.30

mmol/l

1.71

1586

9409

Other mental disorders due to brain damage and dysfunction and to physical disease

446

2688

1.72

23.95

3.3

3.5

25.32

25.10

mmol/l

0.65

429

2607

Other specified/unspecified arthritis

786

5363

1.49

23.91

4.5

3.4

25.33

25.20

mmol/l

0.46

759

5210

Hyperkinetic disorders, excluding more controls

208

901

2.19

23.88

3.6

3.8

25.04

mmol/l

0.00

198

861

Non-Hodgkin lymphoma, all, including Hilmo

456

2768

1.70

23.72

4.0

3.3

25.06

25.20

mmol/l

0.43

447

2670

Crohn disease

355

2005

1.82

23.70

4.9

3.4

25.16

25.28

mmol/l

0.28

348

1926

Other systemic involvement of connective tissue

830

5739

1.47

23.67

3.6

3.3

25.52

25.25

mmol/l

1.41

798

5548

Cervical disc disorders

1025

7354

1.42

23.65

3.4

3.5

25.37

25.18

mmol/l

1.18

984

7134

Calculus of kidney and ureter

941

6662

1.44

23.64

4.0

3.7

25.01

25.11

mmol/l

0.39

917

6444

Other and unspecified nerve root and plexus disorders, also in other diseases

571

3655

1.59

23.52

3.7

3.4

25.63

25.25

mmol/l

1.70

529

3543

DVT of lower extremities

626

4099

1.57

23.51

4.8

3.3

25.23

25.17

mmol/l

0.18

613

3974

Lyme disease, including avohilmo

418

6872

0.60

23.48

2.5

3.5

25.27

25.28

mmol/l

0.02

413

6650

Lyme disease

418

6872

0.60

23.48

2.5

3.5

25.27

25.28

mmol/l

0.02

413

6650

Disorders of synovium and tendon

1472

9443

1.34

23.46

3.7

3.2

25.46

25.20

mmol/l

2.21

1415

9131

Malignant neoplasm of bladder

294

1583

1.94

23.37

5.1

3.3

24.47

25.04

mmol/l

1.71

288

1521

Fracture of lower leg, including ankle

1599

12056

1.32

23.32

4.0

3.5

25.52

25.26

mmol/l

1.96

1533

11676

Other diseases of arteries and capillaries

307

1674

1.90

23.28

5.9

3.1

24.85

25.29

mmol/l

1.42

295

1617

Immunodeficiencies

163

705

2.43

23.16

5.6

3.7

24.94

25.29

mmol/l

0.61

157

675

Pregnancy hypertension

790

4829

1.48

23.06

3.4

3.0

25.27

25.44

mmol/l

0.70

762

4657

Psoriasis

811

5609

1.47

23.06

3.9

3.6

25.32

25.20

mmol/l

0.43

796

5425

Colectomy operation

565

3638

1.60

23.00

4.7

3.5

24.76

25.17

mmol/l

1.80

550

3524

Heartburn

307

1675

1.88

22.96

4.2

3.1

25.22

25.28

mmol/l

0.12

301

1617

Coxarthrosis, primary

1951

12767

1.29

22.93

3.5

3.6

25.39

25.25

mmol/l

0.99

1905

12385

Other necrotizing vasculopathies

269

1417

1.99

22.92

7.0

3.2

24.98

25.34

mmol/l

1.03

259

1366

Ulcerative colitis

655

4345

1.54

22.90

4.5

3.4

24.85

25.22

mmol/l

1.79

628

4194

Primary hyperparathyroidism

361

2078

1.80

22.88

4.8

3.2

25.21

25.42

mmol/l

0.50

345

2020

Other diseases of intestine

490

3051

1.65

22.86

5.8

3.4

24.53

25.23

mmol/l

3.86

468

2956

Other spirochaetal diseases

427

6936

0.61

22.83

2.6

3.5

25.30

25.29

mmol/l

0.05

421

6713

Emphysema

272

1438

1.97

22.82

4.7

3.4

25.42

24.83

mmol/l

1.63

265

1391

Asthma and allergy, excluding more controls

244

1215

2.02

22.78

2.6

2.7

25.52

25.14

mmol/l

1.16

237

1164

Alcohol withdrawal state with delirium

241

1225

2.06

22.73

4.9

3.9

25.30

25.20

mmol/l

0.13

229

1188

ILD, hospital admissions

543

3478

1.61

22.73

4.5

3.5

25.58

25.11

mmol/l

2.05

516

3365

Allergic conjunctivitis

780

10777

0.69

22.72

3.3

3.5

25.33

25.32

mmol/l

0.03

759

10410

Spirochaetal infections, other/unspecified, including avohilmo

427

6926

0.61

22.69

2.5

3.5

25.27

25.29

mmol/l

0.03

421

6704

Interstitial lung disease endpoints

553

3560

1.60

22.64

4.7

3.5

25.58

25.09

mmol/l

2.30

526

3445

Interstitial lung disease

553

3560

1.60

22.64

4.7

3.5

25.58

25.09

mmol/l

2.30

526

3445

Other interstitial pulmonary diseases

553

3560

1.60

22.64

4.7

3.5

25.58

25.09

mmol/l

2.29

526

3446

Mixed and other personality disorders

202

958

2.17

22.63

3.5

25.62

25.21

mmol/l

0.82

196

920

1108

6962

1.40

22.63

3.8

3.4

25.08

25.19

mmol/l

0.45

1074

6759

Disturbances of skin sensation

701

4727

1.51

22.58

3.7

3.3

25.44

25.27

mmol/l

0.79

676

4564

Vascular dementia

409

2364

1.73

22.35

4.2

3.6

25.28

24.98

mmol/l

1.00

396

2291

Disorders of sclera, cornea, iris and ciliary body

1546

11907

1.31

22.23

4.6

3.4

25.25

mmol/l

0.02

1493

11524

Viral hepatitis, including avohilmo

208

1007

2.14

22.15

4.4

3.7

24.80

25.26

mmol/l

1.12

198

967

Disorders of psychological development

282

1397

1.91

22.14

4.5

4.3

24.84

24.93

mmol/l

0.18

273

1332

Outcome of delivery

1012

0.22

22.06

1.8

3.2

26.12

25.16

mmol/l

0.92

972

Other spirochaetal diseases, including avohilmo

438

7013

0.61

22.03

2.6

3.6

25.30

25.28

mmol/l

0.05

431

6790

Alzheimer disease, excluding more controls

581

2416

1.59

22.02

3.1

3.2

25.42

24.96

mmol/l

2.48

559

2352

Postprocedural disorders of digestive system, not elsewhere classified

134

546

2.62

21.90

6.3

3.3

24.39

25.48

mmol/l

2.22

129

523

Arterial embolism and thrombosis

229

1160

2.07

21.85

6.3

3.0

24.60

25.09

mmol/l

1.28

218

1119

Other diseases of blood and blood-forming organs, wide

655

4402

1.52

21.71

5.0

3.5

25.06

25.23

mmol/l

0.60

632

4253

Haemorrhoids and perianal venous thrombosis

1001

7211

1.40

21.61

3.6

3.2

25.21

25.28

mmol/l

0.26

968

6985

Pyogenic arthritis

242

1255

2.01

21.50

6.2

3.5

25.04

25.11

mmol/l

0.10

232

1219

Gonarthrosis

1915

8514

1.28

21.34

3.2

3.3

25.27

25.25

mmol/l

0.09

1851

8252

Lesion of ulnar nerve

401

2416

1.70

21.32

4.1

3.4

25.14

25.18

mmol/l

0.08

385

2330

Speech and linguistic disorders

225

1086

2.04

21.25

5.1

4.5

24.76

24.94

mmol/l

0.41

220

1032

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

265

1421

1.94

21.25

3.5

3.3

25.46

25.16

mmol/l

0.79

257

1365

Viral hepatitis

199

965

2.13

21.14

4.6

3.6

24.89

25.23

mmol/l

0.73

190

927

Hypothyroidism, strict autoimmune, 3 medication purchases required

2321

12600

1.25

21.09

3.5

3.4

25.25

25.21

mmol/l

0.22

2237

12212

Other factor of the environment

195

3.88

21.03

7.5

3.3

25.42

24.95

mmol/l

0.54

188

Soft tissue disorders related to use, overuse and pressure

805

5660

1.45

20.98

4.1

3.2

25.45

25.20

mmol/l

1.19

778

5491

Myocardial infarction, with ST-elevation

621

4168

1.53

20.92

4.6

3.6

24.97

25.04

mmol/l

0.19

602

4031

Chronic gastritis

842

5977

1.44

20.89

4.1

3.2

25.21

mmol/l

0.01

816

5774

Other necrotizing vasculopathies (FG)

228

1175

2.03

20.78

6.3

3.1

25.01

25.23

mmol/l

0.46

220

1142

ILD, hospital admissions 1, main diag only

484

3087

1.62

20.72

4.4

3.4

25.54

25.12

mmol/l

1.58

463

2984

Injuries to the knee and lower leg

3432

15555

1.20

20.65

3.8

3.5

25.38

25.20

mmol/l

2.32

3300

15053

malignant neoplasm of female genital organs, including Hilmo

511

3136

1.59

20.54

3.3

3.1

25.41

25.70

mmol/l

1.14

501

3043

Nail disorders

254

1357

1.93

20.51

5.5

3.4

25.29

25.33

mmol/l

0.05

248

1303

Cerebral aneurysm, nonruptured

272

1489

1.89

20.43

3.7

3.2

25.36

25.37

mmol/l

0.02

266

1431

Herpesviral [herpes simplex] infections

332

1927

1.77

20.30

4.9

3.3

25.10

25.24

mmol/l

0.32

323

1857

Superficial injury of lower leg

726

5038

1.46

20.29

4.1

3.5

25.49

25.16

mmol/l

1.69

710

4883

Asthma and allergy

244

1267

1.93

20.21

2.6

2.9

25.52

25.11

mmol/l

1.30

237

1214

Intestinal malabsorption

157

709

2.32

20.20

7.4

2.9

24.24

25.46

mmol/l

3.52

151

678

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

398

2095

1.68

20.19

4.0

4.2

24.98

24.89

mmol/l

0.22

383

2012

Alcoholic liver disease

334

1957

1.77

19.96

4.3

3.6

24.14

25.18

mmol/l

4.60

319

1895

Other symptoms and signs involving general sensations and perceptions

160

734

2.29

19.91

4.5

3.1

25.43

25.29

mmol/l

0.19

153

706

Colorectal cancer, including Hilmo

880

5917

1.41

19.76

3.7

3.4

24.75

25.32

mmol/l

4.48

853

5729

Contact with and exposure to communicable diseases

238

4322

0.54

19.68

3.7

3.5

24.64

25.16

mmol/l

1.06

191

4157

Chronic viral hepatitis

142

622

2.37

19.49

4.8

3.7

24.94

25.22

mmol/l

0.41

133

602

Follow-up examination after treatment for conditions other than malignant neoplasms

1039

5081

1.38

19.47

3.9

2.9

25.25

25.24

mmol/l

0.03

1010

4892

Lifestyle-related condition

186

3.84

19.47

7.3

3.3

25.55

25.00

mmol/l

0.60

179

Polyuria

703

4898

1.47

19.45

4.1

3.4

25.41

25.19

mmol/l

1.07

687

4751

Injuries to the neck

604

4081

1.51

19.40

3.7

3.6

25.43

25.17

mmol/l

1.22

583

3934

Other sleep disorders

323

1885

1.76

19.38

4.5

3.4

25.40

25.03

mmol/l

1.21

308

1813

Deforming dorsopathies

742

5213

1.44

19.34

3.8

3.5

25.64

25.19

mmol/l

2.79

714

5058

Migraine with aura and triptan purchases

322

1872

1.75

19.34

3.2

3.4

25.33

25.30

mmol/l

0.07

312

1795

Superficial injury of hip and thigh

505

3301

1.57

19.19

4.7

3.4

25.47

25.12

mmol/l

1.40

492

3192

Assault by bodily force

196

981

2.05

19.07

4.5

3.6

24.66

25.33

mmol/l

1.82

186

946

Ovarian cyst

809

3256

1.44

19.06

3.6

3.0

25.30

25.38

mmol/l

0.28

779

3164

Persistent mood disorders

496

3231

1.56

18.99

4.2

3.2

25.45

25.23

mmol/l

0.62

472

3135

Benign neoplasm: Sigmoid colon

612

4179

1.50

18.94

4.5

3.6

24.94

25.19

mmol/l

0.93

603

4051

Other embolism and thrombosis

408

2550

1.64

18.93

5.4

3.3

24.95

25.17

mmol/l

0.63

392

2469

Suppurative and necrotic conditions of lower respiratory tract

206

1060

2.04

18.91

5.1

3.4

25.61

25.16

mmol/l

0.91

199

1016

Fracture of lumbar spine and pelvis

764

5423

1.43

18.84

4.0

3.4

25.43

25.19

mmol/l

1.09

738

5254

Psoriasis vulgaris

523

3457

1.54

18.83

3.9

3.6

25.42

25.18

mmol/l

0.78

513

3327

Phlebitis and thrombophlebitis (not including DVT)

670

4654

1.47

18.81

5.0

3.4

25.21

mmol/l

0.01

655

4504

Coagulation defects, purpura and other haemorrhagic conditions

561

3764

1.52

18.79

5.6

3.4

24.86

25.23

mmol/l

1.87

543

3633

Appendectomy

1637

12336

1.27

18.72

3.5

25.21

25.25

mmol/l

0.19

1588

11903

Intracerebral haemorrhage

446

2856

1.61

18.71

4.1

3.3

25.51

25.11

mmol/l

1.94

432

2771

Gonarthrosis,primary

2722

13634

1.21

18.69

3.2

3.6

25.36

25.26

mmol/l

0.79

2639

13200

Artificial opening status

187

934

2.09

18.62

5.5

2.9

24.80

25.08

mmol/l

0.42

178

897

Other and unspecified tonsillitis

708

4107

1.45

18.52

4.2

3.4

25.07

25.15

mmol/l

0.29

677

3938

Other disorders of nervous system

221

1173

1.96

18.41

4.2

3.3

25.72

25.30

mmol/l

0.82

215

1135

Adverse effects, not elsewhere classified

477

3103

1.56

18.37

4.6

3.4

25.16

25.25

mmol/l

0.28

465

2991

Gastrojejunal ulcer

203

3.59

18.35

4.4

2.9

24.22

25.21

mmol/l

1.24

196

Injuries to the ankle and foot

1852

12714

1.25

18.29

4.4

3.4

25.23

25.22

mmol/l

0.08

1795

12258

Mental retardation

128

549

2.42

18.20

6.1

5.1

25.55

24.78

mmol/l

1.67

123

526

Benign thyroid growths and nodules

926

6338

1.38

18.19

3.5

3.2

25.63

25.40

mmol/l

1.33

895

6157

Benign neoplasm: Adrenal gland

256

1430

1.86

18.16

3.8

3.2

25.62

25.34

mmol/l

0.63

247

1382

Generalized anxiety disorder

322

1910

1.71

17.89

3.0

3.1

25.26

25.20

mmol/l

0.10

317

1823

Other pulmonary heart/vessel disease

181

910

2.09

17.86

5.2

3.2

26.08

25.07

mmol/l

2.16

174

877

Childhood asthma (age<16), excluding more controls

196

768

2.02

17.86

3.1

2.9

24.89

24.94

mmol/l

0.08

189

733

Irregular menses

956

5294

1.37

17.82

3.9

3.0

25.50

25.26

mmol/l

1.36

929

5107

Mental and behavioural disorders due to use of other stimulants, including caffeine

277

3.02

17.77

3.6

3.4

25.49

25.16

mmol/l

0.37

269

Redundant prepuce, phimosis and paraphimosis

608

4122

1.48

17.77

5.0

3.7

25.09

25.07

mmol/l

0.07

591

3991

Osteoporosis with pathological fracture (FG)

274

1574

1.81

17.76

4.3

3.0

26.19

25.33

mmol/l

3.38

264

1537

Secondary right heart disease

168

826

2.15

17.67

5.3

3.2

26.17

25.10

mmol/l

2.28

161

794

Colorectal cancer

787

5455

1.41

17.65

3.5

3.4

24.68

25.29

mmol/l

4.48

762

5284

Pulmonary oedema

350

2.86

17.58

7.4

3.2

24.52

25.07

mmol/l

0.56

337

Malignant neoplasm of urinary organs, including Hilmo

399

2535

1.62

17.44

5.0

3.3

24.41

25.21

mmol/l

4.48

387

2446

Attention to artificial openings

147

691

2.23

17.26

5.7

2.6

25.35

25.06

mmol/l

0.41

138

661

Use of biperiden

167

823

2.12

17.25

3.4

3.3

25.96

25.30

mmol/l

1.20

162

794

Orchitis and epididymitis

312

1869

1.72

17.22

5.0

3.6

25.25

24.95

mmol/l

0.74

300

1808

Disorders of vestibular function (Vertigo)

1384

10589

1.29

17.21

3.6

3.4

25.61

25.29

mmol/l

3.30

1354

10261

Other congenital malformations of the digestive system

137

621

2.28

17.17

8.2

4.2

24.28

25.13

mmol/l

2.56

132

594

Open wound of lower leg

461

3036

1.55

16.99

4.7

3.5

25.31

25.16

mmol/l

0.39

446

2947

Childhood asthma (age<16)

196

784

1.98

16.89

3.1

3.0

24.89

24.94

mmol/l

0.09

189

750

Superficial injury of thorax

453

2976

1.56

16.88

4.3

3.4

25.39

25.13

mmol/l

0.95

440

2864

Pruritus

328

1998

1.68

16.85

5.5

3.1

25.24

25.30

mmol/l

0.13

321

1925

Psoriatic arthropathies

286

1681

1.75

16.84

4.4

3.3

25.61

25.24

mmol/l

1.08

280

1633

Benign neoplasm: Ascending colon

458

3025

1.56

16.82

4.4

3.4

24.90

25.16

mmol/l

0.91

449

2927

Anterior Iridocyclitis

550

3771

1.49

16.59

5.1

3.3

25.20

25.24

mmol/l

0.09

531

3638

Malignant neoplasm of pancreas, including Hilmo

309

1874

1.70

16.39

3.6

3.2

24.73

25.22

mmol/l

1.37

298

1808

Vascular dementia (undefined)

188

977

1.99

16.35

4.4

3.5

25.35

25.03

mmol/l

0.67

178

942

Ulcerative colitis, NAS

360

2262

1.63

16.28

4.8

3.5

24.67

25.28

mmol/l

2.38

345

2178

Pure hyperglyceridaemia

339

2.76

16.25

4.6

2.6

25.37

25.24

mmol/l

0.13

326

Iridocyclitis

618

4352

1.44

16.15

5.0

3.3

25.17

25.24

mmol/l

0.17

595

4211

Background retinopathy and retinal vascular changes

371

2.69

16.12

8.1

3.1

24.57

25.37

mmol/l

1.04

363

Malnutrition

377

2.68

16.11

4.9

3.9

25.54

25.18

mmol/l

0.40

365

Diplopia

390

2508

1.59

16.09

4.8

3.4

25.22

25.27

mmol/l

0.10

375

2421

Other disorders of bone

487

3278

1.51

16.07

4.0

3.2

25.12

25.26

mmol/l

0.44

466

3165

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2532

16551

1.20

16.02

4.0

3.5

25.19

25.25

mmol/l

0.42

2465

15987

Retinal vascular occlusion

419

2748

1.57

15.97

4.2

3.3

25.15

25.16

mmol/l

0.02

404

2662

Recurrent and persistent haematuria

132

4.08

15.90

8.9

2.8

24.67

24.56

mmol/l

0.07

126

Other follicular disorders

196

1049

1.92

15.81

5.0

3.6

24.88

25.18

mmol/l

0.70

196

1007

Mental retardation, wide definition

133

619

2.22

15.63

5.9

4.9

25.54

24.88

mmol/l

1.31

128

595

Multiple myeloma, including Hilmo

173

900

2.02

15.55

5.4

3.0

24.59

25.28

mmol/l

1.78

168

864

Disorders of muscles

287

1727

1.70

15.50

4.8

3.3

24.99

25.16

mmol/l

0.38

280

1673

Other and unspecified visual disturbances

309

1898

1.67

15.47

4.8

3.4

25.39

25.31

mmol/l

0.15

302

1832

Radiculopathy

471

3180

1.51

15.44

3.4

25.34

25.05

mmol/l

1.07

458

3087

Diaphragmatic hernia

1065

8219

1.31

15.43

3.9

3.3

25.01

25.31

mmol/l

2.46

1034

7971

Acute and subacute iridocyclitis

512

3513

1.48

15.43

5.1

3.3

25.25

mmol/l

0.00

495

3394

Congenital malformations of heart and great arteries

326

1966

1.64

15.38

4.9

3.9

25.45

25.18

mmol/l

0.72

318

1895

Urticaria and erythema

875

6566

1.35

15.33

3.9

3.6

25.42

25.21

mmol/l

1.17

851

6353

Retinal vascular disorders

422

2797

1.55

15.32

4.2

3.3

25.13

25.16

mmol/l

0.04

407

2711

Other and unspecified mood [affective] disorders

148

725

2.09

15.31

3.5

3.1

24.86

25.24

mmol/l

0.62

141

700

Abnormal serum enzyme levels

981

7235

1.33

15.29

4.4

3.7

25.04

25.08

mmol/l

0.13

948

7011

SLE (Finngen)

106

457

2.42

15.29

3.5

2.6

24.86

25.63

mmol/l

1.49

101

441

Fracture of skull and facial bones

565

3953

1.45

15.29

4.4

3.6

25.28

25.15

mmol/l

0.36

543

3808

Sarcoidosis

364

2332

1.60

15.28

4.1

3.4

25.10

25.34

mmol/l

0.72

345

2254

malignant neoplasm of female genital organs

436

2841

1.53

15.23

3.2

3.1

25.34

25.66

mmol/l

1.16

426

2757

Superficial injury of abdomen, lower back and pelvis

430

2856

1.53

15.22

4.3

3.4

25.44

25.21

mmol/l

0.68

416

2751

Cyst of kidney

245

1429

1.78

15.12

6.0

3.3

25.03

25.20

mmol/l

0.33

238

1380

Subarachnoid haemorrhage

320

1997

1.65

15.09

4.1

3.3

25.23

25.20

mmol/l

0.06

312

1926

Pre-eclampsia

369

2370

1.58

15.08

4.0

3.0

25.14

25.47

mmol/l

1.05

359

2283

Diseases of inner ear

1586

12297

1.25

15.04

3.6

3.5

25.55

25.28

mmol/l

2.72

1545

11913

Reimbursement for rheumatic diseases

1522

12207

1.25

15.02

3.9

3.5

25.39

25.29

mmol/l

0.54

1465

11815

Complications of internal orthopaedic prosthetic devices, implants and grafts

700

5112

1.39

14.92

4.1

3.2

25.25

25.22

mmol/l

0.06

679

4941

Nontoxic multinodular goitre

554

3886

1.45

14.92

3.5

3.1

25.74

25.36

mmol/l

2.13

532

3767

Polyarthrosis

630

4065

1.42

14.78

3.6

3.4

25.66

25.31

mmol/l

1.93

616

3959

Foreign body in alimentary tract

175

927

1.96

14.78

3.5

3.7

25.21

25.05

mmol/l

0.24

170

890

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

807

6026

1.36

14.75

3.8

3.6

25.22

25.20

mmol/l

0.04

777

5813

Abnormal results of function studies

250

1477

1.74

14.55

6.3

3.4

25.07

25.23

mmol/l

0.28

241

1420

Umbilical hernia

767

5702

1.37

14.51

5.3

3.4

25.25

25.15

mmol/l

0.36

748

5516

Fracture of shoulder and upper arm

1039

8047

1.31

14.46

4.3

3.6

25.35

25.28

mmol/l

0.30

1007

7792

Seborrhoeic dermatitis

298

1848

1.66

14.41

4.1

3.5

25.25

25.23

mmol/l

0.04

290

1777

Pyothorax

158

818

2.02

14.41

5.5

3.4

25.78

25.11

mmol/l

1.57

151

788

Arthropathic psoriasis

301

1871

1.65

14.37

4.4

3.4

25.57

25.35

mmol/l

0.48

295

1799

Non-follicular lymphoma

309

1939

1.64

14.36

4.1

3.5

25.12

25.17

mmol/l

0.11

303

1874

Nontoxic goitre/thyroid nodule

789

5909

1.36

14.22

3.5

3.2

25.59

25.36

mmol/l

1.21

764

5727

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

842

6268

1.34

14.21

3.8

3.6

25.32

25.24

mmol/l

0.34

819

6031

Other arthrosis

1515

8195

1.25

14.19

3.6

3.3

25.34

25.27

mmol/l

0.35

1461

7950

Other psoriatic arthropathies

275

1679

1.68

14.14

4.4

3.4

25.65

25.33

mmol/l

0.86

270

1621

Multiple myeloma

120

568

2.25

14.11

5.1

2.8

24.56

25.30

mmol/l

1.31

115

547

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

120

568

2.25

14.11

5.1

2.8

24.56

25.30

mmol/l

1.31

115

547

Car occupant injured in other and unspecified transport accidents

453

3087

1.49

14.11

3.2

3.5

25.32

25.23

mmol/l

0.24

438

2967

Rheumatoid arthritis

885

5954

1.33

14.11

3.8

3.3

25.31

25.26

mmol/l

0.16

860

5782

Periodontitis

2803

15264

1.18

14.11

4.0

3.4

25.07

25.31

mmol/l

3.32

2702

14779

Psoriatic arthropathies, ICD10

281

1726

1.67

14.10

4.4

3.4

25.64

25.34

mmol/l

0.80

275

1666

Other noninflammatory disorders of uterus, except cervix

585

2763

1.44

14.06

3.3

3.1

25.67

25.53

mmol/l

0.44

567

2696

Open wound of forearm

283

1744

1.66

14.03

3.6

3.3

25.19

25.25

mmol/l

0.13

272

1679

Injuries to the elbow and forearm

1927

13722

1.21

13.99

3.9

3.5

25.35

25.26

mmol/l

0.59

1867

13263

Disorders of ocular muscles, binocular movement, accommodation and refraction

1181

9254

1.28

13.98

4.4

3.5

25.32

25.21

mmol/l

0.59

1144

8940

Superficial injury of wrist and hand

489

3387

1.46

13.97

4.2

3.5

25.20

25.22

mmol/l

0.06

473

3263

Neovascular glaucoma

147

751

2.05

13.92

5.6

3.2

24.55

25.21

mmol/l

1.27

142

727

Malignant neoplasm of urinary organs

333

2143

1.60

13.90

5.0

3.3

24.37

25.24

mmol/l

4.47

323

2065

Idiopathic pulmonary fibrosis

283

1759

1.67

13.80

4.5

3.4

25.63

25.00

mmol/l

1.91

268

1704

Amputation of thigh

129

633

2.16

13.77

7.5

3.1

24.23

25.13

mmol/l

2.10

123

610

Diseases of male genital organs

1485

6014

1.26

13.76

4.6

3.7

25.10

25.05

mmol/l

0.24

1419

5823

Malignant neoplasm of pancreas

253

1528

1.71

13.76

3.6

3.0

24.49

25.25

mmol/l

2.55

242

1470

Lung cancer and mesothelioma

545

3268

1.44

13.72

4.1

2.8

25.88

24.80

mmol/l

9.59

532

3181

Multiple myeloma and malignant plasma cell neoplasms

179

983

1.91

13.70

5.3

3.2

24.62

25.23

mmol/l

1.51

174

948

Acute suppurative otitis media

525

3438

1.44

13.65

5.7

3.4

24.89

25.10

mmol/l

0.81

511

3289

Crohn's disease NAS

170

914

1.91

13.63

4.8

3.4

24.81

25.32

mmol/l

1.00

164

876

Need for immunization against other single infectious diseases

17.70

13.57

41.9

3.2

23.98

23.75

mmol/l

0.09

Hyperplasia of prostate

1141

5037

1.29

13.54

4.5

3.6

25.13

25.01

mmol/l

0.57

1090

4893

Later onset COPD

996

6215

1.31

13.53

4.8

3.4

25.85

24.92

mmol/l

10.50

962

6028

Dislocation, sprain and strain of joints and ligaments at neck level

345

2241

1.56

13.53

3.5

3.3

25.34

25.26

mmol/l

0.19

332

2145

IBD patients in KELA-register

534

3782

1.43

13.53

4.1

3.5

24.83

25.25

mmol/l

1.89

516

3649

Arthropathies in other diseases classified elsewhere

123

595

2.16

13.52

10.4

3.3

24.84

25.15

mmol/l

0.39

118

581

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

334

2165

1.59

13.51

5.0

3.3

24.57

25.24

mmol/l

2.90

325

2088

Pre-eclampsia or eclampsia

390

2600

1.52

13.49

3.9

3.0

25.20

25.48

mmol/l

0.90

378

2511

Artrosis, including avohilmo

2306

10635

1.19

13.48

3.3

3.7

25.31

25.22

mmol/l

0.66

2221

10285

Other congenital malformations of the digestive system, including avohilmo

148

758

2.01

13.46

7.8

4.0

24.35

25.06

mmol/l

2.03

143

724

Drug-induced neutropenia

213

1234

1.78

13.45

4.3

3.2

25.26

25.42

mmol/l

0.27

208

1193

Inflammatory diseases of the central nervous system

230

1364

1.73

13.26

4.0

3.3

25.32

25.30

mmol/l

0.04

222

1312

Excessive, frequent and irregular menstruation

848

3407

1.34

13.26

3.6

3.0

25.55

25.35

mmol/l

0.95

826

3303

Abnormal involuntary movements

380

2538

1.53

13.25

4.0

3.5

25.36

25.18

mmol/l

0.54

368

2449

Other disorders of optic [2nd] nerve and visual pathways

190

1071

1.83

13.18

4.8

3.5

24.43

25.21

mmol/l

2.02

184

1031

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

179

995

1.88

13.17

4.8

3.1

25.66

25.24

mmol/l

0.64

173

952

Keratitis

940

7292

1.30

13.11

4.3

3.4

25.25

25.21

mmol/l

0.15

910

7057

Other renal tubulo-interstitial diseases

297

2.65

13.08

6.9

2.4

23.91

25.55

mmol/l

3.39

286

Chronic periodontitis, including avohilmo

2784

15273

1.17

12.99

4.0

3.4

25.07

25.31

mmol/l

3.38

2682

14788

Bell's palsy

317

2045

1.58

12.97

3.5

3.3

25.43

25.25

mmol/l

0.42

306

1976

Other aneurysm

187

1057

1.84

12.94

4.8

3.0

24.79

25.07

mmol/l

0.50

179

1020

Zoster [herpes zoster], including avohilmo

1494

11817

1.23

12.83

3.7

3.5

25.35

25.28

mmol/l

0.35

1451

11456

Mandibular retrognathia

149

781

1.95

12.76

2.8

3.9

25.49

25.18

mmol/l

0.65

144

746

Migraine without aura and triptan purchases

296

1882

1.59

12.71

3.0

3.5

24.99

25.33

mmol/l

1.36

284

1806

Neuromuscular dysfunction of bladder

266

1659

1.65

12.65

3.9

3.2

25.71

25.14

mmol/l

1.62

246

1601

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

459

3184

1.46

12.61

4.7

3.2

24.89

25.21

mmol/l

1.09

450

3077

Strabismus

646

4767

1.37

12.60

4.5

3.7

25.29

25.15

mmol/l

0.48

624

4605

Speech disturbances, not elsewhere classified

291

1860

1.61

12.55

4.5

3.4

25.27

25.23

mmol/l

0.08

281

1794

Special screening examination for neoplasms

174

968

1.84

12.52

3.9

2.9

25.27

25.23

mmol/l

0.05

166

936

Glaucoma secondary to other eye disorders

147

780

1.97

12.51

5.6

3.3

24.55

25.14

mmol/l

1.08

142

758

Neuralgia and neuritis, unspecified

149

792

1.94

12.46

4.7

3.1

25.80

25.20

mmol/l

1.49

138

765

Other bursopathies

367

2466

1.52

12.45

4.1

3.3

25.28

25.15

mmol/l

0.29

355

2389

Gestational [pregnancy-induced] hypertension

421

2891

1.47

12.41

3.1

3.0

25.29

25.37

mmol/l

0.17

402

2780

Diabetes mellitus in pregnancy

462

2029

1.46

12.35

3.7

3.0

24.94

25.27

mmol/l

1.24

439

1939

Open wound of wrist and hand

1159

8971

1.26

12.29

4.0

3.6

25.01

25.16

mmol/l

0.79

1131

8667

Trigger finger

371

2507

1.51

12.19

3.8

3.1

25.48

25.23

mmol/l

0.76

359

2434

Extrapyramidal and movement disorders

1143

9176

1.26

12.12

4.0

3.5

25.47

25.22

mmol/l

1.80

1097

8893

Persons with potential health hazards related to communicable diseases

411

5833

0.69

12.09

9.8

3.5

24.54

25.18

mmol/l

2.61

349

5631

Oesophageal varices

142

755

1.96

12.04

6.2

3.2

23.44

25.13

mmol/l

5.67

135

725

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1404

7733

1.24

12.02

4.1

3.4

25.10

25.37

mmol/l

2.36

1366

7491

Generalized epilepsy

111

540

2.13

11.95

4.8

4.0

24.96

25.18

mmol/l

0.26

105

520

Use of pramipexole

628

4676

1.37

11.93

4.6

3.4

25.32

25.20

mmol/l

0.41

604

4534

Follicular cysts of skin and subcutaneous tissue

485

3462

1.42

11.91

4.7

3.5

25.29

25.20

mmol/l

0.23

471

3338

Inflammatory bowel disease, strict (require KELA)

534

3873

1.40

11.85

4.1

3.6

24.83

25.25

mmol/l

1.84

516

3736

Other and unspecified follicular disorders

120

604

2.06

11.82

5.3

3.1

24.81

25.09

mmol/l

0.44

120

578

Spondyloarthritis

460

3256

1.43

11.81

4.5

3.4

25.58

25.21

mmol/l

1.41

446

3135

Injuries to the wrist and hand

2762

15858

1.16

11.81

4.0

3.5

25.22

25.24

mmol/l

0.17

2679

15324

Seborrhoeic keratosis

735

5609

1.33

11.77

4.3

3.3

25.22

25.25

mmol/l

0.07

712

5435

Conjunctivitis (acute, non atopic)

698

5257

1.34

11.76

4.1

3.6

25.28

25.17

mmol/l

0.34

683

5083

Non-Hodgkin lymphoma, all

163

913

1.86

11.73

4.5

3.0

24.81

25.15

mmol/l

0.60

158

878

Cerebral palsy and other paralytic syndromes

303

1983

1.56

11.68

4.8

3.6

25.73

25.22

mmol/l

1.60

292

1912

Benign paroxysmal vertigo

828

6428

1.31

11.64

3.5

3.4

25.69

25.27

mmol/l

3.48

813

6224

Missing teeth due to accident, extraction or parodontitis

1806

13579

1.20

11.61

3.7

3.5

25.43

25.27

mmol/l

1.10

1746

13179

Benign neoplasm: Caecum

336

2257

1.53

11.59

4.5

3.4

25.09

25.22

mmol/l

0.25

331

2187

Superficial injury of forearm

251

1576

1.62

11.55

4.7

3.3

25.48

25.31

mmol/l

0.35

242

1513

Pain associated with micturition

326

2173

1.53

11.54

4.2

3.1

25.71

25.20

mmol/l

1.90

316

2101

Dental operations

1852

7982

1.20

11.52

3.9

3.4

25.26

25.24

mmol/l

0.10

1787

7742

Acute appendicitis

1750

13637

1.20

11.52

3.4

3.5

25.28

25.22

mmol/l

0.32

1693

13171

Conjunctivitis (acute, non atopic), including avohilmo

2202

15521

0.85

11.47

3.5

3.6

25.23

25.25

mmol/l

0.12

2134

14994

Other diseases of oesophagus

281

1822

1.58

11.36

4.2

3.3

25.58

25.20

mmol/l

1.08

273

1749

Malignant neoplasm of kidney, except renal pelvis

292

1913

1.57

11.35

5.2

3.2

24.52

25.21

mmol/l

2.75

284

1841

Fall on same level involving ice and snow

1556

12959

1.21

11.35

3.8

3.5

25.43

25.27

mmol/l

1.19

1507

12539

Adhesive capsulitis of shoulder

435

3076

1.44

11.30

4.4

3.2

25.16

25.20

mmol/l

0.06

418

2987

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

175

1012

1.79

11.29

4.4

3.0

23.86

25.11

mmol/l

3.91

169

969

Other disorders of conjunctiva

419

2950

1.45

11.26

4.5

3.5

25.49

25.20

mmol/l

0.97

403

2855

Cervicocranial syndrome

270

1737

1.58

11.22

3.0

3.3

25.49

25.19

mmol/l

0.85

261

1680

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

225

1393

1.67

11.20

4.3

3.1

24.08

25.25

mmol/l

4.56

218

1337

Hydrocephalus

242

1525

1.63

11.17

3.2

3.3

24.96

25.18

mmol/l

0.46

236

1474

Mouth breathing

1017

8119

1.26

11.17

4.3

3.7

25.25

25.19

mmol/l

0.20

988

7850

Disorders of optic nerve and visual pathways

238

1490

1.63

11.15

4.5

3.5

24.65

25.21

mmol/l

1.56

229

1435

Spondylolisthesis/Spondylolysis

462

3310

1.42

11.13

3.3

3.4

25.44

25.16

mmol/l

0.98

443

3213

Appendicitis, broad definition

1870

14209

1.19

11.12

3.5

25.25

25.22

mmol/l

0.16

1810

13723

Suppurative and unspecified otitis media

762

5193

1.31

11.10

5.0

3.5

25.01

25.12

mmol/l

0.42

741

4997

Acute appendicitis, no complications

1311

10701

1.23

11.08

3.4

3.6

25.36

25.22

mmol/l

0.90

1270

10319

Other joint disorders

2225

9905

1.18

11.08

3.7

3.4

25.15

25.20

mmol/l

0.25

2125

9579

Pre-eclampsia or poor fetal growth

495

3565

1.39

11.07

3.7

3.0

25.20

25.38

mmol/l

0.58

477

3436

Early complications of trauma

137

739

1.92

11.07

5.4

3.3

25.14

25.13

mmol/l

0.01

130

710

!Aliquae complicationes praecoces traumatis

137

739

1.92

11.07

5.4

3.3

25.14

25.13

mmol/l

0.01

130

710

Rheumatism, unspecified

319

2137

1.52

11.00

4.0

3.0

25.91

25.31

mmol/l

2.65

305

2085

Malignant neoplasm of colon

492

3576

1.40

11.00

3.6

3.3

24.68

25.21

mmol/l

2.46

482

3456

Systemic lupus erythematosus

106

525

2.10

10.99

3.5

3.1

24.86

25.44

mmol/l

0.97

101

506

Paracetamol or NSAID medication

435

1525

1.45

10.95

3.8

3.5

25.09

25.05

mmol/l

0.08

420

1476

Other benign neoplasms of skin

1038

8342

1.26

10.94

4.2

3.4

25.26

25.23

mmol/l

0.11

1011

8066

Acquired absence of organs, not elsewhere classified

195

2.93

10.91

9.6

2.9

24.34

24.86

mmol/l

0.47

187

SLE, strict definition

466

2.17

10.90

3.7

3.2

24.75

25.42

mmol/l

1.10

447

SLE, ICD10

466

2.17

10.90

3.7

3.2

24.75

25.42

mmol/l

1.10

447

Sequelae of injuries, of poisoning and of other consequences of external causes

581

4333

1.36

10.88

3.5

3.7

25.45

25.21

mmol/l

0.79

555

4197

Focal brain injury

175

1019

1.76

10.85

4.6

3.6

25.43

24.85

mmol/l

1.33

170

978

Aortic aneurysm

715

5394

1.32

10.81

4.1

3.3

25.01

25.16

mmol/l

0.54

692

5240

Malignant neoplasm of skin, including Hilmo

1492

8297

1.21

10.79

4.0

3.4

25.07

25.38

mmol/l

3.18

1454

8042

Diseases of appendix

1882

14298

1.18

10.76

3.4

3.5

25.26

25.22

mmol/l

0.19

1822

13809

Malignant neoplasm of colon, including Hilmo

582

4339

1.36

10.74

3.7

3.3

24.63

25.26

mmol/l

3.84

569

4191

Glaucoma

1710

12260

1.19

10.67

3.8

3.5

25.13

25.28

mmol/l

1.00

1649

11898

Nondiabetic hypoglycaemic coma

5.58

10.65

7.3

3.9

24.93

24.24

mmol/l

0.35

Pedal cyclist injured in other and unspecified transport accidents

290

1920

1.54

10.63

4.7

3.4

25.50

25.27

mmol/l

0.50

282

1850

Pain in joint

1320

6648

1.23

10.59

4.0

3.3

25.21

25.16

mmol/l

0.19

1265

6410

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

180

1070

1.74

10.54

4.5

3.0

23.82

25.20

mmol/l

4.81

174

1027

Persistent delusional disorders

209

1288

1.66

10.53

2.8

3.4

26.14

25.31

mmol/l

2.08

197

1242

5-aminosalicylic acid

475

3449

1.39

10.52

4.2

3.2

25.00

25.20

mmol/l

0.53

458

3333

Anomalies of dental arch relationship, including avohilmo

413

2644

1.43

10.45

3.8

3.4

25.12

25.19

mmol/l

0.16

402

2543

Malignant neoplasm of endocrine gland

186

1114

1.71

10.45

3.4

3.1

26.07

25.45

mmol/l

1.57

178

1072

Coeliac disease

292

1943

1.53

10.44

5.0

3.2

25.18

25.35

mmol/l

0.40

283

1860

Congenital malformations of the circulatory system

340

2263

1.48

10.43

5.0

3.9

25.36

25.17

mmol/l

0.49

333

2177

Alzheimer’s disease (Atypical or mixed)

436

3102

1.42

10.41

3.0

3.6

25.48

25.07

mmol/l

1.86

417

3009

Arterial embolism and thrombosis of lower extremity artery

126

677

1.94

10.40

6.1

3.1

24.64

25.06

mmol/l

0.65

119

655

L04AC Interleukin inhibitors

154

880

1.79

10.22

3.5

25.35

25.24

mmol/l

0.16

149

849

Postmenopausal osteoporosis with pathological fracture

222

1405

1.63

10.19

3.9

2.9

26.44

25.46

mmol/l

3.61

213

1376

Weight loss

298

2007

1.52

10.17

3.4

3.5

25.21

mmol/l

0.00

282

1939

Acute posthaemorrhagic anaemia

120

642

1.95

10.04

5.8

2.8

24.70

25.33

mmol/l

1.08

114

615

Wet age-related macular degeneration

617

4542

1.33

9.99

3.6

3.3

24.92

25.23

mmol/l

1.23

596

4416

Disorders of continuity of bone

239

1539

1.58

9.96

5.4

3.3

25.27

25.41

mmol/l

0.21

231

1481

Other inflammation of eyelid, including avohilmo

669

8626

0.77

9.92

3.5

25.23

25.21

mmol/l

0.06

645

8333

Benign neoplasm: Stomach

286

1922

1.53

9.91

3.4

3.2

25.04

25.35

mmol/l

0.95

279

1858

ILD-related respiratory insufficiency

127

700

1.90

9.80

7.1

3.2

26.39

25.18

mmol/l

2.05

114

674

Sulfasalazine

673

5203

1.31

9.78

3.6

3.2

25.31

25.19

mmol/l

0.39

649

5041

Maternal care for known or suspected fetal abnormality and damage

1330

0.47

9.77

2.8

3.3

25.31

25.16

mmol/l

0.15

1270

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1335

7523

1.22

9.76

4.0

3.4

25.11

25.37

mmol/l

2.24

1296

7287

Effects of foreign body entering through natural orifice

611

4670

1.32

9.72

3.7

3.8

25.31

25.11

mmol/l

0.82

589

4505

Malignant neoplasm of endocrine gland, including Hilmo

208

1307

1.63

9.69

3.3

3.1

25.93

25.46

mmol/l

1.09

198

1257

Sequelae of injuries of head

144

822

1.80

9.68

4.1

3.6

25.08

25.15

mmol/l

0.09

137

790

Paralytic strabismus

213

1350

1.62

9.67

4.4

3.3

25.17

25.21

mmol/l

0.07

203

1298

Injuries to unspecified part of trunk, limb or body region

282

1898

1.52

9.64

4.9

3.5

25.48

25.27

mmol/l

0.46

273

1827

Injuries involving multiple body regions

109

572

1.97

9.62

5.5

3.2

24.70

25.20

mmol/l

1.04

103

550

Assault by sharp object

213

2.66

9.62

3.2

3.6

24.72

25.15

mmol/l

0.34

201

Oxicams

786

3495

1.29

9.60

3.2

4.2

25.09

24.97

mmol/l

0.42

767

3378

Persons encountering health services in circumstances related to reproduction

877

7335

0.80

9.55

3.7

25.54

25.29

mmol/l

1.56

834

7084

Abdominal aortic aneurysm (AAA)

326

2245

1.47

9.54

4.7

3.3

24.45

24.97

mmol/l

1.75

312

2169

Burns and corrosions

333

2319

1.46

9.50

4.1

3.6

25.04

25.18

mmol/l

0.31

325

2233

Diseases of pulp and periapical tissues, including avohilmo

2889

13154

1.14

9.49

3.7

3.5

25.04

25.27

mmol/l

3.00

2780

12737

Haemorrhage in early pregnancy

459

3271

1.37

9.48

2.8

3.0

25.23

25.49

mmol/l

1.12

443

3156

Hypertrophic disorders of skin

135

760

1.82

9.47

3.2

2.9

25.17

25.27

mmol/l

0.14

130

725

187

1152

1.66

9.38

3.5

2.9

25.22

25.02

mmol/l

0.23

182

1109

Hepatocellular carcinoma, including Hilmo

109

582

1.96

9.28

4.1

3.0

23.84

25.12

mmol/l

2.46

104

558

Lesion of lateral popliteal nerve

141

812

1.79

9.25

4.2

3.4

24.98

25.20

mmol/l

0.29

136

785

Coxarthrosis, primary, with hip surgery

1414

11053

1.20

9.21

3.4

3.6

25.30

25.25

mmol/l

0.21

1377

10728

Budesonide

326

2275

1.45

9.19

3.5

3.1

24.82

25.26

mmol/l

1.35

312

2191

Malignant neoplasm of thyroid gland

170

1035

1.68

9.04

3.4

2.9

26.24

25.46

mmol/l

2.15

163

995

Olecranon bursitis

184

1145

1.65

9.03

5.5

3.5

25.28

25.14

mmol/l

0.21

179

1108

Chronic apical periodontitis

3043

15137

1.13

8.99

4.0

3.5

25.08

25.28

mmol/l

2.61

2935

14646

Bacterial, viral and other infectious agents

201

1276

1.61

8.99

4.5

3.6

25.43

25.26

mmol/l

0.36

196

1228

Disorders of lacrimal system

1156

9434

1.22

8.97

3.9

3.4

25.33

25.29

mmol/l

0.11

1118

9127

Fracture of foot, except ankle

559

4268

1.32

8.96

5.0

3.5

25.12

25.26

mmol/l

0.43

538

4115

Early lumbar disc prolapse, operated

173

1057

1.66

8.94

3.2

3.5

25.23

mmol/l

0.01

158

1018

Otitis media, unspecified

234

1412

1.55

8.90

5.4

3.4

24.92

24.95

mmol/l

0.05

222

1346

Other maternal disorders predominantly related to pregnancy

985

4998

1.24

8.89

3.2

3.1

25.28

25.47

mmol/l

1.05

944

4830

Thyrotoxicosis

605

4677

1.31

8.88

3.7

3.3

25.58

25.31

mmol/l

1.18

582

4527

Squamous cell neoplasms and carcinomas of the skin

362

2600

1.42

8.86

4.7

3.2

25.03

25.20

mmol/l

0.38

353

2508

Exposure to smoke, fire and flames

396

2.14

8.83

3.5

3.6

25.35

25.04

mmol/l

0.33

379

Malignant neoplasm of skin

1410

8039

1.20

8.83

4.0

3.4

25.10

25.37

mmol/l

2.43

1369

7790

Malignant neoplasm of thyroid gland, including Hilmo

183

1146

1.63

8.70

3.4

2.8

26.13

25.45

mmol/l

1.77

175

1102

Conjunctivitis

1402

13310

0.84

8.70

3.6

3.5

25.28

25.27

mmol/l

0.06

1366

12847

Autoimmune thyroiditis

224

2.52

8.67

3.3

26.04

25.27

mmol/l

1.00

214

Other enthesopathies

699

5520

1.28

8.62

3.5

3.2

25.51

25.20

mmol/l

1.77

673

5348

Other disorders of eyelid

1303

10355

1.20

8.59

3.7

3.5

25.45

25.28

mmol/l

1.15

1274

10040

Diseases of salivary glands

797

6398

1.26

8.59

3.6

3.5

25.45

25.24

mmol/l

1.01

770

6196

Abscess of lung

239

2.48

8.55

3.7

25.58

24.94

mmol/l

0.45

230

290

2009

1.46

8.51

4.8

2.9

25.35

25.26

mmol/l

0.16

270

1936

Acute nasopharyngitis (common cold)

267

1811

1.48

8.42

3.6

3.3

25.34

25.31

mmol/l

0.04

257

1737

Other other unspecified disorders of the circulatory system

113

630

1.86

8.37

5.1

3.2

25.74

25.19

mmol/l

0.68

106

608

Left bundle-branch block

187

1189

1.61

8.36

3.7

2.7

24.99

25.11

mmol/l

0.17

182

1154

Biological medication for rheuma

364

2635

1.40

8.34

3.7

3.5

25.36

25.28

mmol/l

0.16

348

2538

Disturbance of activity and attention

205

1293

1.56

8.34

3.6

4.3

24.95

24.83

mmol/l

0.22

195

1234

Abnormal weight loss

272

1876

1.48

8.34

3.5

25.26

25.21

mmol/l

0.07

257

1813

Collagenous colitis

239

1606

1.52

8.32

5.2

3.3

24.68

25.40

mmol/l

2.20

230

1550

Thyrotoxicosis, other and/or unspecified

463

3486

1.34

8.27

3.4

3.2

25.31

25.30

mmol/l

0.03

443

3376

Chondropathies

347

2499

1.41

8.25

3.7

3.5

24.98

25.29

mmol/l

1.04

333

2403

Rare circulating lymphoid malignancy, including Hilmo

512

1.95

8.21

4.3

3.3

25.22

25.16

mmol/l

0.07

492

Other menopausal disorders

334

2594

0.71

8.20

2.8

3.1

25.68

25.51

mmol/l

0.48

319

2531

Pilonidal cyst

173

1084

1.62

8.16

3.2

3.3

25.15

25.16

mmol/l

0.01

167

1042

Urticaria

645

5080

1.28

8.16

3.7

3.5

25.42

25.23

mmol/l

0.80

630

4904

Bacterial, viral and other infectious agents, including avohilmo

214

1410

1.55

8.15

4.4

3.6

25.40

25.23

mmol/l

0.36

208

1357

Abnormal spermatozoa

394

2917

1.38

8.08

4.0

25.19

24.92

mmol/l

0.92

387

2821

Puerperal sepsis

244

1654

1.50

8.07

3.5

3.0

26.02

25.53

mmol/l

1.78

238

1598

Other diseases of gallbladder

127

740

1.77

8.06

4.5

3.1

25.54

25.30

mmol/l

0.32

118

715

Benign neoplasm: Rectum

518

3986

1.32

8.04

4.1

3.6

25.21

25.15

mmol/l

0.15

509

3865

Other shoulder lesions

224

1497

1.52

7.97

3.5

3.1

25.36

25.20

mmol/l

0.35

216

1446

Other noninflammatory disorders of cervix uteri

131

773

1.74

7.94

3.8

3.0

25.15

25.40

mmol/l

0.36

126

757

Other juvenile arthritis

403

2.03

7.93

3.3

4.2

24.54

24.81

mmol/l

0.28

386

Haemangioma and lymphangioma, any site

228

1533

1.52

7.93

3.4

25.63

25.31

mmol/l

0.84

223

1478

Other/unspecified synovitis and tenosynovitis

274

1911

1.46

7.85

3.6

3.2

25.65

25.20

mmol/l

1.52

268

1846

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

170

1073

1.61

7.83

4.1

2.9

25.39

25.44

mmol/l

0.07

164

1037

Necrosis of pulp, including avohilmo

1371

11557

1.18

7.76

3.9

3.5

25.08

25.25

mmol/l

1.14

1320

11157

1301

9956

1.19

7.69

4.2

3.5

25.25

25.22

mmol/l

0.10

1270

9652

Bronchitis, not specified as acute or chronic

219

1470

1.52

7.68

4.6

3.2

25.39

25.04

mmol/l

0.70

211

1421

Other abnormal uterine and vaginal bleeding

528

2923

1.31

7.65

3.0

3.1

25.94

25.47

mmol/l

2.38

509

2844

Degenerative macular diseases

364

2684

1.38

7.65

3.8

3.3

25.08

25.23

mmol/l

0.41

349

2607

Polymyalgia rheumatica

422

3183

1.35

7.64

3.7

3.3

25.72

25.18

mmol/l

2.52

406

3097

Prolonged pregnancy

1323

0.54

7.52

1.9

3.2

24.56

25.12

mmol/l

0.91

1263

Haemangioma, any site

213

1432

1.52

7.45

3.5

3.4

25.72

25.31

mmol/l

1.19

208

1378

Pneumothorax

199

1321

1.54

7.44

4.4

3.3

25.84

24.83

mmol/l

3.41

188

1274

Abrasion of teeth

557

7067

0.78

7.43

3.0

3.5

25.60

25.33

mmol/l

1.19

537

6848

Any event in hilmo or specialist outpatient

+∞

7.43

4.0

0.0

24.73

—

mmol/l

—

Hypertrophic scar

118

689

1.75

7.40

3.4

2.9

25.37

25.26

mmol/l

0.14

113

656

Subjective visual disturbances

627

4989

1.27

7.40

4.1

3.4

25.18

25.24

mmol/l

0.14

599

4827

Perineal laceration during delivery

236

1298

1.48

7.34

2.1

3.2

24.85

25.08

mmol/l

0.54

227

1239

Dementia in Alzheimer disease

632

4211

1.27

7.32

2.8

3.5

25.38

25.03

mmol/l

1.92

614

4087

Benign lipomatous neoplasm

745

6056

1.24

7.28

3.8

3.5

25.40

25.23

mmol/l

0.70

719

5859

Adenocarcinoma and ductal carcinoma of pancreas

118

696

1.76

7.28

3.5

2.8

24.67

25.31

mmol/l

0.90

113

667

Impingement syndrome of shoulder

578

4567

1.28

7.26

3.5

3.2

25.53

25.22

mmol/l

1.43

552

4436

Colorectal adenocarcinoma

611

4804

1.27

7.21

3.3

3.4

24.63

25.27

mmol/l

3.83

589

4651

Other and unspecified vascular occlusions

294

2117

1.42

7.20

4.7

3.3

25.32

25.22

mmol/l

0.20

282

2047

187

2.47

7.19

5.6

3.0

25.01

24.95

mmol/l

0.04

179

Suggestive for eosinophilic asthma

233

1607

1.48

7.18

4.2

3.4

25.80

25.16

mmol/l

2.31

226

1548

Calculus of lower urinary tract

171

1111

1.59

7.15

4.3

3.5

24.49

24.97

mmol/l

0.97

166

1070

Thrombocytopenia, unspecified

204

1374

1.52

7.14

5.3

3.3

24.64

25.23

mmol/l

1.73

198

1321

Hypogonadotropic hypogonadism

428

1.95

7.12

3.3

4.1

25.21

25.12

mmol/l

0.09

412

Acute pharyngitis

284

2008

1.41

7.09

4.1

3.5

25.14

25.13

mmol/l

0.01

267

1936

Ocular pain

193

1284

1.53

7.09

4.4

3.3

25.20

25.31

mmol/l

0.19

186

1233

Adalimumab

203

1364

1.51

7.08

3.7

3.5

25.27

mmol/l

0.00

191

1314

Menorrhagia

714

3201

1.25

7.03

3.5

3.1

25.71

25.43

mmol/l

1.31

697

3110

conjunctival haemorrhage

223

1536

1.49

6.99

4.6

3.2

25.65

25.30

mmol/l

0.73

215

1481

Distal bite

419

1.94

6.99

9.0

4.7

24.86

24.89

mmol/l

0.03

395

Benign neoplasm: Rectum, anus and anal canal

568

4511

1.28

6.93

4.1

3.6

25.16

mmol/l

0.01

557

4363

Retinal detachments and breaks

987

8292

1.20

6.90

4.1

3.3

25.05

25.27

mmol/l

1.24

959

8042

Other fall from one level to another

549

4339

1.28

6.87

3.9

3.8

25.25

25.12

mmol/l

0.44

531

4189

Juvenile arthritis (FINNGEN)

489

1.86

6.86

4.3

4.0

24.55

24.99

mmol/l

0.55

466

Hyperkinetic disorders

212

1409

1.48

6.80

3.5

4.3

24.98

24.80

mmol/l

0.40

202

1346

Bronchiectasis

225

1564

1.47

6.74

3.8

3.1

26.22

25.00

mmol/l

4.55

220

1522

Complications predominantly related to the puerperium

417

3189

1.32

6.71

3.0

25.65

25.37

mmol/l

1.00

405

3083

Superficial injury of ankle and foot

255

1809

1.43

6.70

4.5

3.4

25.00

25.25

mmol/l

0.62

244

1734

Spondylopathies (FG)

293

2129

1.39

6.69

3.9

3.3

25.52

25.23

mmol/l

0.77

284

2061

Temporomandibular joint disorders, including avohilmo

894

7217

1.21

6.68

3.1

3.4

25.32

25.27

mmol/l

0.17

860

6971

Trochanteric bursitis

359

2699

1.35

6.62

3.7

3.0

25.51

25.26

mmol/l

0.75

344

2628

Other inflammatory liver diseases

168

1106

1.55

6.57

4.7

3.1

24.85

25.30

mmol/l

1.01

163

1065

Infarction of spleen

126

2.88

6.55

5.7

3.6

24.35

24.91

mmol/l

0.36

121

Otitis externa, unspecified

262

1878

1.42

6.53

4.3

3.5

25.09

25.22

mmol/l

0.25

250

1812

Other intracranial haemorrhages

115

696

1.72

6.53

3.8

3.4

24.99

25.04

mmol/l

0.06

109

668

Abscess of anal and rectal regions

193

1308

1.50

6.51

4.8

3.4

24.81

25.36

mmol/l

1.25

184

1260

Perforation of tympanic membrane

249

1772

1.43

6.51

5.1

3.4

25.48

25.24

mmol/l

0.44

241

1708

Gonarthrosis, primary, with knee surgery

1693

11565

1.15

6.49

3.3

3.6

25.24

25.26

mmol/l

0.09

1650

11225

Other symptoms and signs involving the urinary system

279

2027

1.40

6.47

4.4

3.3

25.18

25.13

mmol/l

0.09

250

1952

Malignant neoplasm of corpus uteri, including Hilmo

247

1760

1.43

6.45

3.0

25.45

25.60

mmol/l

0.27

241

1711

Vitamin B12 deficiency anaemia

298

2191

1.38

6.43

4.7

3.2

24.78

25.17

mmol/l

1.07

290

2123

461

1.88

6.39

4.6

3.3

27.41

24.87

mmol/l

4.42

443

Immunodeficiency associated with other major defects

4.72

6.37

4.0

4.7

26.17

24.24

mmol/l

1.82

Other and unspecified disorders of vitreous body

1095

9137

1.18

6.35

3.5

3.4

25.52

25.33

mmol/l

1.14

1068

8867

Melanocytic naevi

708

5809

1.23

6.35

4.7

3.5

25.05

25.21

mmol/l

0.72

685

5615

Acute laryngitis and tracheitis

206

1396

1.47

6.34

4.0

3.3

25.03

25.18

mmol/l

0.28

196

1337

Malignant neoplasm of stomach, including Hilmo

183

1239

1.51

6.31

3.1

3.0

25.37

25.16

mmol/l

0.35

177

1184

Secondary parkinsonism+Parkinsonism in other disease

529

1.81

6.29

4.9

3.1

25.25

25.12

mmol/l

0.14

510

Other and unspecified mononeuropathies of upper limb

426

1.89

6.25

4.1

3.5

25.46

25.27

mmol/l

0.20

410

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

386

2956

1.32

6.25

4.2

3.6

24.85

25.26

mmol/l

1.27

370

2847

Persons encountering health services in other circumstances

954

7972

1.19

6.23

5.0

3.1

24.93

25.17

mmol/l

1.35

903

7701

Ulcerative colitis (strict definition, require KELA)

359

2724

1.33

6.21

4.4

3.5

24.91

25.24

mmol/l

0.88

344

2622

Papillary adenocarcinoma of thyroid gland

122

756

1.65

6.21

3.2

2.8

26.38

25.48

mmol/l

1.94

117

725

Malignant neoplasm of rectum, including Hilmo

349

2643

1.34

6.21

3.4

3.3

24.76

25.21

mmol/l

1.30

333

2555

Corneal ulcer

425

3301

1.30

6.20

4.8

3.3

25.22

25.26

mmol/l

0.10

415

3189

Fall on and from stairs and steps

664

5433

1.23

6.17

3.6

3.5

25.14

25.19

mmol/l

0.16

637

5264

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

347

2623

1.34

6.17

4.4

3.6

24.90

25.24

mmol/l

0.89

333

2525

Parkinson's disease, including avohilmo

479

3788

1.28

6.15

3.6

3.5

25.56

25.08

mmol/l

2.60

457

3672

Postprocedural musculoskeletal disorders, not elsewhere classified

200

1386

1.48

6.14

2.8

3.4

25.47

25.32

mmol/l

0.20

191

1343

Other strabismus

455

3555

1.29

6.11

4.4

3.6

25.30

25.19

mmol/l

0.30

443

3428

Chronic sinusitis

1010

8583

1.18

6.07

3.5

25.42

25.22

mmol/l

1.09

971

8287

Primary gonarthrosis, bilateral

1490

10915

1.15

6.07

3.3

3.6

25.40

25.26

mmol/l

0.84

1443

10601

Tumor necrosis factor alpha inhibitors

309

2301

1.36

6.07

3.6

3.5

25.37

25.30

mmol/l

0.13

294

2213

Symptoms and signs involving speech and voice

852

7152

1.20

6.07

3.7

3.5

25.50

25.22

mmol/l

1.64

825

6926

Brachial plexus disorders

176

1188

1.50

6.07

3.3

3.2

25.26

25.21

mmol/l

0.06

163

1144

Other and unspecified injuries of neck

107

2.86

6.02

4.1

3.4

25.10

24.70

mmol/l

0.29

102

Lichen planus

323

2430

1.35

6.01

4.0

3.3

25.28

25.33

mmol/l

0.09

317

2351

Stomatitis and related lesions

451

3549

1.28

5.94

4.2

3.5

25.22

25.25

mmol/l

0.07

437

3427

Parkinson's disease

459

3628

1.28

5.94

3.6

3.5

25.55

25.10

mmol/l

2.22

437

3514

Visual field defects

228

1628

1.43

5.93

4.3

3.4

25.05

25.31

mmol/l

0.56

215

1572

Right bundle-branch block

582

1.73

5.91

3.9

2.5

25.13

25.06

mmol/l

0.07

559

Superficial injury of shoulder and upper arm

293

2177

1.36

5.91

4.2

3.4

25.45

25.25

mmol/l

0.47

285

2092

Pediculosis, acariasis and other infestations

138

892

1.58

5.89

5.6

3.4

25.57

25.14

mmol/l

0.54

131

855

Need for immunization against other single viral diseases

301

2.04

5.87

39.7

3.4

23.74

25.09

mmol/l

2.41

293

Atypical facial pain

124

783

1.62

5.87

3.1

2.9

25.59

25.39

mmol/l

0.31

118

756

Motor disorders, excluding more controls

111

2.70

5.87

5.3

8.9

24.27

24.43

mmol/l

0.10

105

Abnormal findings on diagnostic imaging of breast

207

2.27

5.86

4.0

2.5

25.37

25.41

mmol/l

0.02

200

Glaucoma suspect

1004

8573

1.18

5.84

3.7

3.5

25.19

25.28

mmol/l

0.36

969

8314

Pedal cyclist injured in transport accident

502

4012

1.26

5.81

3.9

3.6

25.47

25.20

mmol/l

0.99

488

3874

Other keratitis

256

1868

1.39

5.79

4.6

3.2

25.57

25.34

mmol/l

0.47

248

1797

Carbimazole or st.post thyroidectomy, condition for graves disease

445

3508

1.28

5.79

3.0

3.3

26.00

25.35

mmol/l

3.99

416

3397

Diseases of middle ear and mastoid

1303

9248

1.16

5.78

4.5

3.5

25.12

25.17

mmol/l

0.21

1265

8916

Hypotension due to drugs

298

2.06

5.74

4.5

3.3

25.24

25.20

mmol/l

0.03

288

Accidental poisoning by and exposure to alcohol

228

2.18

5.74

8.2

3.6

26.12

24.70

mmol/l

1.91

213

Mycoses, including avohilmo

2407

16531

1.11

5.73

3.8

3.5

25.26

25.25

mmol/l

0.06

2316

15991

Scabies

106

648

1.67

5.72

5.3

3.3

25.64

25.17

mmol/l

0.51

622

Preterm labour and delivery

412

3222

1.29

5.67

3.4

3.2

25.38

25.54

mmol/l

0.48

402

3119

Injury of unspecified body region

198

1390

1.45

5.67

4.6

3.4

25.45

25.25

mmol/l

0.33

190

1335

Mantle cell lymphoma, including Hilmo

272

2.10

5.65

4.0

2.8

25.29

25.23

mmol/l

0.06

264

Hidradenitis suppurativa

410

1.84

5.65

4.5

3.4

25.09

25.00

mmol/l

0.08

392

Viral warts, including avohilmo

461

3661

1.27

5.64

5.5

3.5

24.90

25.22

mmol/l

1.44

450

3524

Flat foot [pes planus] (acquired)

227

1633

1.41

5.63

3.2

25.61

25.26

mmol/l

0.81

221

1592

Viral infections of the central nervous system

163

1107

1.50

5.54

3.6

3.2

25.39

25.25

mmol/l

0.24

153

1069

Non-allergic asthma

215

1537

1.42

5.54

3.3

3.5

25.35

25.26

mmol/l

0.14

210

1480

Hypoplasia of dental enamel, prenatal

5.88

5.53

34.5

6.4

23.53

23.43

mmol/l

0.04

Inflammatory disease of uterus

236

1712

1.39

5.51

3.1

3.0

25.34

25.36

mmol/l

0.03

226

1657

Nonsuppurative otitis media

445

3053

1.27

5.51

5.7

3.6

25.10

25.05

mmol/l

0.11

430

2932

Atopic dermatitis

935

8715

0.85

5.48

3.4

3.5

25.29

25.22

mmol/l

0.29

906

8399

Malignant neoplasm of corpus uteri

222

1602

1.41

5.47

2.8

3.0

25.44

25.57

mmol/l

0.23

216

1559

Skin changes due to chronic exposure to nonionizing radiation

1216

9587

1.16

5.46

4.3

3.5

25.22

25.21

mmol/l

0.05

1186

9300

Coarctation of the aorta

125

2.60

5.42

4.3

5.1

24.97

24.70

mmol/l

0.22

119

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

209

1484

1.42

5.37

4.3

4.0

25.29

25.12

mmol/l

0.30

202

1423

Multiple sites

13.82

5.36

6.0

6.5

24.18

24.97

mmol/l

—

Other specified/unspecified necrotizing vasculopathies

236

2.14

5.36

7.9

3.6

24.27

25.11

mmol/l

0.94

226

Fissure and fistula of anal and rectal regions

540

4393

1.24

5.35

3.5

3.2

25.53

25.24

mmol/l

1.29

521

4253

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

424

3362

1.27

5.31

3.4

3.7

24.62

25.19

mmol/l

3.19

406

3242

Burn and corrosion of hip and lower limb, except ankle and foot

333

1.92

5.30

5.5

3.7

24.98

25.08

mmol/l

0.10

318

Maternal care for other conditions predominantly related to pregnancy

273

1985

1.35

5.30

2.8

3.1

25.15

25.34

mmol/l

0.45

263

1908

Herpesviral [herpes simplex] infections, including avohilmo

518

4200

1.24

5.29

4.1

3.3

25.06

25.26

mmol/l

0.74

506

4051

Calcific tendinitis of shoulder

129

843

1.56

5.29

3.3

3.2

25.45

25.21

mmol/l

0.36

124

815

Nummular dermatitis

217

1569

1.41

5.29

4.1

3.4

25.21

25.27

mmol/l

0.10

212

1508

Inflammatory diseases of female pelvic organs

1273

7599

1.15

5.28

3.2

3.1

25.36

25.44

mmol/l

0.40

1222

7363

Excessive vomiting in pregnancy

126

818

1.56

5.26

3.3

3.0

25.34

25.31

mmol/l

0.03

119

788

UC patients in KELA-register (code 208), prior to 1994

111

704

1.62

5.25

3.5

3.4

24.59

25.21

mmol/l

0.75

105

677

Congenital malformations and deformations of the musculoskeletal system

164

1121

1.47

5.22

4.6

4.3

25.29

25.05

mmol/l

0.38

158

1076

Basal cell carcinoma, including Hilmo

1279

7571

1.15

5.21

3.9

3.4

25.10

25.37

mmol/l

2.29

1241

7334

Spondylopathies in diseases classified elsewhere

212

2.18

5.18

7.5

3.5

25.54

25.08

mmol/l

0.36

204

Actinic keratosis

1186

9418

1.15

5.18

4.3

3.5

25.23

25.20

mmol/l

0.08

1158

9138

Short Achilles tendon (acquired)

373

1.84

5.11

3.7

3.2

26.58

25.51

mmol/l

0.86

362

Pain and other conditions associated with female genital organs and menstrual cycle

347

2245

1.30

5.10

2.9

3.1

25.36

25.20

mmol/l

0.43

334

2170

Exposure to other and unspecified man-made environmental factors

260

2.03

5.10

4.0

3.5

25.55

24.97

mmol/l

0.75

253

Pediculosis, acariasis and other infestations, including avohilmo

349

2715

1.30

5.09

3.8

3.4

25.15

25.25

mmol/l

0.17

328

2610

Other specific joint derangements/joint disorders

1709

9482

1.13

5.08

3.8

3.4

25.22

mmol/l

0.02

1638

9171

Sequelae of injuries of lower limb

203

1460

1.41

5.08

3.9

3.5

25.30

25.34

mmol/l

0.06

195

1408

Colon adenocarcinoma

361

2829

1.29

5.08

3.3

24.66

25.23

mmol/l

2.23

353

2735

Abnormal findings in secretions and smears from cervix uteri vagina vulva

632

5589

0.83

5.04

2.8

3.0

25.26

25.40

mmol/l

0.52

599

5408

Other diseases of lip and oral mucosa

1012

8755

1.16

5.04

3.8

3.5

25.45

25.27

mmol/l

0.89

985

8483

Lateral epicondylitis

268

2015

1.34

5.04

3.1

25.51

25.24

mmol/l

0.65

260

1948

Burn and corrosion of trunk

472

1.74

5.03

3.2

3.5

25.57

25.15

mmol/l

0.46

454

Chronic periodontitis, complicated

1497

12954

1.13

5.02

4.2

3.5

24.98

25.31

mmol/l

3.15

1438

12559

Parkinson's disease, strict definition

425

3403

1.27

5.01

3.7

3.4

25.61

25.09

mmol/l

2.71

404

3295

Disease of hard tissues of teeth, NOS

1218

7291

0.87

5.01

3.0

3.4

25.25

25.30

mmol/l

0.22

1173

7093

Inflammatory diseases of prostate (prostatitis)

350

2738

1.30

4.99

3.6

3.5

25.28

25.02

mmol/l

0.80

335

2658

Other congenital malformations

164

1138

1.46

4.98

5.0

3.9

25.49

25.12

mmol/l

0.67

159

1092

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1287

10916

1.14

4.97

3.9

3.6

25.51

25.20

mmol/l

2.69

1253

10548

Viral infections of the central nervous system, including avohilmo

170

1193

1.45

4.92

3.5

3.3

25.46

25.25

mmol/l

0.43

160

1150

Other secondary coxarthrosis

552

1.68

4.90

4.4

3.3

25.23

25.13

mmol/l

0.11

536

Endometriosis of rectovaginal septum and vagina

165

1152

1.45

4.90

3.2

3.0

25.65

25.41

mmol/l

0.48

157

1119

Basal cell carcinoma

1235

7384

1.15

4.85

3.9

3.4

25.11

25.38

mmol/l

2.19

1197

7152

Other autoimmune haemolytic anaemias

225

2.11

4.85

6.9

3.1

24.38

25.11

mmol/l

0.71

216

Other and unspecified urticaria

398

3170

1.27

4.83

3.7

3.5

25.56

25.24

mmol/l

1.09

389

3058

Localized swelling, mass and lump of skin and subcutaneous tissue

777

6613

1.18

4.81

4.2

3.4

25.23

25.21

mmol/l

0.07

758

6392

Fracture of neck

176

1252

1.44

4.80

3.7

3.4

25.59

25.08

mmol/l

1.02

170

1207

Early lumbar disc prolapse operation

177

1255

1.43

4.79

3.1

3.5

25.28

25.26

mmol/l

0.03

162

1205

Other and unspecified injuries of lower leg

164

1149

1.45

4.78

5.5

3.6

24.96

25.22

mmol/l

0.56

157

1101

Primary coxarthrosis, bilateral

828

7099

1.18

4.74

3.5

25.37

25.18

mmol/l

0.78

804

6875

Exposure to unspecified factor

2694

16777

1.10

4.73

4.1

3.5

25.37

25.21

mmol/l

1.55

2591

16228

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

601

5011

1.21

4.69

4.0

3.5

25.44

25.26

mmol/l

0.70

579

4835

Vasomotor and allergic rhinitis

785

6544

1.18

4.67

3.1

3.6

25.47

25.19

mmol/l

1.74

759

6317

Disorders of refraction and accommodation

576

4768

1.21

4.66

5.4

3.5

25.27

25.24

mmol/l

0.10

560

4598

Seropositive rheumatoid arthritis

601

4992

1.21

4.64

3.9

3.2

25.14

25.25

mmol/l

0.31

582

4845

Rheumatoid arthritis, including avohilmo

943

8176

1.16

4.62

3.8

3.4

25.31

25.30

mmol/l

0.04

916

7918

Melanocytic naevi of trunk

273

2088

1.32

4.62

5.3

3.4

24.78

25.26

mmol/l

1.70

262

2005

Diseases of oral cavity, salivary glands and jaws

1702

7850

1.12

4.59

3.8

3.4

25.17

25.26

mmol/l

0.49

1641

7632

Degeneration of the brain due to alcohol

411

1.77

4.57

4.7

3.5

24.54

24.95

mmol/l

0.44

394

Degeneration of nervous system due to alcohol

412

1.76

4.53

4.7

3.4

24.54

24.93

mmol/l

0.41

395

Primary biliary cholangitis, wide definition

344

1.83

4.53

3.9

2.5

25.09

25.51

mmol/l

0.29

329

Other and unspecified vasculitis limited to skin

404

1.76

4.53

5.6

3.2

25.21

25.18

mmol/l

0.02

392

Hypersensitivity angiitis

2.81

4.51

15.4

3.9

24.34

25.15

mmol/l

0.49

Mixed conductive and sensorineural hearing loss

317

2485

1.29

4.49

4.0

3.5

25.29

25.17

mmol/l

0.26

307

2407

Fibroblastic disorders

603

5058

1.20

4.48

3.6

3.3

25.14

25.11

mmol/l

0.07

584

4907

Inguinal hernia

1606

9560

1.12

4.46

3.9

3.5

25.13

25.14

mmol/l

0.03

1548

9242

Autoimmune polyglandular failure

10.23

4.45

8.4

8.6

24.05

23.26

mmol/l

—

Crystalline deposits in vitreous body

172

2.22

4.41

4.4

3.3

25.37

24.79

mmol/l

0.61

166

Intentional self-harm by smoke, fire and flames

5.50

4.41

6.6

5.2

24.82

24.55

mmol/l

0.09

Recurrent aphthous stomatitis , including avohilmo

328

2588

1.28

4.38

4.0

3.4

25.34

25.23

mmol/l

0.21

317

2495

Malignant neoplasm of rectum

275

2125

1.31

4.38

3.4

3.2

24.70

25.22

mmol/l

1.28

261

2051

Other disorders of lacrimal gland

888

7701

1.16

4.36

4.3

3.3

25.24

25.32

mmol/l

0.25

860

7443

Conotruncal defects

159

2.22

4.32

7.4

7.3

24.74

24.56

mmol/l

0.15

152

Hereditary hypogammaglobulinemia

3.70

4.32

3.9

3.3

25.43

24.87

mmol/l

0.28

Traumatic amputation of wrist and hand

110

731

1.54

4.30

4.9

3.7

25.28

25.13

mmol/l

0.18

105

706

Varicose veins

1641

11153

1.12

4.28

3.4

25.38

25.26

mmol/l

0.70

1587

10814

Faecal incontinence

204

1515

1.36

4.27

3.5

2.9

25.27

25.31

mmol/l

0.05

194

1473

Other disorders of eye and adnexa

306

2403

1.29

4.26

4.0

3.4

25.32

25.26

mmol/l

0.14

293

2309

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

365

2927

1.26

4.25

3.4

3.8

24.52

25.23

mmol/l

3.96

354

2822

Thoracic aortic aneurysm

386

3120

1.25

4.24

3.9

3.3

25.45

25.19

mmol/l

0.80

378

3025

Injury of muscle and tendon at wrist and hand level

306

2405

1.29

4.24

3.0

3.5

25.25

25.26

mmol/l

0.03

298

2314

Injury of heart

4.43

4.23

4.6

2.9

24.16

24.10

mmol/l

0.03

Vulvovaginal ulceration/inflammation in other diseases

114

764

1.51

4.21

4.0

2.8

25.22

25.39

mmol/l

0.23

106

742

Erectile dysfunction, exclusion

3.20

4.18

6.5

4.4

24.18

24.13

mmol/l

0.02

Giant cell arteritis

122

836

1.50

4.15

4.6

3.2

25.32

25.30

mmol/l

0.02

114

806

Other extrapyramidal and movement disorders in other diseases

621

5264

1.19

4.14

4.0

3.5

25.35

25.15

mmol/l

0.81

601

5098

Human immunodeficiency virus [HIV] disease resulting in other conditions

232

0.25

4.12

2.8

3.2

24.90

24.74

mmol/l

—

224

Fracture of forearm

1362

10934

1.12

4.12

3.9

3.5

25.45

25.31

mmol/l

0.89

1323

10589

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

233

0.25

4.11

2.8

3.2

24.90

24.76

mmol/l

—

225

Other specified/unspecified systemic involvement of connective tissue

125

860

1.48

4.11

3.7

3.0

25.80

25.40

mmol/l

0.52

116

832

Fenamates

266

2326

0.77

4.08

3.5

4.2

25.54

25.01

mmol/l

2.00

258

2249

Persons encountering health services for specific procedures, not carried out

167

1210

1.40

4.08

4.1

2.6

24.40

25.23

mmol/l

2.31

161

1162

Chorioretinal inflammation

416

1.70

4.07

3.5

3.1

24.48

25.37

mmol/l

1.32

402

Congenital malformations of cardiac septa

136

921

1.45

4.07

5.4

4.1

25.15

25.00

mmol/l

0.20

131

879

Vasculitis limited to skin, not elsewhere classified

456

1.67

4.05

5.5

3.2

25.31

25.19

mmol/l

0.11

441

Thyrotoxicosis with diffuse goitre

267

2075

1.30

4.04

3.4

3.1

25.61

25.40

mmol/l

0.46

256

2009

Allergic rhinitis

564

4687

1.19

4.01

3.2

3.7

25.46

25.19

mmol/l

1.20

544

4522

Methotrexate

298

2352

1.28

4.01

3.8

3.0

24.99

25.26

mmol/l

0.71

288

2273

Panniculitis, unspecified

172

2.13

3.98

3.3

3.1

25.24

25.00

mmol/l

0.20

167

Otitis externa

517

4327

1.20

3.98

4.3

3.5

25.22

25.17

mmol/l

0.12

495

4183

Other noninfective disorders of lymphatic vessels and lymph nodes

583

1.58

3.97

5.9

3.2

25.08

25.20

mmol/l

0.11

563

Sicca syndrome [Sjögren]

188

1397

1.36

3.97

3.5

3.1

25.03

25.49

mmol/l

0.97

180

1354

Crowding of teeth, including avohilmo

144

842

1.43

3.96

6.3

3.9

24.59

24.80

mmol/l

0.30

136

806

Injury of eye and orbit

292

2304

1.28

3.93

4.6

3.7

25.22

25.24

mmol/l

0.03

284

2215

Blepharochalasis

767

6645

1.16

3.90

3.5

3.4

25.62

25.27

mmol/l

2.43

747

6430

Other and unspecified acne

139

2.22

3.90

6.6

3.6

24.80

25.04

mmol/l

0.20

131

Occupational exposure to risk-factors

573

1.57

3.83

3.5

25.66

25.11

mmol/l

0.70

550

Hypertrophy of breast in women and men

350

2831

1.25

3.80

3.5

3.1

25.37

25.41

mmol/l

0.10

335

2729

Fracture at wrist and hand level

789

6837

1.16

3.79

4.9

3.6

25.29

25.20

mmol/l

0.31

768

6604

Other (seronegative) rheumatoid arthritis, wide

451

3750

1.21

3.78

3.8

3.3

25.28

25.24

mmol/l

0.08

437

3639

Deep endometriosis

183

1365

1.36

3.77

3.1

2.9

25.60

25.46

mmol/l

0.26

175

1326

Stenosis and insufficiency of lacrimal passages

233

1801

1.31

3.76

3.6

3.2

25.54

25.32

mmol/l

0.49

226

1733

Other peripheral vertigo

232

1793

1.31

3.76

3.7

3.2

25.46

25.33

mmol/l

0.23

223

1733

Other diseases of upper respiratory tract

2991

14463

1.08

3.75

3.6

25.30

25.20

mmol/l

0.83

2892

13977

Peptic ulcer

156

2.14

3.73

6.1

3.2

24.44

25.25

mmol/l

0.69

150

Malignant otitis externa

4.84

3.70

4.8

2.8

24.21

25.16

mmol/l

0.27

Temporal arteritis

107

733

1.50

3.70

4.3

3.2

25.27

25.29

mmol/l

0.02

101

711

ILD medications: acetylcysteine

130

2.25

3.68

3.9

2.9

25.34

24.99

mmol/l

0.19

124

Noninflammatory disorders of female genital tract

788

3420

1.16

3.68

3.1

25.32

25.34

mmol/l

0.08

753

3316

Spontaneous rupture of synovium and tendon

196

1484

1.34

3.67

3.9

3.3

25.53

25.22

mmol/l

0.58

186

1434

Polycystic ovarian syndrome, broad definition

135

961

1.41

3.66

2.6

3.0

24.48

24.97

mmol/l

0.87

130

915

Peritonsillar abscess

411

3395

1.22

3.66

3.7

3.6

25.06

25.15

mmol/l

0.23

400

3270

Myopia

230

1780

1.30

3.63

4.9

3.4

25.20

25.30

mmol/l

0.18

222

1704

Other abnormalities of plasma proteins

279

1.82

3.63

4.6

3.4

24.85

25.33

mmol/l

0.52

268

Giant cell arteritis with polymyalgia rheumatica

107

736

1.49

3.63

4.3

3.2

25.27

25.28

mmol/l

0.01

101

713

Disorders of tooth development and eruption

220

2307

0.77

3.55

4.9

3.2

25.18

25.29

mmol/l

0.18

211

2243

Other/unspecified rheumatoid arthritis

304

2447

1.26

3.54

4.2

3.2

25.16

25.29

mmol/l

0.23

296

2368

Other or unspecified common variable immunodeficiency

3.23

3.54

3.0

3.4

24.94

24.90

mmol/l

0.01

Hypertrophic cardiomyopathy

111

773

1.47

3.52

4.8

3.4

24.91

25.04

mmol/l

0.14

106

744

Victim of lightning

8.19

3.52

5.4

1.8

24.59

26.36

mmol/l

—

Tetralogy of Fallot, a congenital heart defect.

3.19

3.52

7.5

6.0

25.31

24.37

mmol/l

0.78

Ulcerative colitis (strict definition, all Crohn cases excluded)

289

2313

1.26

3.51

3.9

3.5

24.88

25.25

mmol/l

0.90

278

2226

Impotence

153

1127

1.38

3.50

6.0

3.8

25.01

24.91

mmol/l

0.11

143

1096

Alzheimer’s disease (Late onset)

605

5783

0.85

3.49

2.6

3.5

25.28

25.10

mmol/l

0.65

579

5617

Colon adenocarcinoma, helper endpoint

361

2967

1.23

3.48

3.3

3.4

24.66

25.18

mmol/l

1.89

353

2866

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

300

2411

1.25

3.48

3.1

3.0

25.32

25.29

mmol/l

0.06

291

2331

Foreign body entering into or through eye or natural orifice

178

1341

1.34

3.48

3.3

3.8

25.30

25.21

mmol/l

0.14

172

1289

L02BB Anti-androgens

280

2243

1.27

3.46

3.6

3.7

25.05

24.88

mmol/l

0.28

273

2162

Other and unspecified corneal deformities and disorders

491

1.58

3.45

3.1

3.2

25.25

25.40

mmol/l

0.12

475

Alzheimer’s disease, strict definition

651

6062

0.86

3.43

2.6

3.5

25.25

25.11

mmol/l

0.49

625

5887

Other female pelvic inflammatory diseases

294

2366

1.25

3.41

3.5

2.9

25.57

25.49

mmol/l

0.15

277

2297

Donors of organs and tissues

161

2.04

3.41

2.6

2.5

25.73

24.92

mmol/l

0.99

155

Metatarsalgia

195

1492

1.32

3.40

3.6

3.1

25.58

25.18

mmol/l

1.15

187

1443

Injury of muscle and tendon at shoulder and upper arm level

924

8191

1.14

3.40

3.5

25.18

25.19

mmol/l

0.04

894

7932

Disorders of conjunctiva

1750

14793

0.91

3.38

3.8

3.5

25.32

25.26

mmol/l

0.31

1701

14287

Other enthesopathy of foot (+metatarsalgia)

208

1607

1.31

3.38

3.6

3.1

25.52

25.18

mmol/l

0.95

198

1557

Endometriosis ASRM stages 3,4

409

3407

1.21

3.37

3.1

3.0

25.45

25.42

mmol/l

0.05

392

3297

Other disorders of the musculoskeletal system and connective tissue

352

2895

1.23

3.36

3.0

3.5

25.38

25.21

mmol/l

0.36

334

2808

Excessive and redundant skin and subcutaneous tissue

5.18

3.34

1.7

1.9

25.94

25.53

mmol/l

—

Demyelinating diseases of the central nervous system

151

1117

1.37

3.32

3.4

3.2

25.76

25.28

mmol/l

1.11

143

1074

Conductive hearing loss, unspecified

184

1403

1.33

3.32

4.3

3.5

25.41

25.30

mmol/l

0.17

175

1357

Selective deficiency of immunoglobulin M [IgM]

10.26

3.32

10.8

9.4

25.25

25.66

mmol/l

—

Alzheimer’s disease (Late onset), excluding more controls

392

2107

1.22

3.32

2.8

3.2

25.31

24.89

mmol/l

1.64

378

2049

Allergic urticaria

158

1178

1.36

3.31

3.5

3.3

25.05

25.25

mmol/l

0.37

153

1130

Other noninflammatory disorders of vagina

153

1136

1.36

3.30

4.2

3.0

25.62

25.36

mmol/l

0.54

148

1108

Unspecified/other endometriosis

136

969

1.39

3.29

3.1

2.9

25.14

25.24

mmol/l

0.11

130

931

Medullary cystic kidney disease, nephronophthisis

5.10

3.26

7.4

3.2

22.53

24.83

mmol/l

—

Female genital prolapse

624

2985

1.17

3.25

2.8

3.1

25.46

25.49

mmol/l

0.09

605

2905

Artificial joint operation, meniscal resection

2496

14829

1.08

3.24

3.4

3.6

25.33

25.26

mmol/l

0.49

2415

14357

Wilms' tumor, including Hilmo

105

2.33

3.22

6.8

2.8

23.17

25.00

mmol/l

2.43

100

Benign neoplasm of meninges

249

1984

1.27

3.22

3.8

3.1

25.19

25.39

mmol/l

0.48

241

1922

Nonspecific lymphadenitis

113

802

1.43

3.21

4.0

3.1

25.75

25.25

mmol/l

0.72

106

769

Aspergillosis, including avohilmo

152

2.07

3.21

7.4

3.4

25.86

24.62

mmol/l

0.77

147

Acute appendicitis, with complications

439

3707

1.19

3.16

3.5

3.6

25.04

25.17

mmol/l

0.31

423

3578

MS-disease / Multiple Sclerosis

127

922

1.39

3.16

3.4

3.3

25.92

25.22

mmol/l

1.81

119

883

Digeorge syndrome

7.20

3.14

7.0

7.6

25.77

24.33

mmol/l

—

Other and unspecified spinal muscular atrophies

140

2.10

3.11

3.6

3.7

25.51

24.60

mmol/l

0.65

135

Use of levodopa decarbox-comt-inhibitor

669

1.47

3.11

3.6

3.4

25.68

25.23

mmol/l

0.88

645

Other specified and unspecified disorders of eye and adnexa

610

0.55

3.11

2.8

3.3

25.61

25.06

mmol/l

0.51

586

Malignant neoplasm of vulva, including Hilmo

241

1.81

3.09

4.2

2.5

25.49

25.78

mmol/l

0.26

233

Benign lipomatous neoplasm of other sites/unspecified

214

1685

1.29

3.08

3.6

3.3

25.58

25.34

mmol/l

0.43

206

1628

Social disorders starting during childhood or adolecense, excluding more controls

2.97

3.06

3.3

6.0

25.18

25.17

mmol/l

0.00

Congenital malformation of biliary tract

3.54

3.06

12.6

8.8

24.91

24.58

mmol/l

0.08

Malignant neoplasm of testis, including Hilmo

256

1.76

3.05

4.5

3.0

24.02

25.12

mmol/l

1.46

244

Rapidly progressive nephritic syndrome

3.80

3.03

9.4

3.9

24.77

24.38

mmol/l

0.09

Use of levodopa decarboxylase inhibitor

400

3370

1.20

3.03

3.5

3.4

25.58

25.09

mmol/l

2.39

381

3263

Diastasis of muscle

114

2.18

3.01

2.1

3.6

25.11

24.80

mmol/l

0.15

107

Radial styloid tenosynovitis [de Quervain]

102

720

1.43

3.01

2.7

3.0

25.71

25.34

mmol/l

0.52

698

Personal history of other diseases and conditions

169

1285

1.32

3.00

7.4

2.7

25.03

25.08

mmol/l

0.07

164

1235

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

271

2200

1.25

3.00

3.2

3.3

24.60

25.22

mmol/l

1.74

257

2126

Benign neoplasm of urinary organs

119

866

1.40

2.99

4.9

3.2

25.22

25.34

mmol/l

0.14

114

837

Myocardial infarction, unclassifiable

677

5305

1.15

2.97

4.8

3.5

25.06

25.07

mmol/l

0.03

648

5137

Abnormalities of gait and mobility

316

2610

1.22

2.96

4.1

3.5

25.30

25.12

mmol/l

0.43

304

2522

Intussusception

304

1.68

2.96

2.4

3.1

26.13

25.48

mmol/l

0.60

295

Meniscus derangement

1389

8395

1.10

2.95

3.4

3.3

25.42

25.26

mmol/l

1.06

1334

8138

Procreative management

475

4568

0.85

2.95

4.1

3.8

25.48

25.27

mmol/l

0.72

445

4408

Specific developmental disorder of motor function

159

1.94

2.91

5.3

8.4

24.27

mmol/l

0.00

147

Tuberculosis, IBD comorbidity

185

1443

1.30

2.90

3.9

3.1

24.78

25.15

mmol/l

0.68

179

1396

Tuberculosis, wide, including avohilmo

194

1523

1.29

2.89

3.9

3.3

24.87

25.15

mmol/l

0.49

188

1472

Iron deficiency

298

1.67

2.86

3.7

3.8

25.13

24.74

mmol/l

0.57

287

Other and unspecified iridocyclitis

105

754

1.41

2.86

4.8

3.1

25.21

25.40

mmol/l

0.22

100

728

Syndactyly, including avohilmo

3.28

2.85

3.3

2.9

26.12

24.49

mmol/l

0.75

Malignant neoplasm of vulva

196

1.87

2.83

4.8

2.5

25.47

25.50

mmol/l

0.02

188

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

290

2389

1.22

2.79

4.2

3.4

25.33

25.36

mmol/l

0.05

285

2302

Septal defects

124

899

1.37

2.79

5.6

4.5

25.07

24.99

mmol/l

0.09

119

859

Single spontaneous delivery

669

4019

0.87

2.76

2.6

3.4

25.59

25.39

mmol/l

0.76

647

3904

Maternal care related to the fetus and amniotic cavity and possible delivery problems

510

3463

0.86

2.75

2.9

3.2

25.45

25.35

mmol/l

0.26

495

3337

Tuberculosis, wide

191

1509

1.28

2.73

3.9

3.3

24.86

25.14

mmol/l

0.49

185

1459

Motor disorders

167

1.89

2.71

5.3

8.6

24.27

24.31

mmol/l

0.02

157

Supervision of normal pregnancy

187

1357

0.78

2.70

2.4

3.1

25.66

25.18

mmol/l

1.39

180

1308

Toxic effect of other noxious substances eaten as food

3.09

2.69

2.5

3.4

23.80

24.09

mmol/l

0.14

Food allergy

3.56

2.68

4.5

2.3

24.56

24.05

mmol/l

—

Pleural plaque

276

2278

1.23

2.67

3.4

3.5

25.77

24.70

mmol/l

4.80

262

2200

Salpingitis and oophoritis

309

2572

1.21

2.67

3.6

3.0

25.49

25.55

mmol/l

0.11

298

2501

Polyp of the female genital tract

615

3045

1.15

2.66

2.9

3.1

25.67

25.48

mmol/l

0.72

597

2961

Murder, homicide, or other assault by rifle, shotgun and larger firearm discharge

8.14

2.64

1.8

8.9

24.78

23.76

mmol/l

—

Malignant neoplasm of testis

222

1.76

2.63

4.4

3.1

23.86

25.03

mmol/l

1.49

211

Unspecific neurodegenerative disorder

1312

8220

1.10

2.63

3.0

3.6

25.32

25.14

mmol/l

1.14

1268

7981

Tonsillectomy and adenotomy

996

6252

1.11

2.61

3.7

25.15

25.22

mmol/l

0.34

961

6007

Other diseases of hard tissues of teeth

1366

7719

0.91

2.61

3.6

3.4

25.23

25.27

mmol/l

0.20

1316

7506

Human immunodeficiency virus [HIV] disease, including avohilmo

260

0.38

2.60

2.8

3.3

25.02

24.78

mmol/l

—

252

Other and unspecified rosacea

186

1473

1.28

2.60

4.4

3.2

24.91

25.30

mmol/l

0.77

178

1413

Tracheo-bronchomalasia

4.12

2.59

4.5

2.6

26.72

26.29

mmol/l

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

122

2.05

2.59

4.8

2.5

25.80

25.45

mmol/l

0.24

116

Ventricular septal defect, a heart condition

276

1.66

2.58

8.0

6.2

24.71

24.32

mmol/l

0.35

267

Ulcerative rectosigmoiditis

159

1236

1.30

2.57

4.8

3.4

24.96

25.37

mmol/l

0.72

153

1189

Certain conditions originating in the perinatal period

120

794

1.35

2.55

6.4

4.0

24.97

24.78

mmol/l

0.26

114

761

Benign neoplasm: Pituitary gland, craniopharyngeal duct

109

805

1.37

2.54

3.2

3.3

24.78

25.26

mmol/l

0.93

102

769

Scabies, including avohilmo

263

2167

1.22

2.53

3.8

3.5

24.98

25.24

mmol/l

0.50

246

2082

Enthesopathies of lower limb, excluding foot

459

3969

1.16

2.53

4.4

3.5

25.52

25.18

mmol/l

1.43

443

3857

Recurrent dislocation of patella

485

1.48

2.53

3.7

3.1

24.86

24.98

mmol/l

0.09

466

Bartonellosis, including avohilmo

5.90

2.53

3.3

2.1

22.07

25.19

mmol/l

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

3.38

2.52

2.9

2.8

24.42

24.15

mmol/l

—

Nonsuppurative otitis media, including avohilmo

588

4466

1.14

2.52

5.2

3.5

25.09

25.13

mmol/l

0.11

572

4298

Benign neoplasm: Cerebral meninges

221

1796

1.24

2.49

3.7

3.2

25.28

25.37

mmol/l

0.18

214

1739

Other congenital musculoskeletal deformities, including avohilmo

3.28

2.49

5.2

3.8

26.94

23.92

mmol/l

—

Human immunodeficiency virus [HIV] disease

254

0.39

2.48

2.8

3.2

25.02

24.75

mmol/l

—

246

Other peripheral vascular diseases

171

1350

1.28

2.47

4.4

3.0

25.15

25.31

mmol/l

0.20

165

1302

Childhood allergy (age < 16)

175

1136

1.28

2.47

4.1

4.7

24.65

24.54

mmol/l

0.19

170

1082

Adenocarcinoma and papilloma adenocarcinoma of rectum

255

2106

1.22

2.46

3.3

3.2

24.58

25.25

mmol/l

1.80

241

2034

Glycosuria

5.36

2.46

3.3

1.7

25.12

24.30

mmol/l

—

Hallux rigidus

223

2726

0.81

2.45

2.7

3.3

25.60

25.27

mmol/l

0.86

213

2654

Other/unspecified enthesopathies, not elsewhere classified

188

1503

1.26

2.45

3.9

3.2

25.29

25.21

mmol/l

0.12

183

1457

Other osteochondropathies

135

1036

1.32

2.43

3.1

3.7

24.64

25.23

mmol/l

1.07

126

995

Q fever

7.65

2.41

3.8

7.2

26.14

23.97

mmol/l

—

Other and unspecified immunodeficiencies with predominantly antibody defects

161

1.85

2.41

5.2

3.9

24.78

25.04

mmol/l

0.18

156

Juvenile rheumatoid arthirtis

220

1.71

2.41

6.1

3.8

24.30

25.06

mmol/l

0.49

213

Glaucoma-related operations

1227

0.72

2.40

3.1

3.2

24.95

25.35

mmol/l

0.33

1183

Dentofacial anomalies [including malocclusion]

1476

10664

1.09

2.40

3.4

3.5

25.22

25.27

mmol/l

0.23

1429

10304

Malignant neoplasm of head and neck, including Hilmo

245

2021

1.22

2.39

3.8

3.4

25.88

25.19

mmol/l

1.98

239

1947

Drug phototoxic response

5.40

2.39

1.2

5.5

25.88

24.46

mmol/l

—

Polyglandular dysfunction

3.45

2.38

8.1

5.9

23.27

24.37

mmol/l

—

Etanercept

118

892

1.34

2.37

3.8

3.5

25.35

25.22

mmol/l

0.14

113

857

Other injuries of lower limb, level unspecified

155

1.87

2.37

4.5

3.5

25.95

25.09

mmol/l

0.57

150

Postmenopausal bleeding

607

2800

1.14

2.37

3.4

3.1

25.44

25.54

mmol/l

0.32

591

2731

Malignant immunoproliferative diseases

193

1.78

2.35

4.6

3.4

24.98

24.91

mmol/l

0.03

185

Malignant neoplasm of cervix uteri, including Hilmo

332

1.57

2.34

5.3

2.8

25.53

25.59

mmol/l

0.05

320

2.92

2.34

21.2

3.4

23.37

24.28

mmol/l

0.47

Nanophthalmos, microphthalmos and macrophthalmos

5.53

2.34

5.3

3.4

24.92

23.56

mmol/l

—

Testicular dysfunction

604

1.41

2.33

4.1

3.8

25.69

25.17

mmol/l

0.74

579

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

154

0.32

2.33

3.0

3.5

25.80

24.89

mmol/l

—

147

Other vitreous opacities

715

1.38

2.33

3.4

3.3

25.54

25.21

mmol/l

0.35

691

Carcinoma in situ of other and unspecified digestive organs

113

854

1.35

2.32

4.6

3.2

24.54

25.30

mmol/l

1.35

108

824

Tooth eruption problems

202

1579

1.24

2.32

5.0

3.9

24.66

24.93

mmol/l

0.52

191

1516

Other congenital musculoskeletal deformities

3.65

2.31

6.0

4.7

27.29

23.66

mmol/l

—

Other and unspecified haemorrhagic conditions

263

1.64

2.30

5.0

3.5

25.02

25.26

mmol/l

0.19

256

Mantle cell lymphoma

187

1.78

2.30

4.6

2.9

24.90

25.16

mmol/l

0.19

182

Benign neoplasm: Liver/bile ducts (ICD-9)

6.31

2.30

2.6

1.8

24.66

25.92

mmol/l

—

Hypothyroidism, autoimmune, DX-based

2.53

2.26

3.0

2.8

25.38

24.17

mmol/l

0.61

Other general symptoms and signs

584

1.40

2.26

4.3

3.2

25.73

24.86

mmol/l

1.52

558

Kyphoscoliotic heart disease

4.11

2.24

3.9

3.1

26.57

25.55

mmol/l

—

Vestibular neuronitis

201

1639

1.24

2.23

3.6

3.4

25.44

25.30

mmol/l

0.24

194

1581

Sixth [abducent] nerve palsy

619

1.40

2.23

4.1

3.2

25.07

25.32

mmol/l

0.32

596

Malignant neoplasm of oesophagus, including Hilmo

696

1.37

2.23

3.2

25.77

25.07

mmol/l

1.20

668

Malignant neoplasm of breast, HER2-negative

806

4684

1.11

2.23

2.7

3.1

25.68

25.67

mmol/l

0.01

784

4532

Lumbosacral root disorders, not elsewhere classified

197

0.40

2.23

1.6

3.2

25.39

25.34

mmol/l

—

190

Seronegative juvenile rheumatoid arthritis

165

1.79

2.22

2.3

4.5

24.79

25.01

mmol/l

0.11

157

Systemic atrophies primarily affecting the central nervous system

105

791

1.35

2.22

4.0

3.4

25.88

25.19

mmol/l

0.96

762

Myeloid leukaemia

502

1.44

2.22

4.4

3.6

24.23

25.29

mmol/l

1.72

483

Need for other prophylactic measures

958

0.70

2.22

3.3

3.5

24.51

25.30

mmol/l

0.76

921

Lichen planus, including avohilmo

424

3690

1.16

2.22

3.8

3.4

25.35

25.30

mmol/l

0.11

415

3579

Colonic or urogenital fistula

605

5387

1.13

2.21

3.5

3.6

25.47

25.19

mmol/l

1.31

584

5208

Malignant neoplasm of breast

806

4685

1.11

2.21

2.7

3.1

25.68

25.67

mmol/l

0.01

784

4533

Delivery

684

4030

0.89

2.21

2.7

3.4

25.56

25.39

mmol/l

0.62

661

3915

Q fever, including avohilmo

6.24

2.21

3.8

6.6

26.14

23.96

mmol/l

—

Melanocytic naevi of eyelid, including canthus

149

0.33

2.20

2.4

3.4

25.44

24.88

mmol/l

—

144

Tuberculosis

161

1284

1.27

2.20

4.0

3.3

24.78

25.14

mmol/l

0.60

155

1239

Visual impairment including blindness (binocular or monocular)

176

1418

1.26

2.20

6.0

3.3

24.78

25.30

mmol/l

1.12

170

1366

Other disorders of the genitourinary system

283

2389

1.19

2.19

4.3

3.1

25.23

25.38

mmol/l

0.34

275

2319

Malignant melanoma of skin

209

2536

0.82

2.19

3.6

3.2

25.22

25.23

mmol/l

0.01

204

2445

Unspecified urinary incontinence

199

1626

1.24

2.17

3.6

2.8

25.90

25.39

mmol/l

1.07

190

1572

Aphakia

243

1.64

2.17

7.4

3.1

25.98

25.12

mmol/l

0.64

230

Palmar fascial fibromatosis [Dupuytren]

397

3446

1.16

2.17

3.6

3.4

25.05

25.08

mmol/l

0.06

384

3338

Malignant neoplasm of breast, HER2-negative, including Hilmo

815

4714

1.11

2.17

2.7

3.1

25.66

25.67

mmol/l

0.03

792

4561

Malignant neoplasm of breast, including Hilmo

815

4714

1.11

2.17

2.7

3.1

25.66

25.67

mmol/l

0.03

792

4561

Progressive external ophthalmoplegia

5.78

2.16

2.6

2.1

25.04

22.83

mmol/l

—

Other obstetric conditions, not elsewhere classified

368

1991

1.17

2.16

2.7

3.0

24.56

25.19

mmol/l

3.10

349

1907

Rash and other nonspecific skin eruption

204

1673

1.23

2.15

4.5

3.3

25.31

25.30

mmol/l

0.01

197

1614

Sexual assault by bodily force

3.40

2.15

5.8

3.0

25.18

24.48

mmol/l

—

Presbycusis

313

3612

0.85

2.15

2.9

3.4

25.21

25.16

mmol/l

0.08

289

3508

Myeloproliferative diseases

201

1649

1.23

2.13

3.1

3.2

24.63

25.32

mmol/l

1.96

191

1593

Melanoma in situ of trunk

301

0.49

2.10

5.1

3.7

24.37

25.23

mmol/l

1.06

292

Unattended death

162

1.79

2.09

3.5

3.3

25.74

25.02

mmol/l

0.57

155

Bullous pemphigoid

442

1.46

2.08

3.5

3.2

25.61

25.26

mmol/l

0.35

424

Nasal polyp

456

4009

1.14

2.08

3.4

3.7

25.46

25.08

mmol/l

1.85

443

3868

Absence of one kidney, including avohilmo

2.65

2.08

10.7

3.9

25.51

24.23

mmol/l

0.78

Sequelae of other and unspecified effects of external causes

2.14

2.07

2.8

4.0

24.56

24.36

mmol/l

0.09

Ganglion

392

3410

1.15

2.07

3.7

3.2

25.28

25.22

mmol/l

0.14

375

3305

Migraine with aura, drug-induced

140

1.84

2.06

2.3

3.1

24.20

25.09

mmol/l

0.72

135

Benign mammary dysplasia

284

2414

1.19

2.05

4.0

3.0

25.68

25.44

mmol/l

0.63

277

2345

Intracranial injury with prolonged coma

4.29

2.03

2.3

1.9

24.05

24.29

mmol/l

—

Exposure to other and unspecified inanimate mechanical forces

151

1208

1.26

2.02

3.9

3.7

25.11

25.23

mmol/l

0.15

144

1155

Pulmonary artery stenosis

4.20

2.01

4.3

8.4

26.10

23.26

mmol/l

—

Drug-induced acute pancreatitis

3.22

2.01

6.8

2.4

24.05

24.27

mmol/l

—

Urethral stricture

148

1184

1.27

2.00

4.8

3.4

25.18

24.88

mmol/l

0.34

139

1140

Drug-induced autoimmune haemolytic anaemia

4.12

2.00

4.3

3.1

25.42

24.84

mmol/l

—

Achilles tendinitis

208

1724

1.22

1.99

4.5

3.6

25.69

25.11

mmol/l

1.67

201

1666

Pemphigoid

556

1.39

1.99

3.6

3.3

25.63

25.31

mmol/l

0.34

533

Bilateral sagittal split ramus osteotomy operation

370

1.48

1.98

2.6

3.2

25.32

25.30

mmol/l

0.02

352

Carcinoma in situ of oral cavity and pharynx

3.15

1.95

2.0

3.0

25.15

24.23

mmol/l

—

Cryoglobulinemia

3.46

1.94

7.4

4.4

23.67

24.57

mmol/l

—

Use of glatiramer acetate

165

1.73

1.94

2.0

3.7

25.93

25.10

mmol/l

0.53

159

Other salmonella infections, including avohilmo

600

1.37

1.93

6.2

2.8

25.43

25.29

mmol/l

0.18

571

Premature rupture of membranes

193

1663

0.82

1.92

2.2

3.1

25.13

25.23

mmol/l

0.16

184

1590

Malignant melanoma

287

3343

0.85

1.92

3.2

25.16

25.21

mmol/l

0.10

280

3228

Unspecified human immunodeficiency virus [HIV] disease

142

0.34

1.92

3.0

3.7

25.80

25.17

mmol/l

—

135

Fall on and from ladder

182

1498

1.23

1.91

3.6

3.7

25.27

25.12

mmol/l

0.25

176

1449

Aggressive periodontitis

358

1.48

1.90

2.7

3.3

26.12

25.18

mmol/l

1.23

349

Benign neoplasm: Liver/bile ducts

366

1.47

1.90

5.2

3.4

25.26

25.25

mmol/l

0.01

350

Mental and behavioural disorders of puerperium, not classified elsewhere

100

1.94

1.88

2.2

3.5

24.58

25.06

mmol/l

0.27

Crohn's disease (strict) with PSC

3.77

1.88

9.8

4.4

24.20

24.71

mmol/l

—

LeFortI or BSSO operation

441

1.42

1.88

2.6

3.4

25.62

25.30

mmol/l

0.37

421

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

353

1925

1.16

1.87

2.8

3.0

24.56

25.18

mmol/l

2.91

335

1842

Other disorders of choroid

262

1.57

1.87

4.1

3.3

23.55

25.31

mmol/l

2.19

253

Other disorders of bladder

292

2512

1.17

1.86

3.9

3.4

25.57

25.07

mmol/l

1.34

274

2422

Hypersomnia

191

1.66

1.85

3.9

3.5

25.26

25.39

mmol/l

0.09

185

Dislocation, sprain and strain of joints and ligaments of knee

1294

10886

1.08

1.85

3.2

3.5

25.34

25.20

mmol/l

0.82

1235

10526

Oter anti-inflammatory and antirheumatic agents, non-steroids

673

3338

1.11

1.85

3.3

4.2

25.09

24.98

mmol/l

0.33

652

3229

Ankyloglossia

152

1.73

1.84

3.6

7.2

23.75

24.44

mmol/l

0.46

143

Respiratory tuberculosis, confirmed and not-confirmed

136

1091

1.26

1.83

3.8

3.3

24.58

25.09

mmol/l

0.88

131

1055

Malignant neoplasm of cervix uteri

215

1.61

1.83

4.3

2.7

25.62

25.40

mmol/l

0.13

209

Use of donepezil

648

5597

1.11

1.83

3.0

3.5

25.52

25.14

mmol/l

2.25

624

5427

Other salmonella infections

521

1.38

1.82

5.9

2.9

25.45

25.26

mmol/l

0.24

499

Respiratory tuberculosis

136

1092

1.26

1.82

3.8

3.3

24.58

25.10

mmol/l

0.88

131

1056

Degenerative diseases of the nervous system

1146

7643

1.08

1.81

3.1

3.5

25.32

25.12

mmol/l

1.17

1102

7427

Foreign body on external eye

304

2628

1.16

1.81

3.9

25.12

25.18

mmol/l

0.12

292

2537

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

586

5281

1.12

1.81

3.8

3.4

25.07

25.27

mmol/l

0.71

567

5110

Primary biliary cholangitis (PBC)

329

1.49

1.81

3.9

2.5

25.47

25.69

mmol/l

0.13

315

Infection due to other mycobacteria, including avohilmo

264

1.55

1.80

3.7

2.6

26.25

25.39

mmol/l

0.61

253

Use of benzatropine

4.46

1.80

7.0

5.2

23.02

23.55

mmol/l

—

Contact with machinery

250

2132

1.18

1.79

4.2

3.9

24.63

25.09

mmol/l

1.36

240

2054

Malignant neoplasm of oropharynx, including Hilmo

372

1.46

1.78

4.3

3.0

26.23

25.14

mmol/l

1.18

360

Other otitis externa (chronic)

140

1130

1.25

1.78

5.1

3.4

25.23

25.29

mmol/l

0.08

135

1086

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

193

1.64

1.78

5.6

4.1

25.04

25.02

mmol/l

0.01

185

Other bursitis of hip

347

1.47

1.78

3.5

2.9

26.52

25.29

mmol/l

1.10

338

Dextrocardia

4.28

1.77

6.2

5.2

25.68

23.23

mmol/l

—

Hereditary angioödema type 1

4.27

1.77

1.8

2.5

24.00

23.38

mmol/l

—

Chronic laryngitis and laryngotracheitis

225

2652

0.84

1.77

3.7

3.5

25.68

25.19

mmol/l

1.44

214

2564

Acquired atrophy of ovary and fallopian tube

2.80

1.76

2.9

2.1

27.63

24.61

mmol/l

—

Drug-induced Cushing's syndrome

4.16

1.76

1.8

3.3

25.22

25.72

mmol/l

—

Atopic dermatitis, strict definition with reimbursement

497

4268

1.12

1.75

3.7

3.5

25.06

25.17

mmol/l

0.31

480

4101

Medical abortion

1082

6323

0.92

1.74

3.0

3.2

25.33

25.45

mmol/l

0.56

1048

6117

Malignant neoplasm of breast, HER-positive

641

4325

1.11

1.72

2.7

3.1

25.86

25.70

mmol/l

0.60

624

4193

Convalescence

735

1.31

1.71

6.7

2.5

24.94

25.37

mmol/l

0.47

704

Carcinoma in situ of breast, other/unspecified

240

0.49

1.71

2.7

2.6

26.72

25.52

mmol/l

0.55

234

Separation of retinal layers (serosa)

666

1.32

1.71

4.1

3.2

25.30

25.44

mmol/l

0.17

642

FESS (DNB20)

175

2101

0.83

1.71

3.1

3.5

25.40

25.29

mmol/l

0.17

169

2020

Malignant neoplasm of breast, ER-positive, including Hilmo

642

4329

1.11

1.70

2.7

3.1

25.85

25.70

mmol/l

0.58

625

4197

Other acquired deformities of musculoskeletal system and connective tissue

728

1.31

1.70

2.9

3.4

25.27

25.22

mmol/l

0.06

699

Acute epiglottitis

204

1.60

1.69

3.7

3.6

25.63

25.19

mmol/l

0.36

195

malignant neoplasm of male genital organs, including Hilmo

794

4367

1.10

1.68

3.8

3.6

24.90

25.05

mmol/l

0.55

765

4221

Pityriasis rosea

1.89

1.65

4.1

3.3

24.36

24.40

mmol/l

0.03

Embedded teeth, including avohilmo

126

1015

1.25

1.63

4.1

3.5

25.00

25.05

mmol/l

0.05

118

970

Hypertrophy of breast

261

2251

1.16

1.63

3.0

25.35

25.51

mmol/l

0.36

250

2175

Dyslexia and other symbolic dysfunctions, not elsewhere classified

2.42

1.62

4.2

4.3

26.10

25.12

mmol/l

—

Mandibular retrognathia AND surgery (BSSO)

287

1.48

1.62

2.3

3.3

25.61

25.23

mmol/l

0.40

277

Disorders of eyelid in diseases classified elsewhere

516

1.36

1.61

4.3

3.0

25.46

25.28

mmol/l

0.20

492

Other congenital malformations of tongue, mouth and pharynx

143

1.70

1.61

4.2

5.1

23.83

24.41

mmol/l

0.34

136

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

223

1.55

1.60

4.9

3.8

25.24

24.78

mmol/l

0.32

211

Acute myeloid leukaemia, helper endpoint

240

1.54

1.60

5.0

3.2

24.47

25.31

mmol/l

0.66

233

Acute myeloid leukaemia

240

1.54

1.60

5.0

3.2

24.47

25.31

mmol/l

0.66

233

Acute myeloid leukaemia, including Hilmo

240

1.54

1.60

5.0

3.2

24.47

25.31

mmol/l

0.66

233

Other and specified injuries of hip and thigh

415

1.40

1.59

5.2

3.3

24.94

25.04

mmol/l

0.07

397

Contraceptive management

618

4745

0.91

1.58

3.5

3.6

25.36

25.28

mmol/l

0.24

594

4586

Failure in dosage during surgical and medical care

2.84

1.58

3.1

4.2

24.94

24.75

mmol/l

—

Benign neoplasm: Bladder

153

1.68

1.57

5.1

3.6

25.53

24.96

mmol/l

0.54

147

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

3.14

1.56

4.2

3.3

23.90

24.75

mmol/l

—

Cholera

3.59

1.56

2.8

4.7

22.70

23.35

mmol/l

—

Epidermolysis bullosa

3.55

1.56

4.6

7.1

25.72

25.39

mmol/l

—

Other/unspecified seropositive rheumatoid arthritis

595

5418

1.10

1.55

3.9

3.4

25.12

25.27

mmol/l

0.47

576

5245

Leukaemia of unspecified cell type

146

1.69

1.55

2.7

3.7

25.04

24.65

mmol/l

0.28

141

Interstitial emphysema and related conditions originating in the perinatal period

3.53

1.55

39.8

12.3

23.88

22.99

mmol/l

—

Endometriosis

610

3220

1.10

1.54

3.0

25.45

25.40

mmol/l

0.15

590

3127

HSIL lesion of the vulva

250

1.51

1.53

3.4

2.8

25.43

25.49

mmol/l

0.04

244

Cysts of oral region, not elsewhere classified

119

963

1.25

1.53

3.5

3.4

25.04

25.14

mmol/l

0.14

114

925

Seminoma of testis

116

1.77

1.52

4.5

3.0

23.75

25.32

mmol/l

1.47

110

Disorders of parathyroid gland, other and/or unspecified

124

1.76

1.52

4.3

3.0

23.26

25.05

mmol/l

0.83

124

Lichen ruber planus, wide definition including periferal and oral lichen planus

488

4405

1.11

1.52

3.6

3.4

25.32

25.33

mmol/l

0.02

476

4264

Single delivery by forceps and vacuum extractor

121

892

0.81

1.52

2.2

3.7

24.82

24.93

mmol/l

0.13

113

853

Routine general health check-up of defined subpopulation

154

1.64

1.51

2.8

2.4

26.60

25.02

mmol/l

0.72

146

Seropositive rheumatoid arthritis, wide

601

5486

1.10

1.50

3.9

3.4

25.14

25.26

mmol/l

0.34

582

5311

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

193

1.57

1.50

3.6

4.8

23.81

24.36

mmol/l

0.39

186

Perichondritis of external ear

310

1.45

1.49

4.8

3.2

25.62

25.11

mmol/l

0.50

301

Ménière disease

214

1835

1.18

1.49

3.3

3.2

25.61

25.31

mmol/l

0.62

206

1769

Spontaneous abortion

759

4675

1.09

1.49

3.1

25.43

25.45

mmol/l

0.04

735

4515

Presence of other devices

614

5524

1.10

1.48

3.4

3.1

25.25

25.18

mmol/l

0.19

594

5342

Assault by drugs, medicaments and biological substances

2.92

1.47

3.0

4.5

26.40

24.01

mmol/l

—

Insomnia

1942

14203

0.95

1.47

3.3

3.5

25.11

25.30

mmol/l

1.77

1865

13734

Use of rivastigmine

395

4392

0.89

1.46

2.6

3.4

25.34

25.17

mmol/l

0.53

380

4260

Vascular dementia (multiple infarctions)

261

1.48

1.46

4.8

3.2

24.53

24.89

mmol/l

0.23

249

Bullous keratopathy

157

1.64

1.45

2.7

3.0

25.02

mmol/l

0.00

151

Uterine polyps

559

2965

1.11

1.45

3.1

25.61

25.49

mmol/l

0.39

545

2883

Hydrocele

291

2557

1.15

1.45

4.9

3.6

25.04

24.92

mmol/l

0.22

279

2484

Disorders of breast

938

7676

1.08

1.45

3.5

3.1

25.58

25.45

mmol/l

0.64

908

7432

Maxillary retrognathism

204

1.54

1.45

6.1

4.1

25.35

24.91

mmol/l

0.39

189

Personal history of medical treatment

157

1.63

1.44

9.2

2.9

26.69

24.34

mmol/l

1.82

151

Other papulosquamous disorders

173

1.60

1.43

3.7

3.5

25.11

24.96

mmol/l

0.08

167

Malignant neoplasm of gum, including Hilmo

180

0.49

1.43

2.2

2.7

28.00

25.43

mmol/l

—

173

Infection due to other mycobacteria

246

1.49

1.43

3.9

2.7

26.53

25.48

mmol/l

0.73

237

Endometriosis ASRM stages 1,2

246

2137

1.16

1.43

2.6

2.9

25.60

25.41

mmol/l

0.42

238

2055

Seronegative rheumatoid arthritis

245

2130

1.16

1.43

3.4

3.2

25.11

25.19

mmol/l

0.12

238

2070

Cholesteatoma of middle ear

117

955

1.24

1.42

3.1

3.3

25.36

25.19

mmol/l

0.17

112

916

Hypertrichosis

197

1.54

1.41

3.3

3.1

25.56

25.16

mmol/l

0.30

187

Muscular dystrophy

119

1.73

1.41

3.0

3.8

25.24

24.73

mmol/l

0.43

114

Benign neoplasm: Liver

313

1.43

1.41

5.8

3.4

25.22

25.26

mmol/l

0.02

301

Other/unspecified disorders of vestibular function

767

1.27

1.41

4.6

3.0

25.84

25.39

mmol/l

0.78

742

Testicular hypofunction

528

1.32

1.41

4.4

4.0

25.50

25.08

mmol/l

0.45

507

Adenomyosis (Endometriosis of uterus)

186

2173

0.85

1.41

2.9

3.0

25.60

25.46

mmol/l

0.26

179

2118

Toxic effect of pesticides

3.24

1.41

2.0

2.4

26.48

24.62

mmol/l

—

Toxic erythema

2.76

1.40

2.2

2.1

24.58

25.10

mmol/l

—

Plantar fascial fibromatosis

182

1549

1.18

1.40

2.7

3.1

25.60

25.23

mmol/l

0.80

176

1502

Primary open-angle glaucoma

887

7945

1.08

1.39

3.7

3.5

25.13

25.24

mmol/l

0.45

853

7714

Nightmares

2.70

1.39

4.5

3.8

25.77

24.37

mmol/l

—

Absence of one kidney

2.26

1.38

12.6

4.0

24.69

24.23

mmol/l

—

Autoimmune hyperthyroidism

103

831

1.25

1.38

2.9

2.7

25.01

25.46

mmol/l

0.67

798

Exposure to controlled fire, not in building or structure

2.24

1.37

2.9

4.0

26.08

24.47

mmol/l

—

Myeloproliferative diseases (CML excluded)

177

1508

1.18

1.37

3.1

3.3

24.70

25.30

mmol/l

1.41

167

1455

D07AA Corticosteroids, weak (group I)

271

2377

1.14

1.36

3.3

3.8

24.90

25.16

mmol/l

0.58

263

2285

malignant neoplasm of male genital organs

772

4300

1.09

1.36

3.8

3.6

24.91

25.04

mmol/l

0.48

744

4157

Endometriosis of pelvic peritoneum

238

1882

1.15

1.36

2.5

3.0

25.61

25.34

mmol/l

0.64

230

1823

Ethmoidectomy

189

2198

0.86

1.34

3.6

3.4

25.41

25.32

mmol/l

0.16

183

2115

Open bite that required surgery (Lefort1 or BSSO)

1.84

1.33

2.3

3.2

26.21

25.04

mmol/l

0.85

Malignant neoplasm of oropharynx, including Hilmo

107

1.76

1.31

5.8

2.9

26.24

25.22

mmol/l

0.41

102

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

2.08

1.31

7.8

3.0

25.55

25.05

mmol/l

0.26

Guillain-Barre syndrome

243

1.47

1.31

5.6

3.2

26.33

25.20

mmol/l

1.09

234

Delivery, wide proxy

605

3495

0.92

1.30

2.7

3.4

25.47

25.35

mmol/l

0.34

584

3388

Seropositive rheumatoid arthritis, strict definition

307

2731

1.13

1.29

3.7

3.3

25.40

25.29

mmol/l

0.24

298

2641

Glaucoma, exfoliation

300

2667

1.13

1.29

3.6

3.3

24.91

25.20

mmol/l

0.78

289

2595

Pervasive developmental disorders excl. Autism + Asperger

128

1.64

1.29

6.3

8.5

25.07

24.51

mmol/l

0.41

121

In situ neoplasms

994

9325

1.07

1.28

4.1

3.4

25.09

25.26

mmol/l

0.86

969

9026

Essential (haemorrhagic) thrombocythaemia

670

1.27

1.28

2.6

2.9

25.15

25.46

mmol/l

0.28

642

Radiodermatitis

2.34

1.28

2.4

2.8

24.80

24.39

mmol/l

—

Acne, including avohilmo

293

2099

1.13

1.28

4.9

3.6

24.73

24.96

mmol/l

0.58

285

2001

conjunctival scars

2.53

1.27

5.3

2.4

25.72

23.71

mmol/l

—

Seminoma of testis, including Hilmo

131

1.64

1.26

4.8

3.0

23.96

25.04

mmol/l

0.87

125

Other specified/unspecified hearing loss

208

1808

1.16

1.26

4.7

3.5

25.27

25.22

mmol/l

0.08

198

1747

Rhinophyma

124

1.67

1.25

4.6

3.5

25.36

24.47

mmol/l

0.42

118

Carcinoma in situ, other/unspecified

2.85

1.25

8.2

2.9

25.90

24.29

mmol/l

—

Hallux valgus (acquired)

742

4923

1.08

1.25

3.0

3.2

25.43

25.30

mmol/l

0.49

709

4783

Macular pucker

326

3628

0.89

1.21

4.7

3.3

25.15

25.18

mmol/l

0.06

320

3518

Other nutritional anaemias

173

1.54

1.20

5.3

3.2

25.73

24.93

mmol/l

0.43

168

Infections specific to the perinatal period

109

1.68

1.20

4.7

7.5

25.03

24.16

mmol/l

0.49

103

Bitten or struck by other mammals

190

1647

1.16

1.20

3.4

25.43

25.30

mmol/l

0.20

181

1583

Benign neoplasm of eye and adnexa

177

2044

0.86

1.18

3.7

3.3

25.59

25.31

mmol/l

0.46

172

1972

Disorders in reading

149

1.56

1.18

2.2

5.3

24.11

25.17

mmol/l

1.32

143

Benign neoplasm of middle ear and respiratory system

171

1474

1.17

1.18

3.9

3.4

25.60

25.25

mmol/l

0.64

163

1421

General autosomal fish scale disease

2.67

1.18

3.4

4.5

25.06

24.34

mmol/l

—

Secondary sideroblastic anaemia

2.13

1.18

4.8

3.2

21.59

23.91

mmol/l

—

Other and unspecified injuries of wrist and hand

544

1.28

1.17

3.5

24.98

25.11

mmol/l

0.09

522

Guttate psoriasis

199

1.48

1.17

6.6

3.3

25.16

25.04

mmol/l

0.09

192

Other disorders of skin and subcutaneous tissue related to radiation

2.50

1.17

2.6

3.4

26.51

24.97

mmol/l

—

Dental pulpitis, including avohilmo

2046

12546

1.05

1.16

3.7

3.5

25.17

25.24

mmol/l

0.42

1961

12130

Hydatidiform mole

153

0.52

1.15

1.4

3.2

25.04

25.54

mmol/l

—

147

Endocrine disorders, other/unspecified

271

0.62

1.15

2.9

3.4

24.57

25.22

mmol/l

0.28

261

Benign neoplasm: Extrahepatic bile ducts

2.05

1.15

2.2

4.2

25.32

24.45

mmol/l

—

Palatinal maxillary canine

1.93

1.13

26.3

4.9

23.88

24.39

mmol/l

0.20

Diseases of pulp and periapical tissues and dental caries

1835

8992

1.05

1.13

3.7

3.4

25.10

25.29

mmol/l

1.60

1774

8720

Thyrotoxicosis with toxic multinodular goitre

131

1110

1.19

1.13

4.2

3.2

26.13

25.51

mmol/l

1.38

126

1076

Cervical polyps

172

1489

1.16

1.12

2.7

3.1

26.02

25.43

mmol/l

1.61

166

1449

Alcoholic myopathy

2.58

1.12

5.0

3.8

24.32

25.17

mmol/l

—

Disorders of vagus nerve

2.56

1.12

30.2

4.8

25.00

24.32

mmol/l

—

Other zoonotic bacterial diseases, not elsewhere classified

2.55

1.12

2.4

2.5

25.54

24.00

mmol/l

—

Other melanin hyperpigmentation

416

1.32

1.12

4.7

2.9

25.41

mmol/l

0.00

401

Benign lipomatous neoplasm of of intra-abdominal organs

1.95

1.11

3.1

3.7

23.36

24.98

mmol/l

0.89

Benign neoplasm: Other and unspecified parts of mouth

558

1.27

1.11

2.9

3.2

25.30

25.36

mmol/l

0.05

536

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

613

4677

1.08

1.11

4.0

3.4

25.83

25.21

mmol/l

3.92

591

4526

Other congenital malformations of skin, including avohilmo

1170

0.82

1.10

3.1

3.4

25.25

25.22

mmol/l

0.04

1124

Ankylosing spondylitis

155

1334

1.17

1.10

3.7

3.5

25.82

25.14

mmol/l

1.58

150

1289

Carcinoma in situ of other and unspecified genital organs

278

1.39

1.10

3.0

2.6

25.19

25.54

mmol/l

0.30

271

Use of peginterferon beta-1a

2.24

1.09

2.0

3.9

26.74

23.90

mmol/l

—

Injury of nerves at wrist and hand level

523

1.27

1.09

5.5

3.4

25.53

25.03

mmol/l

0.57

504

Other disorders of veins

831

8703

0.94

1.09

3.7

3.3

25.68

25.30

mmol/l

2.49

817

8427

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

296

1.37

1.09

3.0

3.1

25.26

25.57

mmol/l

0.21

285

Undescended testicle

128

1.59

1.09

4.3

7.0

25.63

24.50

mmol/l

0.66

120

Postpartum hemorraghe, parous women as controls

247

2321

0.89

1.08

2.5

2.7

25.09

25.37

mmol/l

0.87

241

2230

Striking against or struck by other objects

694

6469

1.07

1.08

3.7

3.8

25.28

25.12

mmol/l

0.62

670

6243

Complications specific to multiple gestation

2.17

1.07

1.1

2.9

24.67

25.51

mmol/l

—

Operations 1 for CAVS

2.04

1.07

4.8

4.0

25.70

24.70

mmol/l

—

Rosacea

235

2088

1.13

1.06

5.0

3.2

24.99

25.30

mmol/l

0.68

227

2006

Other/unspecified crystal arthropathies

122

1.61

1.06

5.8

3.3

24.53

24.88

mmol/l

0.19

117

L02BA Anti-estrogens

247

2766

0.89

1.06

2.7

3.0

26.04

25.45

mmol/l

1.98

237

2687

Palatinal maxillary operation

1.82

1.06

24.3

4.8

23.89

24.38

mmol/l

0.21

Ankle and foot

138

1.56

1.05

2.7

3.1

25.49

24.96

mmol/l

0.34

133

Abuse of non-dependence-producing substances

2.40

1.05

7.4

3.1

27.46

23.95

mmol/l

—

Femoral hernia

101

843

1.21

1.05

4.3

3.2

25.58

25.32

mmol/l

0.30

101

814

Dysplastic lesion of the vulva of unknown severity

2.39

1.05

4.8

2.1

23.58

24.63

mmol/l

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

147

1.53

1.03

4.5

3.6

25.12

24.85

mmol/l

0.11

142

Other injuries of upper limb, level unspecified

180

1.47

1.03

7.3

3.4

25.02

24.55

mmol/l

0.37

174

Family history of malignant neoplasm

168

1465

1.15

1.02

3.4

2.5

25.27

25.32

mmol/l

0.07

158

1412

Mucinous and mucinous cystic tumor of rectum

100

1.66

1.00

2.7

3.2

24.84

24.89

mmol/l

0.03

Drug-induced interstitial lung disorders, unspecified

2.05

1.00

2.7

3.7

25.16

25.06

mmol/l

—

Malignant neoplasm of prostate, including Hilmo

765

4235

1.07

1.00

3.8

3.6

24.91

25.04

mmol/l

0.45

736

4097

Restless leg syndrome

291

2631

1.11

0.99

4.3

3.4

25.41

25.30

mmol/l

0.28

283

2540

Type 1 diabetes, wide definition, subgroup 2

211

0.61

0.98

12.7

3.5

24.77

25.08

mmol/l

0.08

202

Optic atrophy, wide definition

302

1.34

0.98

7.5

4.4

25.24

25.04

mmol/l

0.10

292

Dengue, including avohilmo

0.00

0.97

0.0

4.5

—

24.74

—

Malignant melanoma, including Hilmo

346

3785

0.91

0.97

3.2

3.3

25.23

25.24

mmol/l

0.04

339

3657

Other benign neoplasm of uterus: Cervix uteri

1.69

0.96

3.4

2.7

23.86

25.16

mmol/l

0.95

Cyst of spleen

2.33

0.96

10.2

2.9

23.77

24.07

mmol/l

—

Antenatal screening

226

1419

0.89

0.95

3.2

3.1

25.45

25.20

mmol/l

0.73

218

1368

Other disorders of penis

219

1954

1.13

0.94

5.6

3.9

24.65

24.95

mmol/l

0.67

212

1894

Primary angle-closure glaucoma

103

873

1.19

0.94

5.2

3.2

25.59

25.38

mmol/l

0.27

848

Voice disturbances

570

5321

1.07

0.93

3.3

3.4

25.60

25.25

mmol/l

1.60

551

5145

Exposure to other specified factors

1908

15765

1.04

0.93

3.9

3.5

25.20

25.25

mmol/l

0.24

1832

15242

Primary open-angle glaucoma, strict

709

6653

1.07

0.93

3.7

3.5

25.08

25.24

mmol/l

0.54

680

6454

Other chondrocalcinosis

262

1.36

0.92

4.4

3.3

25.22

25.10

mmol/l

0.09

253

Contact with other sharp object(s)

108

919

1.18

0.92

4.4

3.7

25.05

25.07

mmol/l

0.02

103

881

Supervision of high-risk pregnancy

197

1334

0.89

0.91

2.7

3.1

25.04

25.20

mmol/l

0.27

188

1287

Congenital malformations of genital organs

124

1061

1.17

0.91

4.5

3.5

25.06

25.26

mmol/l

0.25

116

1017

Contact with other hot metals

228

1.38

0.90

4.2

3.6

25.51

25.03

mmol/l

0.31

220

Chronic myeloid leukaemia, including Hilmo

169

1.45

0.90

2.8

24.12

25.08

mmol/l

0.75

162

Brain glioblastoma

246

1.36

0.89

2.8

3.0

25.54

25.17

mmol/l

0.30

237

Brain glioblastoma, helper endpoint

246

1.36

0.89

2.8

3.5

25.54

25.27

mmol/l

0.21

236

Undescended testis, unilateral

1.61

0.89

5.0

7.7

25.25

24.15

mmol/l

0.56

Brain glioblastoma and astrocytoma

290

1.33

0.88

2.7

2.9

25.33

25.13

mmol/l

0.17

279

Other disorders of patella

292

2660

1.10

0.88

3.7

3.2

25.15

25.23

mmol/l

0.14

277

2584

Adenocarcinoma and Papillary adenocarcinoma of kidney

230

1.37

0.87

7.1

2.8

23.97

25.24

mmol/l

1.61

219

Other and unspecified atrophic disorders of skin

1.67

0.87

10.7

2.7

24.61

24.87

mmol/l

0.10

Localized skin eruption due to drugs and medicaments

170

1.43

0.87

2.5

3.3

24.95

25.18

mmol/l

0.21

164

Dermatophytosis, including avohilmo

1436

14649

0.96

0.87

3.3

3.5

25.25

25.24

mmol/l

0.06

1377

14173

Other and unspecified disorders of psychological development

108

1.54

0.87

1.5

7.6

24.62

24.43

mmol/l

0.10

103

Long labour

232

2181

0.90

0.87

1.9

3.2

25.09

25.36

mmol/l

0.75

215

2104

Parapsoriasis

300

1.32

0.86

3.3

3.2

24.95

25.14

mmol/l

0.16

288

Use of cabergoline

191

0.62

0.86

1.7

3.4

24.07

24.64

mmol/l

0.22

183

N06DA Anticholinesterases

1062

7808

1.05

0.85

2.8

3.5

25.40

25.12

mmol/l

1.98

1026

7572

Use of anticholinesterases

1062

7808

1.05

0.85

2.8

3.5

25.40

25.12

mmol/l

1.98

1026

7572

Colitis due to radiation

188

1.41

0.85

5.5

3.3

25.75

24.96

mmol/l

0.25

178

Acetic acid derivatives and related substances

668

3670

0.94

0.85

3.3

4.3

25.23

24.94

mmol/l

1.31

636

3547

Benign neoplasm: Scapula and long bones of upper limb

140

0.56

0.84

3.9

3.4

28.60

24.66

mmol/l

—

135

Pedestrian injured in transport accident

133

1163

1.15

0.83

3.5

3.4

24.77

25.32

mmol/l

1.06

120

1119

Injury of muscle and tendon at forearm level

276

1.32

0.82

2.8

3.1

24.46

24.98

mmol/l

0.31

266

Nonadministration of surgical and medical care

0.00

0.81

0.0

4.3

—

24.51

—

Endometriosis of ovary

275

2364

1.10

0.80

3.1

3.0

25.38

25.44

mmol/l

0.10

263

2294

Unspecified lump in breast

228

2515

0.90

0.80

3.6

3.0

25.70

25.43

mmol/l

0.62

220

2438

L01XX Other antineoplastic agents

134

1178

1.15

0.79

3.5

3.2

24.66

25.31

mmol/l

1.20

124

1138

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

157

1.43

0.79

3.8

2.9

24.72

25.45

mmol/l

0.38

152

Inguinal of femoral hernia, unilateral

484

1.23

0.79

3.7

3.0

25.21

25.29

mmol/l

0.06

468

Inguinal hernia, unilateral

484

1.23

0.79

3.7

3.0

25.21

25.29

mmol/l

0.06

468

Femoral hernia, unilateral

484

1.23

0.79

3.7

3.0

25.21

25.29

mmol/l

0.06

468

Infliximab

225

1.34

0.79

2.4

3.7

25.59

25.07

mmol/l

0.35

215

Atrophy of thyroid (acquired)

2.29

0.78

4.2

3.1

23.16

24.62

mmol/l

—

Subclinical iodine-deficiency hypothyroidism

2.29

0.78

4.0

3.0

24.92

23.72

mmol/l

—

Hirsutism in women

165

1.41

0.78

3.5

3.2

25.83

25.07

mmol/l

0.66

156

L02BG Aromatase inhibitors

545

5723

0.94

0.78

2.8

3.2

25.73

25.55

mmol/l

0.70

536

5559

Small kidney of unknown cause

1.82

0.78

19.8

3.9

23.67

25.32

mmol/l

—

Failed induction of labour

466

1.23

0.77

1.8

3.5

24.93

mmol/l

0.00

444

Alzheimer disease

1020

6968

1.05

0.77

3.0

3.5

25.34

25.11

mmol/l

1.35

978

6775

Photocontact dermatitis [berloque dermatitis]

2.18

0.76

5.4

4.8

28.30

24.67

mmol/l

—

Prominent ears

1.66

0.76

2.5

3.0

26.26

24.32

mmol/l

1.03

Postpartum hemorraghe, all women as controls

247

2638

0.91

0.75

2.5

3.0

25.09

25.23

mmol/l

0.35

241

2531

Internal derangement of knee

812

7649

1.05

0.75

3.7

3.3

25.07

25.22

mmol/l

0.65

782

7414

Chronic rhinitis, nasopharyngitis and pharyngitis

584

6186

0.94

0.74

3.5

3.6

25.42

25.26

mmol/l

0.56

573

5974

Other disorders of cornea

197

1780

1.11

0.74

3.0

3.2

24.95

25.41

mmol/l

0.99

184

1721

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1080

8750

0.96

0.74

3.4

25.30

25.23

mmol/l

0.26

1035

8460

Kissing spine

2.07

0.74

2.8

4.6

26.72

25.00

mmol/l

—

Benign neoplasm: Central nervous system, other parts/unspecified

1.72

0.74

4.6

4.1

24.78

24.43

mmol/l

—

Malignant neoplasm of prostate

745

4183

1.06

0.74

3.7

3.6

24.93

25.04

mmol/l

0.34

717

4045

Erosion of teeth , including avohilmo

472

4425

1.07

0.74

4.8

3.6

25.23

25.21

mmol/l

0.04

461

4267

Alcohol induced polyneuropathy

168

1.39

0.73

8.2

3.7

26.26

25.04

mmol/l

0.76

161

Benign neoplasm: Pancreas

535

1.21

0.73

3.1

26.19

25.25

mmol/l

1.30

516

Use of other anti-dementia drugs

867

6656

1.05

0.73

2.6

3.5

25.40

25.13

mmol/l

1.66

829

6459

Use of memantine

867

6656

1.05

0.73

2.6

3.5

25.40

25.13

mmol/l

1.66

829

6459

Optic atrophy

282

1.29

0.72

7.8

4.5

24.64

24.99

mmol/l

0.21

273

Other congenital malformations of spinal cord

2.01

0.72

29.2

6.5

23.50

24.08

mmol/l

—

Gestational diabetes (for exclusion)

419

2688

1.07

0.72

3.2

2.9

24.94

25.26

mmol/l

1.24

408

2573

Abnormalities of forces of labour

115

1009

1.14

0.71

2.7

3.0

24.94

25.62

mmol/l

1.63

110

968

HSIL lesion of the cervix uteri, vagina or vulva

250

2291

1.09

0.71

2.6

3.0

25.45

25.31

mmol/l

0.33

243

2204

Benign neoplasm: Mediastinum

1.69

0.71

2.8

4.8

24.30

25.02

mmol/l

—

Other and unspecified acute skin changes due to ultraviolet radiation

464

1.22

0.70

2.5

3.3

25.04

25.20

mmol/l

0.14

447

Benign neoplasm: Spinal meninges

187

1.36

0.70

5.2

3.1

24.79

25.14

mmol/l

0.18

182

Other and unspecified cicatricial alopecia

1.71

0.70

2.1

2.4

24.91

24.76

mmol/l

—

Gingivitis and periodontal diseases

2529

13414

0.97

0.69

3.7

3.5

25.14

25.28

mmol/l

1.22

2422

13005

Other specific arthropathies, wide

320

1.26

0.69

3.4

3.2

24.96

25.31

mmol/l

0.31

309

Malignant neoplasm of other and unspecified female genital organs

267

1.29

0.68

2.3

2.5

24.97

25.88

mmol/l

1.03

257

Marginal zone B-cell lymphoma

188

1.35

0.68

3.8

3.0

24.88

25.60

mmol/l

0.49

183

Sleep disorders

2042

14472

0.97

0.68

3.3

3.5

25.13

25.30

mmol/l

1.54

1962

13994

Malignant neoplasm of retroperitoneum and peritoneum

145

1.41

0.68

2.2

2.6

25.82

25.54

mmol/l

0.18

139

Medicines for HER+ breast cancer

674

6598

0.95

0.67

2.9

3.2

25.82

25.53

mmol/l

1.47

657

6404

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

154

1384

1.12

0.67

3.8

3.3

25.47

25.35

mmol/l

0.15

148

1332

Use of galantamine

188

2065

0.91

0.66

2.4

3.4

25.16

25.10

mmol/l

0.08

180

2000

Pregnancy examination and test

173

966

1.11

0.66

3.2

25.11

25.09

mmol/l

0.02

163

926

Retinal breaks without detachment

288

3105

0.92

0.65

3.5

3.4

24.93

25.26

mmol/l

0.95

280

3001

Drug-induced aplastic anaemia

1.79

0.65

3.4

2.5

24.00

24.34

mmol/l

—

Deviated nasal septum

743

7082

1.05

0.65

3.5

3.6

25.67

25.16

mmol/l

4.15

729

6850

Osteochondrodysplasia with defects of growth of tubular bones and spine

1.78

0.65

1.8

6.0

26.12

23.79

mmol/l

—

Phakomatoses, not elsewhere classified

146

1.39

0.65

4.0

3.5

25.03

24.67

mmol/l

0.20

140

Benign neoplasm: Skin of upper limb, including shoulder

305

1.26

0.65

4.1

3.2

24.26

25.02

mmol/l

0.76

296

Obstructed labour due to malposition and malpresentation of fetus

207

2095

0.91

0.64

2.7

3.2

25.18

25.42

mmol/l

0.68

196

2017

Chromophobe cell carcinoma of kidney

1.49

0.63

7.7

2.7

24.46

25.37

mmol/l

0.48

Sequelae of injuries of upper limb

172

1561

1.11

0.63

3.2

3.5

25.60

25.30

mmol/l

0.50

162

1504

Early syphilis

176

0.67

0.63

4.3

3.4

24.88

24.83

mmol/l

0.03

169

Other congenital malformations of peripheral vascular system

176

0.67

0.63

7.2

4.3

24.10

24.73

mmol/l

0.27

170

Cleft lip and palate

1.61

0.63

2.8

3.8

25.55

24.54

mmol/l

—

Malignant neoplasm of other endocrine glands and related structures

1.72

0.62

1.6

3.2

24.06

25.29

mmol/l

—

Memory loss

177

1942

0.91

0.62

4.3

3.5

25.70

25.15

mmol/l

1.52

170

1882

Unspecified hairloss

0.00

0.62

0.0

3.3

—

24.86

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

0.62

0.0

3.0

—

24.16

—

Benign neoplasm: Lip

371

1.23

0.61

2.6

3.4

25.41

25.10

mmol/l

0.23

360

Use of bromocriptine

0.00

0.61

0.0

3.2

—

23.27

—

Maternal care for known or suspected malpresentation of fetus

167

1313

0.91

0.61

2.6

3.2

25.38

25.17

mmol/l

0.47

158

1250

Burn and corrosion of ankle and foot

218

1.30

0.61

7.6

3.7

24.95

25.01

mmol/l

0.03

210

Marginal zone B-cell lymphoma, including Hilmo

308

1.25

0.61

3.4

2.8

25.19

25.38

mmol/l

0.12

299

Haematosalpinx/Haematoma of broad ligament

0.00

0.61

0.0

2.2

—

24.08

—

Malignant neoplasm of eye and adnexa, including Hilmo

299

1.25

0.61

1.9

3.0

24.22

25.29

mmol/l

1.06

289

Amputation of ankle

0.00

0.61

0.0

4.0

—

23.65

—

Simple and mucopurulent chronic bronchitis

732

1.15

0.61

4.7

3.3

25.56

24.68

mmol/l

1.28

709

Burn and corrosion of head and neck

317

1.24

0.60

3.8

3.6

24.41

24.87

mmol/l

0.33

306

203

1863

1.09

0.60

5.0

3.8

23.91

25.04

mmol/l

2.99

198

1805

Postpartum haemorrhage

247

2203

0.92

0.60

2.5

3.2

25.09

25.38

mmol/l

0.92

241

2120

Other benign neoplasms of connective and other soft tissue

181

1653

1.10

0.60

3.2

3.3

25.06

25.31

mmol/l

0.44

173

1592

Acquired coagulation factor deficiency

0.00

0.59

0.0

3.4

—

23.73

—

All dysplastic lesions of the cervix uteri, vagina or vulva

384

3520

1.07

0.59

3.0

25.57

25.33

mmol/l

0.89

367

3391

Injury of muscle and tendon at hip and thigh level

189

1732

1.10

0.58

3.0

3.5

25.42

25.25

mmol/l

0.31

183

1674

Haemorrhagic and haematological disorders of fetus and newborn

201

1.29

0.58

5.3

9.8

25.07

23.97

mmol/l

1.03

189

Glucosamine medication

1222

9429

1.04

0.58

3.0

3.5

25.50

25.30

mmol/l

1.35

1196

9138

Other congenital malformations, including avohilmo

203

1868

1.09

0.56

4.4

3.7

25.67

25.16

mmol/l

1.28

195

1797

Ehlers-Danlos syndrome, including avohilmo

107

1.41

0.56

4.2

3.0

24.65

25.00

mmol/l

0.14

101

Malignant neoplasm of eye and adnexa

151

1.35

0.55

2.0

3.0

23.94

25.11

mmol/l

0.67

145

Malignant neoplasm of bronchus and lung, including Hilmo

536

4253

1.05

0.55

4.1

3.4

25.86

25.20

mmol/l

3.86

521

4114

Use of ropinirole

665

1.15

0.54

3.3

3.4

25.80

25.23

mmol/l

0.94

642

Interstitial cystitis (chronic), drug-induced

1.49

0.54

1.9

3.4

24.34

24.97

mmol/l

—

Pregnancy with abortive outcome

1194

6429

0.97

0.54

2.9

3.2

25.31

25.44

mmol/l

0.70

1152

6220

Benign neoplasm: Cranial nerves

502

0.83

0.54

3.3

3.4

25.45

25.34

mmol/l

0.08

488

Pregnancy, childbirth and the puerperium

594

3250

0.95

0.54

2.8

3.5

25.38

25.39

mmol/l

0.01

576

3150

Ehlers-Danlos syndrome

1.44

0.53

4.7

2.9

24.60

24.63

mmol/l

0.01

Malignant melanoma of skin, including Hilmo

287

3063

0.93

0.53

3.4

3.2

25.26

25.24

mmol/l

0.05

282

2954

Dysplasia of cervi uteri

306

2294

0.94

0.53

2.7

3.0

25.38

25.32

mmol/l

0.12

293

2222

Carcinoma in situ of endometrium

1.50

0.52

1.6

3.1

25.07

25.65

mmol/l

0.27

Malignant neoplasm of tonsil, including Hilmo

306

1.22

0.51

3.5

2.9

26.52

25.13

mmol/l

1.33

296

Invasive ventilation

144

1314

1.10

0.51

3.9

3.4

25.77

25.06

mmol/l

1.15

132

1266

Other articular cartilage disorders

389

1.19

0.51

2.9

3.6

25.39

24.94

mmol/l

0.33

376

Early syphilis, including avohilmo

190

0.73

0.50

3.8

3.3

25.14

24.91

mmol/l

0.13

181

Other abnormal products of conception

386

2394

1.06

0.50

2.6

3.1

25.26

25.31

mmol/l

0.10

364

2297

Biomechanical lesions, not elsewhere classified

892

0.88

0.50

3.7

3.3

25.25

25.29

mmol/l

0.04

861

Discharge from other and unspecified firearms

1.59

0.50

5.7

3.7

24.91

24.77

mmol/l

—

Disorders of orbit

689

1.14

0.50

2.9

3.1

25.60

25.35

mmol/l

0.26

659

Malignant neoplasm of tonsil and base of tongue, including Hilmo

437

1.18

0.49

5.0

2.9

26.96

25.31

mmol/l

2.43

422

Bacterial meningitis

530

1.16

0.49

3.8

3.3

25.41

25.21

mmol/l

0.16

511

Maternal care for other known or suspected fetal problems

258

1511

1.07

0.49

2.9

3.2

24.85

25.12

mmol/l

0.67

243

1444

Leiomyoma of uterus

1231

6695

1.03

0.49

3.2

3.1

25.60

25.51

mmol/l

0.41

1191

6485

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

128

1165

1.10

0.49

2.7

3.4

25.32

mmol/l

0.00

121

1126

Gender identity disorders

108

0.64

0.49

1.3

3.8

25.06

24.28

mmol/l

—

101

Ulcer of oesophagus, drug-induced

1.44

0.48

5.1

3.5

25.62

24.38

mmol/l

0.53

Other congenital malformations of ear

102

1.38

0.47

2.2

3.9

26.74

24.58

mmol/l

1.51

Atypical mycobacterium lung infection

218

1.25

0.47

3.2

3.3

27.54

24.78

mmol/l

2.50

210

Migraine, single triptan purchase ok & required. ICD-code if available is included

1418

9864

0.97

0.47

3.2

3.6

25.35

25.36

mmol/l

0.01

1375

9523

Triptan medication for migraine, single purchase ok

1418

9864

0.97

0.47

3.2

3.6

25.35

25.36

mmol/l

0.01

1375

9523

Medical treatment for female infertility

191

2038

0.93

0.47

2.5

3.0

25.48

25.22

mmol/l

0.49

174

1959

Otosclerosis

121

1328

0.91

0.47

3.4

3.3

25.09

25.39

mmol/l

0.46

114

1282

Excessive attrition of teeth

1266

12176

1.03

0.47

4.1

3.5

25.15

25.25

mmol/l

0.49

1228

11756

Other prurigo

183

1.27

0.46

4.1

3.3

25.70

25.22

mmol/l

0.25

175

Graves disease, strict definition

156

1439

1.09

0.45

2.7

3.0

25.51

25.36

mmol/l

0.22

146

1379

Other disorders of white blood cells

103

932

1.11

0.45

4.5

3.4

24.95

25.20

mmol/l

0.27

898

Malignant neoplasm of other and ill-defined sites, including Hilmo

302

1.20

0.45

3.6

2.8

24.50

25.42

mmol/l

1.01

290

Benign neoplasm: Skin of eyelid, including canthus

328

3107

1.06

0.45

3.6

3.4

25.33

25.22

mmol/l

0.27

315

3012

Poor fetal growth

121

1104

1.10

0.44

3.0

2.9

25.26

25.13

mmol/l

0.17

113

1051

Selective deficiency of immunoglobulin A [IgA]y

1.39

0.44

16.0

5.2

22.51

24.47

mmol/l

—

Benign leiomyoma with endometriosis

254

2699

0.94

0.44

2.9

3.1

25.79

25.45

mmol/l

1.02

244

2621

Alzheimer disease, including avohilmo

1126

7570

1.03

0.44

3.0

3.6

25.36

25.13

mmol/l

1.41

1081

7357

Acquired stenosis of external ear canal

185

0.75

0.44

6.2

3.4

23.96

25.03

mmol/l

0.61

176

Mesothelioma

207

0.76

0.44

3.5

3.0

25.76

25.05

mmol/l

0.47

201

Lesion of plantar nerve

106

963

1.11

0.44

3.2

3.0

25.44

mmol/l

0.01

938

Malignant neoplasm of tongue, including Hilmo

471

1.15

0.43

4.6

2.8

26.66

25.27

mmol/l

1.46

456

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

177

1647

1.08

0.43

3.4

3.3

25.27

25.31

mmol/l

0.05

170

1592

Coccidioidomycosis

0.00

0.43

0.0

2.3

—

24.23

—

Other specified diseases of spinal cord, drug-induced

0.00

0.43

0.0

3.6

—

24.43

—

Coccidioidomycosis, including avohilmo

0.00

0.43

0.0

2.3

—

24.23

—

Phlebitis and thrombophlebitis of femoral vein, drug-induced

0.00

0.42

0.0

2.9

—

24.69

—

Hydroxyapatite deposition disease

0.00

0.42

0.0

3.5

—

23.73

—

Encephalocele

0.00

0.42

0.0

2.7

—

24.63

—

Other and unspecified disorders of sclera

0.00

0.42

0.0

2.8

—

24.53

—

Malignant neoplasm of placenta, including Hilmo

0.00

0.41

0.0

1.8

—

22.76

—

Chalazion

209

1960

1.07

0.41

3.3

3.4

25.58

25.22

mmol/l

0.66

199

1879

Inhalation and ingestion of food causing obstruction of respiratory tract

168

1.26

0.41

3.8

4.1

25.00

25.08

mmol/l

0.05

162

Malignant neoplasm of other and ill-defined digestive organs

159

1.27

0.41

2.1

2.9

25.82

25.20

mmol/l

0.36

150

Inguinal or femoral hernia, bilateral

231

2452

0.94

0.41

3.5

3.8

25.30

24.97

mmol/l

0.74

221

2372

Pedestrian injured in collision with railway train or railway vehicle

0.00

0.41

0.0

2.4

—

24.12

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

108

987

1.10

0.41

2.7

3.1

25.18

25.49

mmol/l

0.46

102

960

Chronic conjunctivitis

454

0.85

0.40

3.2

3.3

26.12

25.23

mmol/l

1.06

437

Contact with lifting and transmission devices, not elsewhere classified

281

0.81

0.40

3.1

3.6

25.69

24.90

mmol/l

0.74

270

Atopic dermatitis, strict definition

449

4207

1.04

0.40

3.7

25.04

25.17

mmol/l

0.36

434

4048

Use of antiglaucoma preparations and miotics

193

1809

1.07

0.40

4.8

3.3

24.47

25.21

mmol/l

1.62

182

1760

Chronic hepatitis NAS

196

1.24

0.40

12.5

3.2

23.25

25.05

mmol/l

1.68

191

Palindromic rheumatism

160

1.26

0.39

4.5

3.2

24.92

25.05

mmol/l

0.07

155

Ulcer of vagina/vulva

363

1.16

0.39

2.3

2.9

25.11

25.48

mmol/l

0.32

352

Benign neoplasm: Peripheral nerves and autonomic nervous system

258

0.81

0.39

3.0

3.3

25.55

25.21

mmol/l

0.31

250

Horner syndrome

197

1.23

0.38

2.8

3.4

24.72

25.07

mmol/l

0.17

189

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

1.34

0.38

1.8

3.2

26.64

24.13

mmol/l

—

Inguinal hernia, bilateral

227

2403

0.94

0.38

3.5

3.8

25.30

24.98

mmol/l

0.70

217

2324

Dermatitis due to ingested food

339

1.16

0.37

6.7

5.2

24.27

24.49

mmol/l

0.24

323

Benign neoplasm: Skin of lip

216

1.21

0.37

4.8

3.1

24.94

25.14

mmol/l

0.10

208

False labour

343

2028

1.05

0.37

2.6

3.3

25.13

25.22

mmol/l

0.22

328

1944

Anti-inflammatory and antirheumatic products, non-steroids

733

3807

0.97

0.37

3.3

4.4

25.16

24.94

mmol/l

0.83

705

3676

Overjet

270

1.18

0.37

16.4

5.0

24.44

24.64

mmol/l

0.21

253

Serous carcinoma of ovary

125

0.71

0.36

1.7

2.8

24.24

25.62

mmol/l

—

119

Benign neoplasm: Connective and other soft tissue of abdomen

1.42

0.35

3.5

3.7

25.35

24.81

mmol/l

—

Neonatal jaundice from other and unspecified causes

157

1.24

0.35

5.8

10.6

24.71

23.85

mmol/l

0.56

147

Other specified/unspecified nutritional deficiencies

1.33

0.34

8.3

3.4

25.04

24.89

mmol/l

0.08

Infections with a predominantly sexual mode of transmission, including avohilmo

569

5379

0.97

0.34

4.3

3.4

25.07

25.22

mmol/l

0.51

545

5174

Retinal detachment with retinal break

285

2719

1.05

0.34

4.7

3.4

24.62

25.24

mmol/l

2.30

278

2626

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

152

0.77

0.34

6.2

10.3

24.07

23.93

mmol/l

0.06

145

Scar conditions and fibrosis of skin

548

1.12

0.34

4.2

2.9

25.78

25.45

mmol/l

0.36

528

Benign neoplasm: Female genital organ, unspecified

1.32

0.33

1.5

2.3

27.48

24.73

mmol/l

—

Tic and related disorders

100

1.30

0.33

5.4

5.0

24.46

24.91

mmol/l

0.26

Carcinoma in situ of skin of upper limb, including shoulder

592

0.89

0.33

4.7

3.3

24.30

25.25

mmol/l

1.50

570

Melanoma of uvea

192

1.21

0.33

1.5

3.3

24.24

25.27

mmol/l

0.93

186

Foreign body or object entering through skin

101

933

1.09

0.32

3.3

3.7

25.15

25.20

mmol/l

0.05

898

Malignant neoplasm of oropharynx

304

1.16

0.32

3.9

2.9

26.81

25.26

mmol/l

1.45

293

LSIL lesion of the cervix uteri

114

1227

0.93

0.32

2.9

2.8

25.53

25.38

mmol/l

0.19

109

1174

Mesothelioma, including Hilmo

262

0.83

0.32

3.7

3.1

25.69

25.16

mmol/l

0.40

255

Mumps

348

0.86

0.32

4.8

3.3

25.21

25.18

mmol/l

0.01

338

Disorders of acoustic nerve

464

0.88

0.31

3.1

3.5

25.53

25.39

mmol/l

0.11

451

Other congenital malformations of circulatory system

380

1.14

0.31

4.0

3.5

25.52

25.24

mmol/l

0.25

370

Injury of muscle and tendon at lower leg level

302

2893

1.05

0.31

4.2

3.7

25.18

25.11

mmol/l

0.14

295

2797

Diseases of external ear

802

7817

1.03

0.31

4.4

3.6

25.13

25.17

mmol/l

0.14

776

7573

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

336

0.86

0.31

7.7

3.2

24.83

25.04

mmol/l

0.13

326

Other and unspecified glaucoma

167

1577

1.06

0.30

4.2

3.3

25.11

25.22

mmol/l

0.15

156

1529

Other predominantly sexually transmitted diseases, not elsewhere classified

206

2168

0.95

0.30

3.5

3.2

25.27

25.28

mmol/l

0.02

199

2077

Erectile dysfunction

171

1807

0.94

0.30

5.0

3.8

25.08

24.88

mmol/l

0.32

162

1742

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

1.26

0.30

2.4

3.5

24.34

24.14

mmol/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

271

2594

1.05

0.29

3.5

3.3

25.04

25.21

mmol/l

0.41

261

2489

Single delivery by caesarean section

209

1132

1.05

0.29

3.0

3.7

24.59

25.05

mmol/l

1.06

198

1087

Granulosa cell carcinoma of ovary

1.28

0.28

2.6

26.37

25.46

mmol/l

—

Other and unspecified disease of Bartholin gland

428

0.88

0.28

2.8

2.9

26.06

25.64

mmol/l

0.28

417

Benign neoplasm of male genital organs

375

1.13

0.28

2.7

3.8

25.00

25.05

mmol/l

0.03

358

Other inflammation of eyelid

282

2709

1.04

0.27

3.9

3.4

25.29

25.22

mmol/l

0.16

271

2610

Cutis laxa senilis

122

1.24

0.27

2.1

3.0

24.85

25.32

mmol/l

0.15

122

Benign neoplasm: Short bones of lower limb

150

0.79

0.27

5.4

3.5

25.25

24.88

mmol/l

0.23

144

113

1.25

0.27

3.9

3.3

25.64

24.57

mmol/l

0.71

106

Normotensive glaucoma

182

1911

0.95

0.26

3.0

3.1

25.36

25.28

mmol/l

0.11

171

1862

Other secondary gonarthrosis

104

973

1.07

0.26

3.6

3.4

25.42

25.34

mmol/l

0.07

943

Malignant neoplasm of tonsil

272

1.15

0.26

3.8

2.8

26.62

25.10

mmol/l

1.23

263

Excessive earwax

1609

14341

1.02

0.26

3.2

3.7

24.96

25.29

mmol/l

4.16

1543

13916

Graves ophthalmopathy, strict

310

0.87

0.26

2.7

3.3

25.71

25.46

mmol/l

0.17

303

Cleft lip and cleft lip and palate

1.31

0.26

2.8

4.1

25.55

24.60

mmol/l

—

Chronic Coagulation defects

310

1.13

0.26

5.8

3.9

25.92

25.14

mmol/l

0.74

299

Habitual aborter

141

1.21

0.26

3.9

3.5

24.25

24.95

mmol/l

0.48

135

Thyroiditis, unspecified

207

1.17

0.25

3.8

3.1

25.91

25.25

mmol/l

0.46

201

Unspecified privation

181

1897

0.95

0.25

5.4

3.4

25.02

25.26

mmol/l

0.49

172

1822

Female infertility, cervical, vaginal, other or unspecified origin

338

2236

0.97

0.24

3.0

25.13

25.31

mmol/l

0.54

324

2164

Coxibs

691

3709

0.98

0.24

3.1

4.3

25.09

24.94

mmol/l

0.52

661

3583

Propionic acid derivatives

740

3807

0.98

0.24

3.1

4.4

25.12

24.94

mmol/l

0.61

708

3676

Congenital malformations of breast

158

0.82

0.23

2.5

2.8

25.26

24.89

mmol/l

0.16

151

Infections with a predominantly sexual mode of transmission

420

4311

0.97

0.23

4.8

3.4

25.29

25.20

mmol/l

0.20

402

4152

Loose body in joint

400

0.90

0.23

3.1

3.3

24.71

25.01

mmol/l

0.26

387

Congenital malformations of breast, including avohilmo

168

0.83

0.23

2.4

2.9

25.23

24.84

mmol/l

0.18

161

Laboratory evidence of human immunodeficiency virus [HIV]

0.00

0.23

0.0

2.4

—

25.26

—

Traumatic spondylopathy

1.26

0.23

3.4

3.6

25.44

25.07

mmol/l

—

Eccrine sweat disorders

1.26

0.23

3.4

3.5

30.26

24.84

mmol/l

—

Testicular hyperfunction

0.00

0.22

0.0

6.4

—

23.58

—

Behçet disease

1.23

0.22

2.0

3.1

25.88

24.36

mmol/l

—

Pemphigus vegetans

0.00

0.22

0.0

5.0

—

24.74

—

Pedal cyclist injured in collision with train or tram

0.00

0.22

0.0

1.0

—

25.22

—

Spotted fever [tick-borne rickettsioses]

0.00

0.22

0.0

2.1

—

24.28

—

Disorders of visual cortex

0.00

0.22

0.0

6.5

—

25.26

—

Neurological devices associated with adverse incidents

0.00

0.22

0.0

3.7

—

24.96

—

Glanders and melioidosis

0.00

0.22

0.0

2.3

—

25.15

—

Glanders and melioidosis, including avohilmo

0.00

0.22

0.0

2.3

—

25.15

—

Malignant neoplasm of meninges

0.00

0.22

0.0

4.7

—

26.40

—

Spotted fever [tick-borne rickettsioses], including avohilmo

0.00

0.22

0.0

2.1

—

24.28

—

Postpartum care and examination

127

840

0.95

0.22

3.5

3.3

25.01

25.09

mmol/l

0.10

118

804

Other protozoal diseases, not elsewhere classified/unspecified, including avohilmo

0.00

0.22

0.0

7.5

—

23.31

—

Other protozoal intestinal diseases, including avohilmo

252

0.87

0.22

9.2

2.8

23.67

25.28

mmol/l

1.62

241

Disorders of conjunctiva in diseases classified elsewhere

0.00

0.22

0.0

4.0

—

25.47

—

Malignant neoplasm of lip

156

0.83

0.22

3.1

3.0

24.90

25.47

mmol/l

0.13

149

Congenital edentulism

0.00

0.21

0.0

3.0

—

25.29

—

Chlamydial lymphogranuloma (venereum)

0.00

0.21

0.0

7.4

—

25.38

—

Operations of war

0.00

0.21

0.0

2.6

—

24.47

—

Palsy of conjugate gaze

0.00

0.21

0.0

3.8

—

24.88

—

Congenital syphilis, including avohilmo

0.00

0.21

0.0

1.8

—

23.72

—

Degeneration of iris and ciliary body

0.00

0.21

0.0

4.0

—

24.44

—

Plasmodium vivax malaria

0.00

0.21

0.0

3.9

—

24.02

—

Plasmodium vivax malaria, including avohilmo

0.00

0.21

0.0

3.9

—

24.02

—

Crushing injuries involving multiple body regions

0.00

0.21

0.0

5.1

—

25.08

—

Other congenital malformations of integument

0.00

0.21

0.0

3.5

—

25.16

—

Mumps, including avohilmo

356

0.90

0.21

4.7

3.3

25.00

25.16

mmol/l

0.09

346

Genetic anomalies of leukocytes

0.00

0.20

0.0

3.4

—

24.56

—

Chlamydial lymphogranuloma (venereum), including avohilmo

0.00

0.20

0.0

6.5

—

25.54

—

Chronic bullous disease of childhood

0.00

0.20

0.0

3.6

—

24.38

—

Carcinoma in situ of skin of other and unspecified parts of face

222

2142

1.04

0.20

5.0

3.3

24.91

25.15

mmol/l

0.49

217

2079

Unspecified pneumoconiosis

0.00

0.20

0.0

7.9

—

25.15

—

Polydactyly

0.00

0.20

0.0

6.8

—

22.74

—

Vertical strabismus

539

1.08

0.19

2.9

3.2

25.63

25.39

mmol/l

0.21

513

Malignant neoplasm of respiratory system and intrathoracic organs

524

4249

1.02

0.19

3.9

3.4

25.80

25.20

mmol/l

3.34

508

4110

Malignant neoplasm of other and unspecified parts of tongue

260

1.12

0.19

3.4

2.9

25.86

25.40

mmol/l

0.19

252

Non-small cell lung cancer, including Hilmo

361

3297

1.03

0.19

3.9

3.2

25.95

25.17

mmol/l

3.64

356

3188

Liposarcoma, including Hilmo

175

1.15

0.19

2.7

25.30

25.51

mmol/l

0.12

169

Congenital malformations of ovaries, fallopian tubes and broad ligaments

581

0.93

0.19

2.4

3.0

25.02

25.32

mmol/l

0.30

557

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

147

1.17

0.18

3.8

3.3

26.74

24.71

mmol/l

1.10

141

Use of selegiline

898

0.94

0.18

3.1

3.3

25.88

25.17

mmol/l

1.41

869

Carcinoma in situ of skin of ear and external auricular canal

358

1.10

0.18

6.3

3.3

24.37

25.08

mmol/l

0.76

342

Fall involving playground equipment

1.22

0.18

8.6

6.9

24.07

24.69

mmol/l

0.25

Glaucoma secondary to eye inflammation

138

1.17

0.18

4.3

3.3

24.69

24.57

mmol/l

0.04

131

Pedestrian injured in collision with car, pick-up truck or van

397

1.09

0.17

4.8

3.1

24.92

25.25

mmol/l

0.23

384

Injury of blood vessels at wrist and hand level

110

1.19

0.17

8.8

3.9

25.82

24.59

mmol/l

1.09

105

Ankylosing spondylitis, ICD10

142

1366

1.04

0.16

3.7

3.6

25.93

25.29

mmol/l

1.38

137

1315

Arteriovenous malformation of peripheral vessels

1.15

0.16

9.1

4.6

24.81

24.52

mmol/l

—

Non-small cell lung cancer, squamous

106

1013

1.05

0.16

4.0

3.0

26.70

25.02

mmol/l

4.57

106

973

Apocrine sweat disorders, other sweat gland disorders

1.12

0.16

4.6

2.9

26.58

25.11

mmol/l

—

Chronic diseases of tonsils and adenoids

1650

10511

0.99

0.16

3.7

3.5

25.24

25.23

mmol/l

0.02

1594

10141

Malignant neoplasm of breast, HER-negative

357

3507

0.98

0.16

3.0

3.1

25.51

25.71

mmol/l

0.57

349

3404

Other coagulation defects

126

1213

1.04

0.15

5.6

3.3

25.57

25.26

mmol/l

0.48

121

1164

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

110

1056

1.04

0.14

3.2

3.1

25.08

25.15

mmol/l

0.07

104

1020

Other disorders of breast

188

1937

0.97

0.14

3.8

2.9

25.58

25.43

mmol/l

0.25

183

1874

Malignant neoplasm of heart, mediastinum and pleura

264

0.90

0.14

4.3

3.3

25.86

24.98

mmol/l

0.99

256

Triptan medication for migraine, min. 3 purchases

890

6734

0.99

0.14

2.9

3.4

25.26

25.32

mmol/l

0.22

864

6492

Cerebral amyloid angiopathy

103

1.18

0.14

3.8

3.4

26.17

25.27

mmol/l

0.47

Inflammation of lacrimal passages (chronic)

296

1.09

0.13

3.7

3.2

25.10

24.99

mmol/l

0.07

283

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

109

0.82

0.13

2.2

2.6

24.74

25.53

mmol/l

—

104

Carcinoma in situ of breast, lobular

106

0.84

0.13

3.7

2.7

25.24

25.30

mmol/l

—

106

Sudden idiopathic hearing loss

186

1912

0.97

0.13

3.4

3.5

24.84

25.26

mmol/l

0.94

180

1854

Exposure to excessive heat of man-made origin

148

0.87

0.12

20.7

3.9

25.35

24.60

mmol/l

0.31

141

Degenerative myopia

104

1.16

0.12

5.6

3.5

24.72

24.90

mmol/l

0.06

104

Complications of labour and delivery

977

5364

1.01

0.12

3.0

3.2

25.42

25.52

mmol/l

0.41

955

5187

Other protozoal intestinal diseases

179

0.89

0.12

9.0

3.0

23.28

25.23

mmol/l

1.55

174

Caries of dentine, including avohilmo

2086

10580

1.01

0.12

3.8

3.5

25.10

25.29

mmol/l

1.64

2007

10265

Behavioural syndromes associated with physiological disturbances and physical factors

2185

14875

0.99

0.12

3.4

3.6

25.14

25.30

mmol/l

1.41

2103

14384

Transitory endocrine and metabolic disorders specific to fetus and newborn

154

0.89

0.11

5.4

10.2

24.64

23.97

mmol/l

0.26

147

HSIL lesion of the cervix uteri

203

1984

1.02

0.11

2.6

3.0

25.49

25.32

mmol/l

0.34

196

1907

Other bursitis, not elsewhere classified

146

0.89

0.10

3.3

3.1

25.86

25.09

mmol/l

0.32

140

Other hearing loss

687

6727

0.99

0.10

3.7

3.5

25.15

25.16

mmol/l

0.04

650

6517

Disorders of lacrimal system and orbit in diseases classified elsewhere

351

0.94

0.10

2.8

3.3

25.16

25.51

mmol/l

0.27

338

Labour and delivery complicated by fetal stress [distress]

215

1427

0.98

0.09

2.5

3.1

24.62

25.21

mmol/l

1.69

199

1363

Carcinoma in situ of breast

1.07

0.09

1.4

2.6

26.04

24.97

mmol/l

—

Ectopic pregnancy

218

2223

0.98

0.09

2.7

3.2

25.31

25.51

mmol/l

0.35

212

2150

Pathological resorption of teeth

566

1.04

0.09

4.5

3.2

25.84

25.09

mmol/l

0.76

547

Malignant neoplasm of other and ill-defined sites

1.06

0.08

3.3

2.9

24.55

24.80

mmol/l

—

Mesial bite

107

1.13

0.08

7.2

4.6

24.04

24.34

mmol/l

0.20

102

Kela-code for behavioural disturbances in mental retardation

144

0.90

0.08

1.7

3.1

26.55

24.90

mmol/l

0.79

139

Benign neoplasm: Skin of trunk

684

0.96

0.08

4.0

3.2

25.51

25.20

mmol/l

0.34

658

Changes in corneal membranes

0.81

0.08

2.4

3.4

23.56

24.99

mmol/l

—

Other cestode infections, including avohilmo

0.79

0.08

13.2

2.9

24.84

24.48

mmol/l

—

Scarlet fever

0.80

0.08

3.0

2.8

23.00

24.66

mmol/l

—

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

391

1.05

0.08

2.9

2.7

26.32

25.26

mmol/l

0.74

378

Acute hepatitis B

1.03

0.08

2.1

4.1

25.99

24.57

mmol/l

—

Acute hepatitis B, including avohilmo

1.03

0.08

2.1

4.1

25.99

24.57

mmol/l

—

Malignant neoplasm of penis

0.80

0.08

6.0

3.0

27.67

25.39

mmol/l

—

Sexual dysfunction

264

1.06

0.07

4.3

3.1

25.57

25.07

mmol/l

0.42

254

Carcinoma in situ of skin

189

1923

0.98

0.07

4.8

3.3

25.05

25.24

mmol/l

0.35

184

1864

Lagophthalmos

245

1.06

0.07

5.3

3.3

25.14

25.00

mmol/l

0.09

237

Other hammer toe(s) (acquired)

373

3352

1.01

0.07

3.5

3.3

25.61

25.36

mmol/l

0.81

360

3264

Anogenital herpesviral [herpes simplex] infection, including avohilmo

127

1297

0.98

0.07

3.4

3.2

24.99

25.14

mmol/l

0.28

118

1246

Macular hole

119

1165

1.02

0.07

3.5

3.1

25.39

25.43

mmol/l

0.05

113

1125

Exophthalmic conditions

177

1.08

0.06

3.0

3.1

25.19

25.00

mmol/l

0.07

172

Other superficial mycoses, including avohilmo

154

1513

1.02

0.06

3.7

3.4

25.24

25.29

mmol/l

0.06

147

1456

Circumscribed brain atrophy

396

0.96

0.06

3.6

3.4

25.93

25.16

mmol/l

0.70

383

Peroneal tendinitis

197

1.07

0.06

2.1

3.2

25.43

25.30

mmol/l

0.08

192

Other specified and unspecified disorders of lens

178

1.07

0.06

3.9

2.8

26.36

25.47

mmol/l

0.55

170

Tic and related disorders

141

0.92

0.05

5.4

5.1

24.46

24.65

mmol/l

0.10

132

Graves ophthalmopathy

344

0.96

0.05

2.8

3.3

25.16

25.42

mmol/l

0.19

337

Xanthelasma of eyelid

151

0.92

0.05

5.3

2.9

25.56

25.31

mmol/l

0.13

146

Follow-up examination after treatment for malignant neoplasms

187

1846

1.01

0.05

3.7

3.0

25.99

25.12

mmol/l

1.91

178

1782

Malignant neoplasm of other and unspecified parts of mouth

120

0.91

0.05

5.4

2.5

27.12

25.10

mmol/l

0.79

113

Malignant neoplasm of oral cavity

625

0.97

0.04

3.7

2.8

25.94

25.28

mmol/l

0.59

601

Benign neoplasm: Tonsil

201

0.94

0.04

4.4

3.2

25.34

25.10

mmol/l

0.13

195

Other disorders of amniotic fluid and membranes

134

1312

0.99

0.04

3.2

25.34

25.18

mmol/l

0.20

125

1254

Cholesteatoma of external ear

150

1.07

0.04

8.9

3.6

25.75

24.71

mmol/l

0.76

145

Other assisted single delivery

160

0.94

0.04

2.5

3.3

25.24

24.82

mmol/l

0.31

153

Maternal care for known or suspected abnormality of pelvic organs

284

1932

0.99

0.03

2.3

3.2

25.03

25.30

mmol/l

0.64

273

1855

Recurrent dislocation and subluxation of joint

885

1.02

0.03

3.2

25.37

25.14

mmol/l

0.25

854

Liposarcoma

131

1.07

0.03

3.2

2.7

24.73

25.26

mmol/l

0.31

126

Malignant neoplasm of breast, ER-negative, including Hilmo

394

3662

1.01

0.03

3.0

3.1

25.54

25.71

mmol/l

0.48

384

3556

Malignant neoplasm of bronchus and lung

455

3782

1.01

0.03

4.0

3.3

25.85

25.19

mmol/l

3.29

443

3662

All dysplastic lesions of the cervix uteri

297

2940

0.99

0.02

2.8

3.0

25.50

25.27

mmol/l

0.67

282

2826

Mucosal proctocolitis

198

1965

1.01

0.02

4.2

3.5

24.76

25.24

mmol/l

0.93

187

1895

Other deformity of hallux (acquired)

148

0.94

0.02

1.6

3.1

25.91

25.02

mmol/l

0.60

143

LSIL lesion of the cervix uteri, vagina or vulva

168

1667

1.01

0.02

3.2

2.9

25.60

25.44

mmol/l

0.28

161

1598

Benign neoplasm of ovary

291

2925

0.99

0.02

3.2

3.1

25.68

25.47

mmol/l

0.43

281

2841

Benign neoplasm: Spinal cord

212

1.04

0.02

3.2

3.5

25.57

25.12

mmol/l

0.23

204

Non-small cell lung cancer, squamous, helper endpoint

106

1071

0.99

0.02

4.0

3.5

26.70

24.90

mmol/l

5.16

106

1033

Spermatocele

159

1602

0.99

0.02

3.6

3.7

24.15

24.89

mmol/l

2.03

153

1553

Dental caries, including avohilmo

1961

10021

1.00

0.02

3.7

3.5

25.11

25.30

mmol/l

1.48

1889

9721

ILD medications: nintedanib

1.08

0.02

3.4

24.91

24.77

mmol/l

—

Benign neoplasm: Connective and other soft tissue, unspecified

177

0.96

0.01

3.4

24.50

25.17

mmol/l

0.46

172

Anogenital herpesviral [herpes simplex] infection

708

0.99

0.01

3.8

3.1

24.80

25.12

mmol/l

0.47

681

Malignant neoplasm of tonsil and base of tongue

367

0.98

0.01

3.6

3.0

26.71

25.25

mmol/l

1.45

355

Other and unspecified disorders of pigmentation

106

0.94

0.01

1.7

2.7

25.88

24.38

mmol/l

—

101

Malignant neoplasm of parotid gland

156

0.96

0.00

1.4

3.0

25.61

25.07

mmol/l

0.30

150

Malignant neoplasm of parotid gland, including Hilmo

184

1.03

0.00

1.6

3.2

24.94

25.12

mmol/l

0.09

178

Pleural plaque with presence of asbestos

175

1743

1.00

0.00

3.6

3.8

25.94

24.81

mmol/l

3.28

164

1683

Female infertility

379

2275

1.00

0.00

3.1

3.0

25.15

25.30

mmol/l

0.46

363

2202

Postmenopausal atrophic vaginitis

502

2736

1.00

0.00

3.4

3.1

25.51

25.52

mmol/l

0.04

490

2668

Pollen allergy

244

2402

1.00

0.00

3.0

3.8

25.38

25.11

mmol/l

0.70

229

2305

Failed attempted abortion

1.04

0.00

13.7

3.6

23.47

24.83

mmol/l

—

Other abnormal auditory perceptions

165

1.03

0.00

3.2

25.69

25.19

mmol/l

0.42

160

Deep bite that required surgery

146

1.03

0.00

3.7

3.1

26.45

25.14

mmol/l

0.99

137

Malignant neoplasm of tongue

355

0.99

0.00

3.4

2.8

26.01

25.39

mmol/l

0.34

342

Other nonscarring hair loss

133

0.98

0.00

1.8

2.8

24.60

25.09

mmol/l

0.12

128

Villonodular synovitis (pigmented)

122

0.98

0.00

2.0

3.3

25.60

24.93

mmol/l

0.44

117

Malignant neoplasm of nasal cavity and sinuses

128

1.02

0.00

2.3

2.7

26.08

24.86

mmol/l

0.95

123

Other disorders of breast and lactation associated with childbirth

138

1.01

0.00

2.2

3.3

25.76

24.89

mmol/l

0.98

131

Artificial joint re-operation

141

1406

1.00

0.00

4.8

3.2

25.00

25.40

mmol/l

0.60

134

1361

Tic disorders

131

0.99

0.00

5.4

4.9

24.46

24.50

mmol/l

0.02

122

Carcinoma in situ of skin, other sites/unspecified

341

1.00

0.00

5.7

3.4

26.02

25.33

mmol/l

0.69

331

Carcinoma in situ of skin of scalp and neck

669

1.00

0.00

5.8

3.4

24.60

25.04

mmol/l

0.52

645

Benign neoplasm: Prostate

136

1.03

0.00

2.6

3.4

24.16

25.15

mmol/l

0.59

128

Adenocarcinomas of cervix

0.95

0.00

2.7

24.05

25.13

mmol/l

—

Anthrax, including avohilmo

0.00

0.0

4.0

—

25.42

—

Imbalance of constituents of food intake

0.00

0.0

2.8

—

24.86

—

Mosquito-borne viral encephalitis

0.00

0.0

1.9

—

23.84

—

Miliaria, unspecified

0.00

0.0

2.0

—

24.98

—

Disorders of plasma-protein metabolism, not elsewhere classified, drug-induced

0.00

0.0

1.4

—

23.08

—

Dengue haemorrhagic fever, including avohilmo

0.00

0.0

1.4

—

24.70

—

Other hypersecretion of intestinal hormones

0.00

0.0

3.4

—

24.82

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

0.0

5.4

—

24.68

—

Delta-beta thalassaemia

0.00

0.0

4.2

—

24.93

—

Other protozoal diseases, not elsewhere classified/unspecified

0.00

0.0

8.3

—

22.67

—

Benign neoplasm: Mesothelial tissue of peritoneum

0.00

0.0

6.2

—

24.36

—

Obstetric and gynaecological devices associated with adverse incidents

0.00

0.0

1.8

—

22.76

—

Malignant neoplasm of placenta

0.00

0.0

2.2

—

22.80

—

Testicular hypofunction, drug-induced

0.00

0.0

3.0

—

25.68

—

Other chronic figurate erythema

0.00

0.0

2.9

—

23.61

—

Other specified disorders of eye and adnexa in diseases classified elsewhere

0.00

0.0

3.3

—

23.47

—

Dietary calcium deficiency

0.00

-0.00

0.0

2.8

—

24.20

—

Fetal blood loss

0.00

-0.00

0.0

8.0

—

24.94

—

Exposure to high-pressure jet

0.00

-0.00

0.0

2.4

—

23.56

—

Enophthalmos

0.00

-0.00

0.0

3.3

—

25.00

—

Bacterial vaccines

0.00

-0.00

0.0

1.4

—

24.57

—

Drug photoallergic response

0.00

-0.00

0.0

1.9

—

24.73

—

Familial dysautonomia

0.00

-0.00

0.0

3.1

—

24.04

—

Accident to nonpowered aircraft causing injury to occupant

0.00

-0.00

0.0

4.6

—

23.32

—

Echinococcosis

0.00

-0.00

0.0

7.4

—

24.61

—

Echinococcosis, including avohilmo

0.00

-0.00

0.0

7.4

—

24.61

—

Immobility syndrome (paraplegic)

0.00

-0.00

0.0

2.7

—

25.00

—

Macular hole, drug-induced

0.00

-0.00

0.0

4.4

—

25.02

—

Elastosis perforans serpiginosa

0.00

-0.00

0.0

2.8

—

26.22

—

Congenital pneumonia

0.00

-0.00

0.0

8.0

—

23.86

—

Plague

0.00

-0.00

0.0

3.1

—

24.72

—

Carcinoma in situ of other/unspecified female genital organs

0.00

-0.00

0.0

3.0

—

23.82

—

Other neonatal haemorrhages

0.00

-0.00

0.0

9.0

—

22.54

—

Systemic sclerosis induced by drugs and chemicals

0.00

-0.00

0.0

1.7

—

25.03

—

Pneumoconiosis associated with tuberculosis

0.00

-0.00

0.0

4.6

—

20.50

—

Sequelae of toxic effects of substances chiefly nonmedicinal as to source

0.00

-0.00

0.0

4.7

—

23.54

—

Traumatic amputation at neck level

0.00

-0.00

0.0

2.3

—

26.26

—

Deformity of orbit

0.00

-0.00

0.0

1.6

—

23.66

—

Ascariasis

0.00

-0.00

0.0

3.3

—

24.17

—

Disorders of other visual pathways

0.00

-0.00

0.0

7.2

—

24.18

—

Use of tolcapone

0.00

-0.00

0.0

4.3

—

23.39

—

Malnutrition in pregnancy

0.00

-0.00

0.0

1.7

—

24.79

—

Thalassaemia trait

0.00

-0.00

0.0

1.9

—

22.13

—

Carcinoma in situ, thyroid and other endocrine glands

0.00

-0.00

0.0

3.5

—

23.33

—

Anhidrosis

0.00

-0.00

0.0

4.3

—

24.19

—

Mosquito-borne viral encephalitis, including avohilmo

0.00

-0.00

0.0

1.9

—

23.84

—

Bilateral

0.00

-0.00

0.0

1.6

—

23.14

—

Other fluke infections, including avohilmo

0.00

-0.00

0.0

3.4

—

26.44

—

Trichuriasis, including avohilmo

0.00

-0.00

0.0

3.8

—

21.98

—

Taeniasis

0.00

-0.00

0.0

5.4

—

26.40

—

Other disorders of blood and blood-forming organs in diseases classified elsewhere

0.00

-0.00

0.0

3.0

—

24.36

—

Benign neoplasm: Mesothelial tissue of pleura

0.00

-0.00

0.0

5.2

—

24.52

—

Placental disorders

1.00

-0.00

2.9

3.6

25.99

25.16

mmol/l

—

Benign neoplasm: Pluriglandular involvement

0.00

-0.00

0.0

5.4

—

25.24

—

Acquired epidermolysis bullosa

0.00

-0.00

0.0

4.7

—

23.22

—

Other fluke infections

0.00

-0.00

0.0

3.4

—

26.44

—

Androgen resistance syndrome

0.00

-0.00

0.0

4.0

—

22.80

—

Diastrofic dysplasy

0.00

-0.00

0.0

2.6

—

22.77

—

Scleritis and episcleritis (ICD-9) only

0.00

-0.00

0.0

6.7

—

23.45

—

Pseudomembranous colitis, drug-induced

0.00

-0.00

0.0

2.1

—

24.11

—

Tinnitus

463

4630

1.00

-0.00

3.1

3.5

25.33

25.26

mmol/l

0.17

443

4487

Trichuriasis

0.00

-0.00

0.0

3.8

—

21.98

—

Air embolism (traumatic)

0.00

-0.00

0.0

10.8

—

25.37

—

Pulmonary haemorrhage originating in the perinatal period

0.00

-0.00

0.0

2.6

—

22.42

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Bicarbonate [Moles/volume] in Venous blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS